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ABSTRACT 
 
Ovarian tissue cryobanking is considered an available method for 
preserving female fertility and represents the best option in young 
pre-pubertal cancer patients. Cryopreservation can be performed on 
ovarian cortical fragments or on the entire organ. To move forward, 
the cryopreservation of both avascular ovarian fragments and of 
whole ovaries must be improved. To this purpose, we performed a 
detailed comparison between conventional slow freezing and 
directional freezing on both cortical fragments and whole ovary. 
We provide that directional freezing improves the viability of 
cryopreserved ovarian tissue both in whole ovaries and cortical 
fragments, but we observed a better preservation of follicles when 
the samples were frozen as entire organ. 
We also developed a perfusion system for ex vivo culture of whole 
ovary demonstrating that it is possible to maintain live sheep ovary 
outside the body for up 4 days.  This perfusion culture system could 
provide a future alternative for women at risk of ovarian 
involvement due to the threat of reintroducing malignant cells. 
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1  INTRODUCTION 
1.1 CANCER AND FERTILITY 
 
1.1.1 Cancer prevalence 
Cancer is a major public health problem in the Europe ,United States 
and many other parts of the world. In these states, one in 4 deaths is 
due to cancer. The estimated total number of cancer deaths in 
Europe in 2012 was 1.75 milion, of which 56% (976,000) were in men 
and 44% (779,000) in women [1]. A total of 2,437,163 death were 
recorded in the United States in 2009, 567,628 of these from cancer 
[2]. Cancer is the second leading cause of death, following heart 
desease, accounting for 23% of all deaths. However, within 20-years 
age groups, cancer is the leading cause of death among both men 
and women aged 40 to 79 years (Figure 1) [2]. 
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Figure 1. The first five leading causes of death by age and sex in 
United States in 2009 (from Siegel et al., 2013). 
 
There are more than 200 different types of cancer. The four most 
common cancer sites are breast cancer (464,000 cases, 13.5% of all 
cancer cases), followed by colorectal cancer (447,000, 13.0%), prostate 
cancer (417,000, 12.1%) and lung cancer (410,000, 11.9%) [1] (Figure 
2). 
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Figure 2. Ten leading cancer types for the estimated new cancer 
cases in United States in 2012 (from Siegel et al., 2013). 
 
Cancer death rates decreased by 1.8% per year in males and by 1.5% 
per year in females during the most recent 5 years of data (2005-
2009) [2]. 
 
1.1.2 Cancer prevalence in women 
There were just over 1.6 million new cases of cancer (excluding non-
melanoma skin cancer) in Europe in 2013. Breast cancer is the most 
common invasive cancer in women, affecting > 464,000 women 
annually in the Europe and accounting for 28.8% of all cancer 
diagnosed in women [1]. In women this cancer was by far the most 
frequently diagnosed neoplasm, followed by colorectal (205,000, 
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12.7%), lung (119,000, 7.4%) and corpus uteri (99,000, 6.1%) cancers 
(Figure 3 and Table 1). 
 
 
Figure 3. Distribution of the expected cases for the 5 most common 
cancer in Europe in 2012 in females (from Ferlay et al, 2013). 
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Table 1. Estimated numbers of new cancer cases (per 100,000) in 
female, by cancer site in Europe 2012. 
 
ESTIMATED NEW CASES 
SITE CASES 
Oral cavity & pharynx 25.8 
Oesophagus 10.8 
Stomach 55.4 
Colon and rectum 205.2 
Liver 20.6 
Gallbladder 17.9 
Pancreas 51.8 
Larynx 3.9 
Lung 119.2 
Melanoma of skin 53.1 
Breast 463.8 
Cervix uteri 58.3 
Corpus uteri 98.9 
Ovary 65.5 
Kidney 43.3 
Bladder 32.9 
Brain, nervous syste, 26.4 
Thyroid 40.7 
Hodgkin lymphoma 8.3 
Non-Hodgkin lymphoma 43.9 
Leukemia 35.9 
All sites but non-melanoma skin cancers 1610.5 
6 
 
1.1.3 Toxicity of cancer therapies 
Although cancer incidence rates in women less than 50 years old 
continue to increase during recent years, mortality rates are 
decreasing due to modern advances in treatment. In 1990 the 
prevalence of cancer survivors was 1 in 1,000 for young adults (15-45 
years of age). By the years 2010, as many as 1 in 250 patients in this 
age  group will have survived cancer [3]. However, increasing 
numbers of survivors are now confronted with the long-term 
consequences of exposure to these treatments. Adverse effects of 
cancer treatment include disorders of the endocrine system, cardiac 
and pulmonary dysfunction, renal and hepatic impairment, 
secondary malignant disease and phychosocial difficulties. 
Childhood and adolescence is a period of emotional and 
psychological instability, during which issues of sexuality, including 
fertility, are of particular importance. Many treatments for cancer, 
both in childhood and in later life, can impair future fertility. In fact, 
surgery, radiotherapy and chemotherapy, can have a profound 
impact of ovarian function, leading to premature menopause and 
loss of fertility. Treatment that disrupts fertility in later life can have 
a devasting effect, both at the time of therapy and whenever the 
patient wishes to start a family [4]. Therefore the effect of any 
proposed therapy is important to consider, as well as which 
strategies exist to protect or restore fertility in later life. 
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1.1.4 Gonadal toxicity after cancer treatment 
Gonadal damage in female patients treated for cancer can result 
from either systemic chemotherapy or radiotherapy affecting the 
spinal pelvic area including whole-body irradiation. Fertility can 
also be impaired as a result of cranial irradiation by disruption to the 
hypothalamic-pituitary-gonal axis. 
The risk of subfertility can be classified according to the type of 
malignant disease and its associated treatment (Table 2). 
Acute ovarian failure can occur during or shortly after completion of 
irradiation or chemotherapy [5, 6] and may be transient or 
permanent. In contrast, premature ovarian failure (POF) or 
premature menopause typically manifests after a post-treatment 
return of regular menses with subsequent loss of ovarian function 
before the age of 40 years. As expected, surgical ablation of the 
ovaries leads to immediate and permanent loss of function. 
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Low risk 
(<20%) 
Acute lymphoblastic leukemia 
Wilms’ tumor 
Soft-tissue sarcoma: stage I 
Germ-cell tumors 
Retinoblastoma 
Brain tumour: surgery only, cranial irradiation 
<24Gy 
Medium risk 
Acute myeloblastic leukemia 
Hepatoblastoma 
Osteosarcoma 
Ewing’s sarcoma: non-metastatic 
Soft-tissue sarcoma: stage II or III 
Neuroblastoma 
Non-Hodgkin lymphoma 
Hodgkin’s disease: alternating treatment 
Brain tumor: craniospinal radiotherapy, cranial 
irradiation >24Gy 
High Risk 
(>80%) 
Whole-body irradiation 
Localised radiotherapy: pelvic 
Chemotherapy conditioning for bone-marrow 
transplantation 
Hodgkin’s disease: treatment with alkylating-drugs 
Soft tissue sarcoma: stage IV (metastatic) 
Table 2. Best assessment of risk of subfertility after current 
treatment for common cancers in childhood and adloscence (from 
Wallace et al., 2005). 
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Unlike men, women only have a finite number of germ cells at birth, 
and the total diminishes with age. The human ovary has a fixed 
number of primodial follicles, at a maximum at 5 months of 
gestational age. These follicles are progressively lost with increasing 
age in a biexponential fashion, culminating in menopause at about 
age of 50 years. The rate of oocyte decline rises at about age 37 years 
when there about 25000 primordial ooyctes, and precedes the 
menopause by 12-14 years when roughly 1000 oocytes remain. 
Younger patients have more oocytes, and thus gonadal damage 
could seem to be less severe than that in older patients because the 
ovary can still support regular ovulatory cycles even with small 
numbers of follicles (Figure 4). 
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Figure 4 . Ovarian tissue after chemiotherapy. See the absence of 
primordial follicles, and the tissue fibrosis. Ematossilin-Eosin 
preparation, 10X magnification (from Lo Presti et al., 2004). 
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1.1.4.1 Effect of chemotherapy 
Chemotherapy has an adverse effect on ovarian tissue. The damage 
will depend on the agent used [7, 8], the dose [7, 9], and the age of 
the patient [9-11] (Table 3). Many drugs are gonadotoxic, including 
procarbazine, cisplatin, and the alkylating drugs such as 
cyclophosphamide, melphalan, and chlorambucil [12-17] (Table 4). 
AGE POF 
<20 years 13% 
20-30 years 50% 
> 30 years 100% 
 
Table 3.  Percentage of premature ovarian failure by age 
following chemotherapy. 
 
 
HIGH MEDIUM LOW 
Cyclophosphamide Cisplatin Vincristine 
Ifosfamide Carboplatin Methotrexate 
Chlormethine Doxorubicin Dactinomycin 
Busulfan  Mercaptopurine 
Melphalan  Vinblastine 
Procarbazine   
Chlorambucil   
 
 
Table 4. Estimated risk of gonadal dysfunction with cytotoxic 
drugs. 
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The mechanisms by which the chemotherapeutic agents cause 
ovarian toxicity vary depending on the specific actions of the drug. 
The toxic effect by cyclophosphamide seems to be mainly on the 
granulosa cells and the surrounding basement membrane [18], with 
the sensitivity being related to the size of the follicle as shown in a 
study in the mouse model [19]. A decrease in overall ovarian size, as 
a consequence of a loss of large number of follicles of various stages, 
including the pool of primordial follicles, is seen in the ovary after 
chemotherapy [20]. Chemotherapy can also provoke injury to the 
ovarian blood vessels and focal fibrosis of the ovarian cortex [21]. A 
histological study on human ovarian biopsies from women that had 
received chemotherapy demonstrated that the number of primordial 
follicle count was decreased in the group of chemotherapy-treated 
patients, with the lowest follicle count found in patients that had 
been treated with alkylating agents, such as cyclophosphamide [22]. 
It was also shown that there was a considerable fall in anti-Müllerian 
hormone (AMH) concentrations as well as partial decrease of inhibin 
B during the anti- cancer treatment, indicating damage of small and 
preantral follicles [23]. Moreover, combinations of chemotherapeutic 
drugs, regardless of whether they include alkylating agent, can also 
have detrimental effects of the ovary and its follicles. 
A recent large study of post-treatment parenthood in patients that 
had been treated for  Hodgkin’s lymphoma [24] demonstrated that 
the 10-year probabilities of achieving parenthood in Hodgkin’s 
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lymphoma patients were 55% after treatment with chemotherapy of 
low gonadotoxicity, 51% after use of chemotherapy considered to be 
of medium gonadotoxicity and 27% after use of chemotherapy 
regarded as high gonadotoxic treatment [24]. 
It has been demonstrated in studies in female mice exposed to 
cyclophosphamide that even if pregnancy is accomplished, the rate 
of spontaneous abortion and fetal malformations may be 
substantially increased [19]. In contrast, available human large 
registry studies have revealed that there is no higher risk of genetic 
abnormality, birth defects, or cancer (aside from hereditary 
syndromes) in the children of cancer survivors that had been treated 
with chemotherapy [25]. One retrospective study conducted on 
childhood cancer survivors treated by chemotherapy showed no 
significant differences in neonatal outcome between cancer survivors 
and the control group [26]. 
 
1.1.4.2 Effect of radiotherapy 
Radiation therapy can disrupt the functioning of the hypothalamic-
pituitary axis [27] or directly cause ovarian failure [6, 28, 29] (Figure 
5). The damage will depend on the field of treatment, total dose, 
fractionation schedule and age at the time of treatment [6, 30]. 
Cranial irradiation may damage the central nervous system, 
including the hypothalamic-pituitary axis leading to precious 
puberty and gonadotropin deficiency. Abdominal, pelvic and spinal 
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irradiation may directly affect the gonads, leading to infertility and 
impaired sex steroid production [31]. 
 
Figure 5. Ovarian tissue after radiotherapy. Absence of primordial 
follicles and tissue fibrousis (A); damage at oocyte structure (B); 
total damage of stromal and follicles structure (C). Ematossilin-
Eosin preparation, 10X magnification (from Lo Presti et al., 2004). 
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Disruption of the hypothalamic-pituitay-ovarian axis can lead to 
amenorrhea and infertility. Radiation-induced damage is possible 
within the hypothalamus, pituitary gland, or both, and can lead to 
dysregulation of the hormonal milieu responsible for regulation of 
menstruation and fertility. This hormonal environment is 
predominantly balanced by the secretion of gonadotropin-release 
hormone (GnRH), follicle-stimulating hormone (FSH), luteinize 
hormone (LH), estradiol, progesterone, and prolactin. 
Ionizing radiation can also cause direct DNA damage to ovarian 
follicles, leading to follicular atrophy and decreased ovarian 
follicular reserve, as shown by the Faddy-Gosden model (Figure 6). 
This can hasten the natural decline of follicles numbers, leading to 
impaired ovarian hormone production, uterine dysfunction due to 
inadequate  estrogen exposure, and early menopause. Also the 
radiosensitivity of oocyte is thought to vary during the growth 
phase. In fact, the susceptibility to radiation-induced cell death 
depends on the developmental stage of the germ cell at the time of 
exposure. The oogonia in prenatal life that are undergoing mitosis 
are highly susceptible to radiation induced cell death. As the cells 
pass through the stages of meiotic division, resistance to radiation 
damage generally increases. Although  the radiosensitivity of the 
oocyte varies during the growth phase , primordial follicles are 
thought to be more resistant than maturing follicles [31]. 
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Figure 6. Faddy-Gosden model. The solution of the Faddy–Gosden 
equation enables the size of the oocyte pool to be determined for 
any given age from birth to menopause, at an estimated age of 51 
years.Graph shows the calculation of an estimated surviving 
fraction for a patient treated at age 10•5 years with whole-body 
irradiation (14•4 Gy) who developed ovarian failure at age 13 
years, which was 0•56% (from Wallace et al., 2005). 
 
A recent mathematical model employed by Wallace et al. suggested 
that the dose required to destroy 50% of the immature oocytes 
(LD50) is less than 2Gy [29]. Therefore, the authors demonstrated 
that it is possible to predict the age at which ovarian failure is likely 
to develop after radiation to a field that includes the ovary in women 
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treated for cancer. They have shown that the effective sterilizing 
dose (ESD), or dose of fractionated radiotherapy [Gy] at which 
premature ovarian failure takes place immediately after treatment in 
97.5% of patients, falls with increasing age at treatment. The 
estimated ESD at birth was 20.3 Gy; at 10 years, 18.4 Gy; at 20 years, 
16.5 Gy, and at 30 years, 14.3 Gy (Figure 7). The wide individual 
variability in ovarian follicular reserve at time of treatment can 
explain differences in onset of premature ovarian failure between 
patients treated at similar ages. 
 
Figure 7. Risk of developing acute ovarian failure, defined as 
ovarian failure whitin 5 years, stratified by age and radiation dose 
to the ovary (from Wo et al., 2009). 
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1.1.5  Current fertility preservation options 
A diagnosis of cancer is a life crisis for any person. Its impact varies 
with the type of cancer; treatment prospects; and the physical, 
emotional, and social resources of the patient. Younger persons face 
the additional potential loss of reproductive function and the 
opportunity to have children. Surveys of cancer patients reveal a 
very strong desire to be informed of available options for fertility 
preservation and future reproduction [32]. At the same time that 
patients (and their parents in cases of minors) receive a diagnosis of 
cancer, they must also consider possible effects on fertility. The 
options of fertility preservation in women are more than in men , but 
all are more intrusive, depend on the patient’s age, type of 
treatment, diagnosis, whether she has a partner, the time available 
and the potential that cancer has metastasized to her ovaries [33]. 
Established fertility preservation methods recognized at this time for 
female patients include shielding to reduce radiation damage to 
reproductive organs, fertility-sparing surgery and embryo 
cryopreservation following ovarian stimulation with gonadotropins 
and In Vitro Fertilization (IVF) (Figure 8). 
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Figure 8. Strategies for fertility preservation in female patients 
(from Rodriguez-Walberg 2013). 
 
All remaining options are still considered experimental. There have 
been technical improvements in methods for cryopreservation of 
oocytes after ovarian stimulation in the recent years resulting in an 
increasing number of pregnancies and children born worldwide 
after fertilization of frozen-thawed oocytes, however, overall 
pregnancy rates are still relatively lower than those with embryo 
freezing [34, 35]. There is also the option of retrieving immature 
oocytes without stimulation aiming at maturing them later in vitro, 
which has been developed in few centers worldwide [36]. The 
remaining option of freezing gonadal tissue is typically offered 
when there is insufficient time for ovarian stimulation and it is the 
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only option than can be offered to pre-pubertal girls. The ovarian 
tissue of whole ovary are usually retrieved through laparoscopy and 
it is aimed for future re-transplantation or for in vitro follicle culture, 
both techniques still in development (Figure 9). 
 
 
Figure 9. Current options for fertility preservation by 
cryopreservation and assisted reproductive techniques in adult 
and in prepubertal females (from Rodriguez-Walberg 2013). 
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1.1.5.1 Ovarian transposition 
Shielding to reduce radiation to the reproductive organs when 
possible, is the standard medical procedure currently offered to 
female patients. When shielding of the gonadal area is not possible, 
the surgical procedure that moves the ovaries out of the radiation 
field, known as oophoropexy or ovarian transposition, may be 
considered. This procedure was initially described by laparotomy 
but it may be also carried out laparoscopically [37-40]. Briefly, the 
ovary and fallopian tube are dissected from the uterus, mobilized 
out of the pelvis, and ligated to the peritoneum as high and laterally 
as possible (Figure 10) [41]. 
 
Figure 10. Ovarian transposition procedure 
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The most common indications for this procedure have been 
gynecological cancers such as cervical and vaginal cancer that 
include pelvic irradiation without oophorectomy in their treatment 
protocols. Pelvic irradiation may also be indicated in the treatment 
of pelvic and abdominal Hodgkin’s disease or sarcomas and ovarian 
transposition may be a fertility preserving option in selected cases. 
There is a great variation in the reduction of risk of ovarian failure 
by ovarian transposition (16–90%) and about 50% of those patients 
may retain some menstrual function and fertility. Failure of this 
procedure is related to scattered radiation and damage of the blood 
vessels that supply the ovaries [25]. 
 
1.1.5.2 Hormonal Protection by Ovarian Activity Suppression 
Ovarian protection from gonadotoxic treatment with GnRH agonists 
is still controversial. The idea of maintaining the ovarian metabolism 
quiescent to avoid any damage caused by oncologic treatment is still 
to be confirmed, and there are doubts about whether GnRH agonist 
administration has a potential beneficial effect on ovarian tissue 
because of the lack of FSH receptors on primordial follicles. The 
observation was made that prepubertal girls had lower rates of 
ovarian failure after chemotherapy and radiation therapy than post-
pubertal patients. With this in mind, some postulate that continuous 
GnRH exposure leads to downregulation of the pituitary and 
induction of a prepubertal state. This ovarian quiescence during 
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cancer treatment might decrease susceptibility to gonadotoxic 
treatments. While some data in monkeys [42, 43] and in small, non-
randomized clinical studies [44, 45] show benefit with GnRH 
therapy, one prospective randomized trial [46] showed no benefit. 
Primordial follicles in humans do not have follicle-stimulating 
hormone (FSH) receptors, so suppression of FSH with a GnRH 
agonist theoretically would not be protective. Younger patients may 
be less susceptible to chemotherapy because they have a greater 
number of oocytes, not because their ovaries are quiescent during 
chemotherapy. 
 
1.1.5.3 Embryo cryopreservation 
Embryo cryopreservation is currently the only highly successful 
method of preserving fertility for female cancer patients but this 
option requires the patient to be of pubertal age, have a partner or 
use donor sperm, and be able to undergo a cycle of ovarian 
stimulation, which is not possible when the chemotherapy has to be 
initiated immediately or when stimulation is contraindicated 
according to the type of cancer. This strategy requires that the 
patient undergos ovarian stimulation for the in vivo maturation of 
oocytes and subsequent retrieval of mature oocytes prior to initiation 
of cancer therapy. The oocytes are fertilized on the day of egg 
retrieval and the resultant embryos are cryopreserved. At the time of 
the patient’s choosing, embryos can be thawed and transferred into 
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either the patient’s own uterus, providing that her uterus is viable 
for pregnancy, or that of another woman (gestational surrogate).  
The basic technologies necessary for embryo freezing are in clinical 
use throughout the world on a daily basis and reported survival 
rates per thawed embryo range from 35% to 90%, implantation rates 
from 8% to 30%, and cumulative pregnancy rates of 30-40% [47, 48]. 
However, this procedure may not be an option for women with 
highly aggressive malignancies, including leukemia, some 
lymphomas, and sarcomas, which warrant immediate cancer 
treatment [49]. Successful ovarian stimulation requires several weeks 
to months depending on the response of the patient to the 
stimulation protocol, which may compromise the patient’s long-term 
outcome. Many cancer patients do not respond well to the standard 
IVF stimulation protocols, which may result in decrease quality 
and/or quantity of oocyte collected during the cycle [50, 51]. In 
addition, ovarian stimulation is associated with high-serum estrogen 
concentrations. In fact, during conventional gonadotropin-
stimulated ovulation induction for IVF, it is hoped that a minimum 
of around 4, and ideally about 10–15, dominant follicles develop. 
Generally, the actual number of mature follicles attainable decreases 
with declining ovarian reserve. During the process of ovulation 
induction, the development of multiple dominant follicles may give 
rise to substantial increases in ovarian estradiol production due to 
increased granulosa cell number. In these situations, circulating 
25 
 
estradiol concentrations may exceed 3,000 pg/ml . This is 
substantially greater than that of a natural, unstimulated ovulatory 
cycle with peak estradiol levels of about 300 pg/ml. This can be a 
concern for women with estrogen-dependent cancers such as certain 
breast cancers and benign diseases such as endometriosis [52]. A 
strategy to successfully induce ovulation for IVF in these women 
without producing high estradiol levels has been described [53, 54]. 
It involves adding an aromatase inhibitor to the usual gonadotropin-
based ovarian stimulation protocol. Aromatase inhibitors prevent 
the formation of estrogen from androgen precursors and resultant 
serum estradiol levels are substantially reduced compared with 
conventional IVF stimulation and can actually be less than that seen 
in a natural cycle. Finally, ovarian stimulation is often not 
considered ethically appropriate for prepubertal females, and the 
requirement for a partner or sperm donor makes embryo 
cryopreservation undesirable for single women who prefer not to 
use sperm donor. 
 
1.1.5.4 Oocyte cryopreservation 
Oocyte cryopreservation is an alternative option for patients with 
the same characteristics as those described above for embryo 
cryopreservation but who are not with a partner and do not wish to 
use donated sperm. In this case, IVF of their oocytes to produce 
embryos to be frozen for future implantation is not possible. Thus, 
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the oocytes themselves must be cryopreserved either as mature or as 
immature oocytes. Human oocyte cryopreservation has been rapidly 
incorporated into clinical practice in several centers [55-57]. 
Mature oocyte freezing appears, at least in theory, to be the most 
logical way of storing female germ cells, comparable to the routinely 
performed sperm banking. It is an attractive option for women 
without a partner, if they have time to complete ovarian stimulation 
before cancer therapy. However, ovarian stimulation and oocyte 
collection are not applicable for children [53, 58, 59]. 
The first live birth with mature oocyte cryopreservation was 
reported in 1986 [60],  but due to very low success rates (<2%) there 
were only five live births reported using this technique for over a 
decade [34]. Oktay et al., hypothesized that this low rate was derived 
from the fact that the metaphase II (MII) oocyte is a large and highly 
specialized cell that is extremely fragile [34] (Figure 23). 
In 1997, intracytoplasmic sperm injection (ICSI) was first used to 
fertilize frozen-thawed oocytes [55], circumventing zona pellucida 
hardening caused by the premature exocytosis of the cortical 
fragments induced by cryopreservation process. 
Although micromanipulation techniques helped improve 
fertilization of cryopreserved oocytes, further optimization of oocyte 
cryopreservation required another decade. In 1999, the first live birth 
with oocyte cryopreservation after vitrification was reported [61] 
followed by only a few case reports and clinical studies up until 2005 
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[34]. At that time, there were approximately 100 reported live births 
from oocyte cryopreservation; these were reviewed in a meta-
analysis [34] which concluded that success rates with oocyte 
cryopreservation using slow freezing were lower than that of IVF 
with fresh oocytes. 
A comparison between slow freezing and vitrification on oocyte 
freezing showed that  that vitrification was more successful in terms 
of both embryological and clinical outcome [62] and although the 
efficiency of slow-freezing protocols has also been improved [63-69], 
the reported success rates remained lower compared with 
vitrification. 
With the improvements in oocyte cryopreservation technology and 
associated clinical outcomes, its clinical applications widened, 
resulting in more than a thousand live births reported to date [70, 
71]. Over the past 5 years, oocyte cryopreservation, especially with 
vitrification, has proven to be an efficient technique, resulting in 
pregnancy outcomes similar to that of IVF with fresh oocytes. As a 
results of this progress, the American Society of Reproductive 
Medicine has recently stated that mature oocyte cryopreservation 
should no longer be considered experimental for medical 
indications, outlying elective oocyte cryopreservation. 
To circumventing the problem of hormonal stimulation in sensitive 
cancer and spindle damage in mature oocytes, cryopreservation of 
immature oocytes has been undertaken. Oocytes at the diplotene 
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stage of prophase I, or germinal vesicle (GV) stage, survive the 
cryopreservation procedure better than those frozen at the MII stage 
[72]. These cells have reached full size and complete meiotic 
competence but have not yet resumed their maturation process and 
initiated their second metaphase. Although the risk of hardening of 
the zona pellucida or damage to the cytoskeleton cannot be avoided, 
it is probable that the absence of a meiotic spindle and the presence 
of a nuclear membrane protecting the chromatin guarantees the 
absence of cytogenetic anomalies during further cellular divisions 
(Figure 11). 
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Figure 11. Germinal vesicle (A) and metaphase-II (B) human 
oocytes vary in critical cellular features, and thus perhaps in their 
ability to withstand cryoinjuries. At the germinal vesicle stage 
(prophase-I), oocytes have an intact nucleus with partially 
condensed chromatin and microtubules characteristic of 
interphase; in contrast, metaphase-II oocytes contain a meiotic 
spindle with dynamic microtubules and condensed chromosomes 
(IVM: in vitro maturation; pb: polar body) from Combelles et al., 
2012). 
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The immature oocyte may be used in one of two ways: 1) the GV 
stage oocyte undergoes in vitro maturation (IVM) and is then 
frozen/cooled or 2) the GV stage oocyte is cryopreserved and upon 
thawing/warming it undergoes IVM (Figure 12). 
 
 
 
Figure 12. Diagram depicting how immature oocytes may be used 
for fertility preservation and restoration. Immature germinal 
vesicle (GV) stage oocytes can either be in vitro matured prior to 
cryopreservation or cryopreserved before in vitro maturation 
(IVM) to metaphase-II (M-II), followed by fertilization with 
intracytoplasmic sperm injection (ICSI) (from Combelles et al., 
2012). 
 
Freezing immature oocytes followed by in vitro maturation thus 
offers practical and theoretical advantages [73], but this method is 
still suboptimal. Frozen–thawed immature oocytes have to follow a 
process of in vitro maturation before they are ready to be fertilized. 
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Oocyte maturation is considered as the reinitiation and completion 
of the first meiotic division from the GV stage to the MII stage, and 
the accompanying cytoplasmic maturation phase for fertilization 
and early embryonic development [74]. The coordination of nuclear 
and cytoplasmic maturation in vitro has proved very difficult to 
achieve. Although there are several reports of pregnancies achieved 
after in vitro maturation of fresh GV-stage oocytes [75, 76], only one 
live birth has resulted from an immature oocyte cryopreserved at the 
GV stage, with subsequent in vitro maturation [77]. In conclusion,  
the cryopreservation of GV stage oocytes will not be a practicable 
strategy until in vitro maturation of these oocytes becomes more 
reliable [78]. 
 
1.1.5.5 Ovarian tissue banking 
Ovarian tissue banking is the only viable option in prepubertal girls 
because sexual maturity is not required. As this procedure does not 
cause any significant delay to initiation of cancer treatment and it 
does not require ovarian stimulation [58, 79-82], some adult patients 
also prefer to preserve fertility by this method. In adults, however, 
this option is mainly indicated when there is a lack of time available 
for ovarian stimulation and whenever a hormonal stimulation 
treatment is contraindicated by medical reasons. Ovarian tissue 
banking has several theoretical advantages over other fertility-
preserving strategies: 1) ovarian tissue may contain hundreds of 
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oocytes [83]. Thus, cryopreservation of ovarian tissue is a potentially 
more efficient method of storing reproductive potential; 2) unlike 
collection of oocytes and production of embryos, which require 
time-consuming hormonal stimulation, oophorectomy does not 
delay cancer treatment; 3) primordial follicles consist of immature 
oocytes surrounded by a single layer of flattened pre-granulosa cells. 
These oocytes are much smaller, metabolically less active, and are 
not arrested at a stage where the spindle is present. All of these 
characteristics may make them better suited for cryopreservation 
than mature metaphase II oocytes; 4) the immature oocytes within 
the ovarian tissue would be matured much later in life, thereby 
obviating the need for exogenous gonadotropin stimulation. Thus, 
ovarian tissue banking is appropriate for prepubertal girls. 
Ovarian tissue banking has its disadvantages as well: 1) surgery is 
required to obtain the ovarian tissue; 2) ovarian tissue is theoretically 
difficult to freeze because of its heterogeneity. Each cell type that 
comprises ovarian tissue (oocytes, granulosa cells, interstitial cells) 
has unique biological characteristics that require different freezing 
protocols; 3) oocytes within ovarian tissue are immature, and require 
maturation before fertilization can occur. Follicles within ovarian 
tissue are arrested in early meiosis and cannot be fertilized. 
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1.2 CRYOBIOLOGY 
 
1.2.1 Hystorical background 
Cryopreservation originates from the Greek word “kryos”, which 
means “cold or frost”, it indicates storage of cells or tissue, usually in 
liquid nitrogen, at temperatures below -130°C. The lowest natural 
temperature on earth is -80°C. Under normal pressure, the inert gas 
nitrogen which is commonly used in cryopreservation becomes a 
liquid at -196°C. 
A small number of species like various fish, frogs and insects can 
survive at low temperature using two different biological principles 
or a combination of these. The first process is cell dehydration, 
which reduces the freezing point secondary to a concentration of 
solutes. The other mechanism is by endogenous production of 
special antifreeze molecules, like sugars, which prevent formation of 
large ice crystal. However, recent studies provide the first 
demonstration that freeze tolerance can also occur amongst 
vertebrate species. A freeze tolerance vertebrate would make an 
excellent model system for studies of the medical cryopreservation 
of tissues and organs. 
The main goal of the cryopreservation procedure is to minimize 
tissue injury from low, subzero temperatures [84]. The storage at a 
low temperature can continue for decades and the only theoretical 
limitation of storage time is influence by cosmic radiation, which 
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over several thousand years would degrade the genome of the 
cryopreserved cells. This factor can be neglected in any practical 
work of cryopreservation in our society. In other words, by usage of 
cryopreservation the biological clock can be halted for an unlimited 
time [85]. 
The term cryobiology refers to the knowledge and understanding of 
the effects of low temperature on cellular system and the utilization 
of this information to develop improved cryopreservation protocols. 
The science of cryobiology can be considered to have its starting 
point about 70 years ago [86]. At that time, Luyet tried to achieve 
cryopreservation by cooling epidermal plant cells quickly and 
published a monograph about his pioneer work in 1940 (Luyet, 
1940). Three years later a scientist from England succeeded in 
cryopreservation of human and fowl spermatozoa, using glycerol as 
the agent that would protect against freezing injury (Polge et al. 
1949). 
The studies of cells and organ freezing have increased considerably 
since then and in particular in the clinical area of reproductive 
medicine [87]. The cryopreservation technique may also expand into 
transplantation surgery. The possibility of organ storage and future 
transplantation was early also recognized by the pioneering liver 
transplantation surgeon Thomas Starzl (Starzl 1970) and it may well 
be that the technique of cryoperservation may be routinely used in 
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the future to store organs that are retrieved and where a suitable 
recipient cannot be found at that moment. 
 
1.2.2 Fundamental cryobiology 
The cells are constituted of mostly water, which makes up 60-85% of 
the cell volume [88]. In addition to free water, biological systems also 
contain “bound “water molecules. The “bound“ water molecules are 
intimately hydrogen-bonded to the atoms within molecules are such 
as proteins, RNA, DNA or membrane phospholipids head groups. 
These water molecules form a substantial coat around the biological 
molecule and are essential to maintain cells structure and function 
[84] (Figure 13). The “bound” water molecules are incapable of 
freezing [89]. Thus, water plays an important role in cryobiology 
since at cooling to low subzero temperature, 90% of water in a cell 
will convert into ice [88] and the 10% of bound water will not freeze. 
 
36 
 
 
Figure 13.  Figure illustrates how water molecules can be either 
free or bound to larger molecules of the cell. 
 
Cell is in osmotic equilibrium, which means that concentration of 
any solution inside and outside the cell are the same, since the cell 
membrane is semipermeable. In the other words, water moves in or 
out of the cell depending on changes in solution concentration 
outside the cell and permeability of the cell membrane (Figure 14), 
which vary for each specific cell type. 
In addition to passive diffusion through the membrane lipid bilayer 
[90], water moves through water transport pores known as 
aquaporins [91]. These active transport proteins can transport water 
up to 100 fold more efficient than passive  diffusion. Also, 
permeability is temperature dependents [92], so that permeability is 
higher with increasing temperature. 
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Osmotic stress is defined as shrinkage and swelling of a cell due to 
osmotic differences between the inside and outside of the cell. When 
these changes are large it may lead to major damage of the cell and 
in the worst scenario to cell death. 
 
Figure 14. The figure illustrates the principles of osmotic 
equilibration. Water molecules move from compartment of lower 
concentration to a compartment of higher concentration, to 
equalize the concentrations. 
 
 
In pure water, the highest temperature at which ice can form at 
normal pressure is 0°C, but ice nuclei form only very reluctantly at 
this temperature, with the result that nuclei do not usually form 
until the temperature falls below 0°C. In fact, ice in general forms at 
temperatures between -5 and -15°C; through spontaneous or 
induced (by seeding) ice nucleation. Once an ice nucleus has formed, 
further water molecules can very rapidly bond onto this frozen 
surface, allowing it to grow in size. 
When the ice forms there is a release of heat (the latent heat of fusion 
or crystallization), as the change from liquid to crystal releases 
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energy. The amount of energy released may be considerable and 
commonly brings the temperature of the whole sample back up to 
0°C. With pure water the temperature will remain at 0°C until the 
freezable water has formed ice, after which it will re-equilibrate with 
the ambient temperature. Following the crystallization of pure 
water, very little remains unfrozen even at temperatures as high as 
±5°C (>80% ice) or ±10°C (>90% ice) state [84]. 
To thaw all this ice the temperature has to rise above the freezing 
point. Pure water therefore melts at 0°C, the same as the highest 
temperature at which ice crystals can first form. During the thawing 
process, the change from crystal to liquid requires energy energy 
input. The solution which remain free on ice in a temperature below  
freezing point is in a supercooled state [84]. 
It is well established that cell survival rate during cryopreservation 
depends mostly on the cooling rate  [93]. In extensive studies of 
survival of yeast cells and human red blood cells, as a function of 
cooling rate, it was showed that a curve of survival versus cooling 
rate exhibited the shape of an inverted U (Figure 15). This curve can 
be interpreted as the resultant of two different mechanisms of which 
one damages living cells at high cooling rates and the other damages 
at low cooling rates. If the rate is too fast or too slow, the cells do not 
survive and balancing these two cryoinjuries is the key to success 
[93]. 
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Figure 15. The U shape. The survival of frozen cells is a function of 
cooling rate 
 
1.2.3 Cryoprotectant solutions 
Adding salts and other solutes to pure water lowers the temperature 
which ice forms/melts. There is no limit to how low the 
freezing/melting point can be depressed by solutes, with the result 
that solutions with very high concentrations may never form ice, 
rather they will solidify into an ice-free (vitreous) state. Even when 
salts and solutes are present, they rarely become incorporated into 
the ice crystals themselves, because of the very specifc shape and 
bonding requirements of the growing ice crystals. Molecules other 
than water molecules are instead excluded from the growing ice 
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crystals, and tend to accumulate between crystals or are physically 
pushed ahead of an advancing ice front. The formation and growth 
of ice crystals can, however, be modifed by compounds such as 
antifreeze proteins [94], ice blocking agents [95] and cryoprotectants. 
Many chemicals have been recognized as having a cryoprotective 
function and these are known as “cryoprotecting agents” (CPAs). 
During the freezing process, CPAs can serve several functions 
including lowering the freezing point, binding water to prevent it 
freezing at zero degree and decreasing membrane damages [96]. 
According to their ability to transport through cell membrane, CPAs 
can be divided into two categories, permeable and non-permeable. 
Permeable CPAs can diffuse trough cell membrane and non-
permeable CPAs do not enter the cytoplasm. 
Permeable CPAs are small, non-ionic molecules with low toxicity 
and high solubility in water. The rate of CPA permeation and 
dilution is determined by the species, cell type and stage of 
development, solution composition, temperature and hydrostatic 
pressure [84, 97]. The most commonly used permeable CPAs are 
DMSO, propylene glycol (PROH) and ethylene glycol (EG). The 
exact mechanism by which these permeable CPAs protect living cells 
from cryoinjury is not completely understood. However, their 
general mechanisms seem to be by lowering the freezing point by 
replacement of some of the bound water molecules in and around 
proteins, deoxyribonucleic acid and head groups of phospholipids 
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[84]. Moreover, the permeable CPAs stabilize cellular proteins in the 
cytoplasm as well as in the cell membrane [98]. At entrance into the 
cell, they also reduce the concentration of electrolytes by lowering 
the amount of ice formed at a given temperature [99]. 
Non-permeable CPAs are usually long-chain polymers that are 
soluble in water and increase the osmolality of the solution. The 
most frequently used non-permeable CPAs are disaccharides 
(sucrose, glucose, fructose, sorbitol, saccharose, trehalose), some 
macromolecules (polyvinilpyrrolidone, polyvinyl alcohol, Ficoll) and 
proteins (bovine serum albumin; BSA). They contribute to cell 
dehydration, counteract osmotic stress and reduce the toxicity of 
permeable CPAs [100]. 
 
1.2.4 Cryopreservation techniques 
There are two principally different cryopreservation procedures: 
vitrification and slow freezing.  Recently, a new directional freezing 
technology was introduced [101, 102] which provides identical 
cooling rates through the specimen being frozen and it is aimed to 
cryopreserve whole organs. All three procedures include four 
common steps: exposure of the samples to CPA, freezing/cooling to 
the storage temperature (-196°C), thawing/warming and CPA 
removal. The terms “freezing and thawing” relate to the slow and 
directional freezing procedures whereas “cooling and warming” are 
more correct in relation to the vitrification procedure. 
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1.2.4.1 Vitrification 
The term vitrification originated from the Greek word “vitri”, which 
means “glass”. Vitrification is a procedure in which 
solution/specimen solidifies to form a glasslike, or vitreous, state 
without any ice crystal formation during cooling and remains in this 
state throughout the warming step [84]. 
The main idea of ultrarapid cooling is to pass rapidly through the 
critical temperature zone where the cells are most sensitive for 
chilling injury [97]. To achieve this glass-like solidification, high 
cooling rates are used in combination with high concentrations of 
CPA that interact strongly with water molecules to prevent ice 
formation , are used. In general, the rate of cooling/warming and the 
concentration of the cryoprotectant required to achieve vitrification 
are inversely related. Typically, the temperature is reduced directly 
from 0°C to -130°C by plunging the sample into LN. Cooling rate at 
vitrification varies in the range of 2,500 to 30,000°C/min or greater. 
However, one has to take into account that every cell seems to 
require its own optimal cooling rate. Also, the natural state of liquid 
water inside living cells is retained during vitrification [103], leading 
to minimal disturbance within the cryopreserved sample. A sample 
that will be vitrified is exposed to CPA at the same manner as during 
slow freezing, but the vitrification procedure requires higher 
concentration of CPAs to achieve high cooling rate. Warming after 
vitrification is usually also fast. A major potential drawback of 
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vitrification is the use of high concentration of cryoprotectant, and 
an unintentional negative impact of these cryoprotectants in turn can 
be their toxicity, which may affect the cell or tissue. 
Vitrification has been recommended as the method of choice for 
oocytes or embryos. All developmental stages of human embryos 
cultured in vitro have been successfully vitrified and warmed, with 
resulting offspring.  In 1999 and 2000 successful pregnancies and 
deliveries after vitrification and warming of human oocytes were 
reported [61]. Since that time, and because it seems to be that both 
entities appear to be especially chill-sensitive cells in assisted 
reproductive technology (ART), oocytes and blastocysts seem to 
receive a potentially significant boost in survival rates by avoiding 
ice crystallization using vitrification. 
Vitrification is very simple, requires no expensive programmable 
freezing equipment, and relies especially on the placement of the 
embryo in a very small volume of vitrification medium (refered also 
as “minimal volume approach”) that must be cooled at extreme rates 
not obtainable in traditional enclosed cryo-storage devices such as 
straws and vials. The importance of the use of a small volume, also 
referred to “minimal volume approach“ was described and 
published in 2005 [85, 104]. In addition, recent publications have 
shown the dominance of warming rate over cooling rates in the 
survival of oocytes subjected to a vitrification procedure [105, 106]. 
Vitrification has also been proposed for cryopreserve whole organs. 
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However, there is evidence that a large tissue or whole organ will 
require slow cooling rates [107]. In fact, fractures of the organ could 
be caused by vitrification and warming procedures, and 
devitrification if the storage temperature is above the glass transition 
temperature [108]. The problem is eliminating or sufficiently limiting 
ice formation throughout the large organs without inducing 
unacceptable toxicity caused by high doses of CPA [108, 109] (Figure 
16). 
 
 
Figure 16. The effect of volume, cooling rate and CPA 
concentration on the probability of ‘glass’ fractures (form Arav et 
al., 2002). 
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1.2.4.2 Conventional  freezing 
Conventional slow freezing is a method which aims to have a 
protocol that is slow enough to dehydrate the cells in order to 
prevent intracellular crystallization and fast enough to minimize 
osmotic stress to the cells [110]. The conventional cooling procedure 
is usually ended when the temperature lies between -30°C and -80°C 
and after the sample can be plunged into LN [84]. When applied on 
cells the conventional freezing method reduces the likelihood of 
intracellular ice formation by initiation of extracellular ice crystal 
formation at a high subzero temperature. The freezing rate is then 
responsible for how fast the extracellular ice crystals will grow. The 
extracellular ice draws water out of the cell until little amount of free 
water remains and only small (non-lethal) ice crystal has been 
formed [111]. The best outcome of this cryopreservation method is 
obtained when the rate of freezing allows equilibrium between cell 
dehydration and the rate at which water is integrated into 
extracellular ice crystals. 
The rate of dehydration, which is the movement of water outward 
across the cell membrane, depends on the cooling rate that is 
determined by temperature drop in relation to time. Thus, the 
movement of water through the cell membrane decreases as a 
consequence of lower temperature [112]. 
It is important to emphasize that in this procedure, the cooling rate is 
dependent on the size and permeability of the specific cells/tissue to 
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be cryopreserved. When trying to freeze a large tissue or a whole 
organ with conventional freezing, one of the major problems is that 
cooling rates will vary across the samples depending on the 
geometry (surface, depth, and volume) and heat conductivity. In 
fact, the conventional slow-freezing method involves lowering the 
temperature of the chamber in a controlled stepwise manner. This 
method is based on using multidirectional (equiaxial) heat transfer 
to achieve a rate of temperature change in the sample that depends 
on the thermal conductivity and geometrical shape of the container 
and of the biological material within it [98, 113-115]. The thermal 
gradient within the sample is determined implicitly by the 
temperature of the chamber and the thermal conductivity of the 
materials of the sample, and is not directly controllable. 
Furthermore, the ambient temperature gradients within the freezing 
chamber and the unreliability of temperature recording 
measurements add to the difficulty of achieving the optimal cooling 
rate. 
One of the major problems that occurs during cryopreservation of 
large tissue using conventional freezing is the released of latent heat 
when crystallization occurs. There are two problems regarding latent 
heat release. The first problem is that the heat is transferred to colder 
areas in which the ice is just formed and so it could possibly re-
warm the ice and cause local melting (Figure 17). 
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Figure 17. Release of latent heat. See the temperature differences 
between the core and the surface of the sample and between 
sample and the freezing chamber. 
 
The second problem is that the isothermal period. When samples of 
large volume with relatively surface/volume are frozen, the release 
of latent heat may cause a long isothermal period in the material 
being frozen. At the same time, the temperature in the freezing 
chamber or on the surrounding medium is lowered, increasing the 
temperature different between the sample and its surrounding 
(Figure 17). Consequently, since the thermal conductivity of water 
(0.6) is lower than that of ice (1.6), when latent heat is no longer 
released, the temperature in the material being frozen will drop very 
quickly to a temperature close to the temperature of the surrounding 
environment (Figure 18). This might lead to a non-optimal cooling 
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rate and possibly to cellular damage trough intracellular 
crystallization [113-116]. 
 
 
 
Figure 18. Different temperatures within samples (blue and red 
curves) and its surrounding (green curve) during the freezing 
process. 
 
The current method to overcome the problem of cell damage due to 
release of latent heat is the removal of the excessive heat through 
adjustment of the cooling rate at specific time points and ensuring 
uniform freezing by maintaining a high ratio of surface to volume. In 
other words, the sample to be frozen is made as thin as possible, 
whereupon heat from the inner part of the sample, which is being 
released through the surface of the sample, will be removed faster 
due to the steep temperature gradient. In this way, it is possible to 
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apply the optimal cooling rates for each sample while providing a 
heat sink for rapid absorption of the released latent heat. 
 
1.2.4.3 Directional freezing 
Recently, a new directional freezing technology (MTG) was 
introduced [101, 102] which provides identical cooling rates through 
the specimen being frozen and it is aimed to cryopreserve whole 
organs (Figure 19). 
 
Figure 19. The Multi-Thermal-Gradient (MTG) freezing device. 
(A) Liquid nitrogen inlet; (B) cooling block; (C) entrance of the 
sample’s glass tube; (D) metal rod, which advances the sample’s 
glass tube forward into the cooling channel in the cooling block; 
and (E) electric motor (from Gavish et al., 2008). 
 
The technology is based on a series of heat conductive block (usually 
built of brass or aluminum) arranged in a line, with a straight track 
running through the blocks. Along the blocks, different 
temperatures (T1, T2 and T3, Figure 8)  can be set, in order to 
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obtained a temperature gradient along the blocks (G1, G2 and G3). 
The blocks are separated by gap and the temperature of the block on 
one side of the gap (T1) is above the freezing point  temperature and 
on the other side of the gap (T2)  is below the freezing point 
temperature, thereby imposing a temperature gradient across the 
gap (G1). Biological samples to be frozen are placed inside test tube 
and are moved along the track at a certain velocity (V). The samples 
are frozen at rates according to the specific  protocols of the samples; 
the rate of freezing is given by the temperature gradient multiplied 
by the velocity (CR1,2,3=G1,2,3*V) (Figure 20). 
 
 
Figure 20. Schematic sketch of a directional freezing apparatus. G= 
gradient; T= temperature; V= velocity. 
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The MTG can generate a linear thermal gradient in an organ/tissue 
to be cooled.  It is possible to change heat transfer in a directional 
way according to the heat transfer in the sample. The movement of 
the sample in the thermal gradient does not exceed this velocity in a 
way that heat will remain directional. In this way, heat transfer will 
propagate in the tissue in a linear way and the cooling rate for each 
point in the organ will propagated at the same (Figure 21). 
 
 
Figure 21. Multi-thermal gradient unidirectional freezing profile 
of a sheep ovary. See the same temperatures between the ovarian 
core and cortex. Arrows = latent heat release (from Arav et al., 
2010). 
 
Heat transfer in directional solidification is opposed to the direction 
of sample movement. This is when the velocity is shower than the 
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speed at which the heat is removed from the center of the sample 
toward the direction of the liquid and toward the conductive 
material of the device. In directional freezing ice formation occurs 
according to the solution’s freezing point temperature. Therefore 
supercooling, a non-equilibrium thermodynamic state in which a 
solution is cooled below its freezing point without crystallization,  is 
avoided completely. 
The freezing technology is based on directional freezing in which the 
biological material is transferred through a linear temperature 
gradient so that the cooling rate and ice front propagation is 
precisely controlled. Thus maximizing the survival rate of cells 
subjected to freezing and thawing requires the careful control of the 
freezing process. Although this method is rather new, results 
showed that directional freezing is a promising method for cell, 
tissue and entire organ cryopreservation [101, 117, 118]. 
 
1.1.4.4 Thawing 
The thawing process and the removal of cryoprotectant are also 
important step for a successful procedure. There is an opinion that 
the ice formed during thawing is less dangerous [119], although 
some authors recognize slow thawing as a prime destructive factor 
[102]. The longer the duration of the thawing period, the greater the 
damage occurring to the cells. The increase of the solute effects and 
the maximal growth of ice crystals are responsible for this damage. 
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The large crystals have an abrasive action producing a mechanical 
disruption of cells. Crystal growth is maximal at the range of 0°C 
and -40°C. The disruptive ultrastructural change in cells increasing 
with recrystallization. The thawing is most destructive if it is not 
done completely, so that all of the frozen tissue is thawed, which 
takes full advantage of recrystallization. For this author [102] 
basically two types of damage occur during slow thawing. The first 
is recrystallization, which is the growth of ice that was formed 
during the freezing process, and the second is the refreezing of the 
solution that occurs after complete thawing. 
 
1.3 CRYOPRESERVATION OF OVARIAN CORTEX 
 
1.3.1 Cryopreservation of ovarian cortex 
One on the option available in cryopreservation of ovarian tissue is 
the preservation of ovarian cortical fragments. Ovarian cortical 
tissue is typically removed by laparoscopy, a minimally invasive 
procedure lasting approximately 1 h and requiring general 
anesthesia. The superficial cortical tissue must be sharply dissected 
from the underlying medullary portion of the ovary [120]. The cortex 
can be shaved to a thickness of approximately 1 mm to promote 
early revascularization once the thawed tissue is transplanted [121]. 
If the whole ovary or a large portion is removed, the cortex can be 
further sectioned into 5 × 5 mm segments and cryopreserved. Once 
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the patient has survived her cancer and its treatment, the potential 
uses for the thawed ovarian tissue include in vitro maturation and 
fertilization of the immature follicles or transplantation of the tissue 
(Figure 22). 
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Figure 22. Uses of cryopreserved ovarian cortical fragments 
include transplantation and in vitro maturation of immature 
follicles and fertilization (from Oncofertility Medical Practice: 
Clinical Issues and Implementation, 2012). 
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The initial work on ovarian tissue cryopreservation, during the 
1950s, made use of the mouse model. In this species viability of 
frozen-thawed ovarian tissue was shown for the first time in any 
species [122]. In a later study, Parrot [123] showed that restoration of 
fertility is possible in mice after orthotopic grafting of frozen-thawed 
ovarian tissue.  In 1994, Gosden et al. [79] reported the first live 
births after ovarian cortex cryopreservation and transplantation in 
sheep.  Similar reports have been published in rats [124] and rabbits 
[125]. 
The first case of cryopreservation of human tissue was described in 
1996. Hovatta et al. [126] showed that cryopreservation of human 
ovarian tissue is feasible. They cryopreserved ovarian tissue from 19 
patients aged 19–44 years using two different cryoprotectant 
protocols and histological investigations of fresh and frozen-thawed 
ovarian tissues showed similar follicular atresia rates and the 
morphology of follicles and oocytes in non-frozen and frozen-
thawed ovarian tissues was not different. In vivo restoration of 
ovarian function after cryopreservation and autologous 
transplantation of ovarian cortex in human beings was first 
documented by Oktay and Karilkaya [127]. This orthotopic 
transplantation resulted in follicular development in ovarian tissue 
pieces grafted laparascopically beneath the left peritoneum in 
response to menopausal gonadotropin stimulation. Subsequently, 
restoration of normal endocrine function and follicular growth, after 
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heterotopic transplantation of the ovarian cortex, was reported by  
the same group [128, 129]. 
The first live birth from frozen-thawed ovarian cortex after 
autologous orthotopic transplantation was reported by Donnez et al. 
[130]. Doubts on the source of pregnancy was raised by Oktay and 
Tilly as to whether it arose from transplanted tissue or from the 
inactive ovary, which could have resumed its function [131]. 
Subsequently a series of live births after orthotopic transplantation 
of previously frozen cortical tissue have been reported by different 
groups [132-139]. Furthermore, very recently Stern et al. reported the 
first clinical pregnant after heterotopic ovarian transplantation in 
human [140]. 
Ovarian cryopreservation and transplantation of ovarian fragments 
appears to hold promise for fertility preservation in cancer patients, 
but there are numerous issues that need to be resolved. One of the 
major problems, is related to the freezing process. In fact, unlike 
single-cell freezing, it is much more difficult to optimize conditions 
for tissue freezing because tissue is composed of many different cell 
types. The main danger is intracellular ice crystal formation and salt 
concentration [141]. Currently, the best follicular survival rate 
obtained in frozen-thawed human ovarian tissue is approximately 
70%–80%, with the majority of follicles morphologically normal by 
light microscopy [142, 143]. Furthermore, distinctive ultrastructural 
changes has been detected in frozen-thawed tissue by electron 
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microscopy [144, 145]. The other main obstacle to the wide 
application of ovarian cortex cryopreservation is that the majority of 
transplanted follicles are lost by ischaemic damage by the time 
sufficient neoangiogenesis has supplied the graft. This happens 
because transplantation of fragments of ovarian cortex is performed 
without vascular re-anastomosis, perfusion of the tissue depends on 
the growth invasion of new blood vessels. The ischemic injury 
occurring directly after transplantation without vascular 
anastomosis is involved in the dramatic follicular depletion 
observed in grafted ovarian tissue. This follicular depletion is a main 
concern, especially in humans and large animal species that have a 
dense ovarian cortex. At least 25% of the primordial follicles are lost 
as a result of cryopreserved xenografts of human ovarian tissue into 
mice [142, 144]. Others estimated that ischemic injury during 
autograft processes induces the depletion of 60–95% of the follicular 
reserve, including the loss of virtually the entire population of 
growing follicles [146, 147]. This phenomenon is associated with a 
dramatic reduction of the graft size and a significant fibrosis in most 
grafts [148]. It appears that ovarian slices can convey only short-term 
function due to loss of most follicles by ischaemia. 
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1.3.2 Cryopreservation of whole ovary 
An alternative strategies to preserve fertility is the transplantation of 
the cryopreserved whole intact ovary. Whole ovary transplantation 
with vascular anastomosis was proposed as a mechanism to reduce 
ischemic damage and, in theory, prolong the longevity of the graft 
[149]. In this technique, the whole ovary with its vascular pedicle, is 
removed, cryopreserved, thawed, and then transplanted using a 
microvascular anastomosis into a heterotopic or orthotopic site. 
These procedure reduces the ischemic interval between 
transplantation and revascularization by allowing immediate 
revascularization of the transplanted tissue [150]. Vascular 
anastomosis of fresh ovary was successfully performed using the 
ovarian artery, inferior epigastric vessels, carotids vessels or iliac 
artery in various animal models [124, 151-154]. A limited number of 
human studies with transplantation of fresh intact ovaries in 
orthotopic [155, 156] and heterotopic [157, 158] sites have been 
attempted with some success. The first full-term pregnancy obtained 
using orhotopic whole fresh ovary transplantation between 
monozygotic twins who are discordant for POF was reported in 2008 
by Silber et al. [155]. A fresh ovary from the fertile twin was 
implanted in her monozygotic twin with POF. 
Whole frozen ovary transplantation with microvascular anastomosis 
was first described in rats by Wang et al. [124]. They described 
successful vascular transplantation of frozen–thawed rat ovaries and 
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reproductive tract in four of seven (57%) transplants, which survived 
for ≥60 days, were ovulatory and resulted in one pregnancy. Chen et 
al. [159] showed that frozen–thawed rabbit ovaries remained 
functional for at least 7 months after microvascular transplantation 
in 13 of 15 (86.7%) animals. 
The challenge of whole ovary cryopreservation and transplantation 
technology is not only the surgical technique but also the 
cryopreservation protocol for an entire organ. It appears that, in 
large mammals and humans, cryopreserving an intact ovary may 
prove more problematic than in small animals, largely due to the 
physical constraints that limit an appropriate heat transfer between 
the core and the periphery of the organ [102]. In addition, the large 
volume of the whole organ poses some limitation to the perfusion 
and diffusion of cryoprotectants [160, 161] (see chapter 1.1.4.2). Both 
are essential for preventing intravascular ice formation which would 
irreversibly compromise a rapid and efficient resumption of the 
blood supply [162]. Nevertheless, data obtained from experiments 
mostly performed in sheep show some positive results [163] and 
pregnancies [164] but also highlight stromal and vascular damage 
following either slow freezing [165, 166] or vitrification [167, 168]. 
Imhof et al. reported that 18 months after transplantation of whole 
ovary frozen with slow freezing, the follicular survival rate was less 
than an 8% [169]. Other authors reported an even lower follicular 
survival rate (6%) and the depletion of the entire follicular 
61 
 
population after whole ovary vitrification and transplantation [168]. 
Bedaiwy et al. [170] reported the restoration of ovarian function after 
autotransplantation of intact frozen–thawed sheep ovaries with 
microvascular anastomosis, but it should be noted that 8 of 11 
ovaries were lost due to thrombotic events in the reanastomosed 
vascular pedicle. Although transplantation of whole cryopreserved-
thawed ovary was not performed in humans, cryopreservation of a 
whole ovary using a slow freezing protocol has been successfully 
attempted. Recently, Martinez-Madrid et al. [171] described a 
cryopreservation protocol for intact human ovary with its vascular 
pedicle and observed high survival rates of follicles (75.1%), small 
vessels and stroma, and a normal histological structure in all the 
ovarian components after thawing. Recently, a multigradient 
freezing device was used with promising results (see chapter 1.2.4.3). 
In fact, this freezing method combined with microvascular 
anastomosis have improved outcome, and long lasting ovarian 
function has thus been obtained in sheep. Arav et al. [117] reported 
progesterone activity 36 months after vascular transplantation of 
frozen–thawed sheep ovaries in three of eight transplants, and 
retrieval of six oocytes, resulting in embryonic development up to 
the 8-cell stage after parthenogenic activation. Even after 6 years the 
cryopreserved and transplanted tissue appeared functional as was 
indicated by histological examination. Normal tissue architecture, 
healthy blood vessels and follicles at different stages were all 
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observed in these ovaries. Even after 6 years the cryopreserved and 
transplanted tissue appeared functional as was indicated by 
histological examination. Normal tissue architecture, healthy blood 
vessels and follicles at different stages were all observed in these 
ovaries [172].  These results are promising in finding an optimal 
method for the cryopreservation of whole ovaries, so that in the 
future it will be possible to restore fertility long-term and to prevent 
premature menopause in young female cancer patients. 
 
1.3.3 Safety concerns with ovarian tissue transplantation 
Autotransplantation of frozen and thawed ovarian tissue is only 
possible if absence of cancer cells in the graft is confirmed and there 
is a legitimate concern for the reseeding of malignant cells when 
carrying out ovarian transplantation. Theoretically, ovarian tissue 
could carry micro-metastases that could “re-infect” a patient who 
had been previously cured of her cancer. The risk of ovarian 
mestastasis was summarized by Sonmezer and Oktay [47] (Table 5). 
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Low risk 
Squamous cell carcinoma of the cervix 
Ewing’s sarcoma 
Breast cancer stage I-III 
Wilm’s tumore 
Non-hodgkin’s lymphoma 
Hodgkin’s lymphoma 
Osteogenic sarcoma 
Non-genital rhabdomyosarcoma 
Moderate risk 
Breast cancer stage IV 
Colon cancer 
Adeno/adenosquamous carcinoma of the cervix 
Upper gastrointestinal system malignancies 
High risk 
Leukemia 
Burkitt lymphoma 
Neuroblastoma 
Genital  rhabdomyosarcoma 
 
Table 5. The risk of ovarian metastatis (from Sonmezer and Oktay 
2004). 
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Ovarian transplantation might be particularly concerning with 
blood-born malignancies such as leukemia, where the cancer cells 
are already in the blood, and therefore presumably within the 
cryopreserved ovarian tissue. The transmission of lymphoma via 
graft of ovarian tissue from diseased donor mice to healthy 
recipients was reported by Shaw et al. [173]. This study showed that 
fresh and cryopreserved ovarian biopsy samples taken from mice 
with lymphoma transmitted cancer into recipients. The transplant of 
human ovarian tissue, however, from patient with Hodgkin’s 
lymphoma in SCID mice did not transfer the disease to the recipients 
[174]. Hence, it is necessary to develop a method in the ovarian 
tissue to eliminate the risk of transmission of these cells with 
transplantation, or to consider xenografting, or in vitro maturation 
which would minimize re-introduction of cancer cells of women 
having suffered from heamatological malignancies are under 
development [175]. 
 
1.4 COMPARATIVE ANATOMY OF SHEEP AND HUMAN  OVARY. 
All experiments described in this thesis were performed on sheep 
ovary. The sheep is a traditional experimental animal in 
reproductive physiology research. There exist a large knowledge 
base concerning physiological changes of the ovine ovary and the 
similarities between the human and ovine ovary in regards to tissue 
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architecture make it suitable as a research tool towards optimization 
of procedures for human use. 
The main ovarian functions are differentiation and release of mature 
oocyte competent for fertilization and production of steroid 
hormones necessary for secondary sexual characteristics and 
subsequent achievement of pregnancy. 
Sheep and human ovaries are oval-shaped female gonads. In sheep 
the ovaries are  approximately 15-20 mm in length, 10-15 mm width 
and weigh approximately 2.0 g (about 1/6th of the size of a human 
premenopausal ovary). In human ovaries are about  4 cm long, 1.5 
cm wide, 1 cm thick and weight 2-4 g. 
In both species, the ovarian surface is irregular because the follicles 
and corpora lutea protrude markedly.  The tissue architecture of 
ovine and human ovaries is similar with a well-defined tunica 
albuginea and a collagen-dense cortical stroma containing the 
primordial follicles [117]. 
In sheep, ovaries are located in the antero-lateral abdominal wall of 
the female pelvis whereas in human they are located in the lateral 
wall of the female pelvis beneath the external iliac artery. The 
ovaries are suspended from the broad ligament near the end of the 
oviduct and lie near the tips. 
The ovarian artery in sheep is in close apposition to the wall of the 
utero-ovarian vein. The contact area between vein and artery 
increases by the tortuous path of the artery over the surface of the 
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vein. The walls of the artery and vein are thin in the contact area 
between the two vessels (Figure 23). 
The human ovarian artery, which ordinarily arises from the aorta, 
passes along the ovary, dividing into a number of branches. At 
several places in the broad ligament there are anastomotic 
connections between the tubal branch of the uterine artery and the 
ovarian artery. A branch of the uterine artery nourishes the round 
ligament. The veins generally accompany the arteries (Figure 24). 
 
 
Figure 23. Diagrammatic presentation of arteries (clear) and veins 
(cross-bar) of a uterine horn and the adjacent ovary from sheep. 
The ovarian artery is tortuous and is closely applied to the utero-
ovarian vein which drains most of the uterine horn (from Ginther 
, 1974). 
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Figure 24. Blood supply of the human female reproductive organs. 
(from the 20th U.S. edition of Gray's Anatomy of the Human 
Body). 
 
The ovary consists of a medulla and cortex (Figure 28). The medulla 
is the central part, which contains loose connective tissue, nerves 
and blood and lymphatic vessels. The ovarian cortex is the outer part 
of the ovary surrounding the medulla and is composed of the 
ovarian follicles that embedded in specialized stroma. The small 
ovarian follicles lie at a depth of approximately 0.03 mm in the 
ovarian cortex. Follicles are the functional units of the ovary and are 
composed of an oocyte and surrounding somatic granulosa cells 
(Figure 25) with or without theca cells, depending on the 
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developmental stage of the follicle. Granulosa cells and basal 
membrane separates the granulosa cells from the stromal/thecal 
tissue. Intercellular contacts between granulosa cells are provided by 
gap junctions, forming a compact functional syncytium of cells that 
allows metabolic exchange and transportation of molecules. 
 
 
Figure 25. Schematic drawing of the cyclic changes of the ovary 
(form Mileknovic et al. 2011). 
 
It has been estimated that there are about 100,000–200,000 follicles in 
lambs at birth [176]. Follicles are classified as: primordial (the earliest 
stage) containing an oocyte surrounded by a single layer of flattened 
granulosa cells; primary surrounded by at least one cuboidal layer of 
granulosa cells; secondary with more than one layer of cuboidal 
69 
 
granulosa cells and theca externa and interna cells which originate 
from ovarian stroma; tertiary when a fluid filled antrum inside the 
granulosa cells is become evident. During follicular development 
also the oocyte increases in diameter and becomes surrounded by a 
zona pellucida (Figure 26), which is a thick extracellular coat of 
glycoproteins. The zona pellucida plays an important role during 
oogenesis, fertilization and preimplantation development. 
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Figure 26. Classification of ovarian follicles during 
folliculogenesis. 
 
71 
 
During follicular development, the follicle grows from an initial size 
of 30 µm to up 7 mm in sheep and from 40 µm to up 15-22 mm in 
human (Figure 30). A large pool of resting primordial follicles is laid 
down during fetal development, with the first follicles being formed 
at about 70 days of gestation in sheep and about 100 days in human. 
This pool is nonrenewable and during the lifetime of the animal, 
follicles develop to primary, secondary and tertiary stages before 
ovulating. Very few follicles progress to ovulation and most die by 
atresia at any stage of development. The duration of the transition 
from a primordial into pre-ovulatory follicles is similar between 
sheep (180 days) [177]  and human (200 days) [178] (Figure 27). 
 
Figure 27. Schematic diagram of follicle growth in sheep and in 
human from the primordial stage to the preovulatory stage 
(modified from Mileknovic et al, 2011). 
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2  AIM 
 
Ovarian tissue cryobanking is considered a viable method for 
preserving female fertility and represents the best option in young 
pre-pubertal cancer patients. Cryopreservation can be performed on 
ovarian cortical fragments or on the entire organ. However, both 
procedures are still considered to be experimental by the American 
Society for Reproductive Medicine and require further research to 
reach a reliable clinical application and provide a concrete 
improvement to the quality of life of these patients. 
To move forward, the cryopreservation of both avascular ovarian 
fragments and of whole ovaries must be improved. To this purpose, 
we performed a detailed comparison between two different methods 
of cryopreservation on both cortical fragments and whole ovary. 
Based on our results [179] and those in literature [102, 180], in this 
thesis the sheep ovary was chosen as a model because its size and 
texture are comparable to young human ovaries. 
Although re-implantation of frozen-thawed ovarian cortical 
fragments is the most common approach to ovarian banking the 
main  problem associated with this method is the loss of over 50% of 
the primordial follicles due to cryopreservation and tissue ischemia 
that take places after transplantation. Current research is 
investigating the potential of whole ovary transplantation with 
vascular anastomosis as a mechanism to reduce ischemic time. 
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However, cryopreservation of whole ovary is more complicated than 
cortical fragments, due to the large volume of the sample to be 
frozen. 
In the first part of this thesis, we perform a direct comparison 
between conventional and directional freezing, cryopreserving 
sheep whole ovaries. This study was carried out in order to analyse 
if the new directional freezing method allows a better preservation 
of ovaries, reducing the problem associated with conventional 
method, including stromal and vascular damage. 
In the second set of experiments, ovarian cortical strips were frozen 
with both freezing methods, in order to determine whether 
directional freezing could also improve the viability of ovarian 
fragments. The obtained results were compared with whole ovaries 
frozen with the same method. 
In both set of experiments, we analysed ovarian tissue morphology 
after freezing/thawing, including the determination of stromal cells 
density and blood vessels integrity. Follicle viability after 
freezing/thawing, was investigated by in vitro culture evaluating the 
capacity of primordial follicles to growth into primary stage. 
Furthermore, we investigated the ability to respond to thermal stress 
and the dynamics of DNA repair mechanisms. 
Finally, in the last part of this thesis, we developed a perfusion 
system for ex vivo culture of  whole ovaries, which could provide 
appealing alternative to the re-trasplantation of frozen-thawed 
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ovarian tissue, with the purpose to eliminate the risk of transmission 
of cancer cells in women who have systemic hematologic 
malignancies. 
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3  MATERIAL AND METHODS 
Unless otherwise indicated, chemicals were purchased from Sigma- 
Aldrich (Italy). 
 
3.1 Ovaries collection 
One hundred and forty-one sheep ovaries with ovarian pedicle were 
collected at the local abattoir and transported to the laboratory in 
physiological saline (9.6 g/l NaCl). All the selected ovaries were in 
follicular phase and the ovarian vessels were cut so as to be a long as 
possible. 
Ovaries were randomly assigned to fresh control group (CTR) and 
experimental groups. The experimental groups included: 
1. Directional freezing of whole ovary; 
2. Directional freezing of ovarian fragments; 
3. Conventional freezing of whole ovary; 
4. Conventional freezing of ovarian fragments . 
 
3.2 Sample preparation 
Samples to be frozen as whole organs were perfused via the ovarian 
artery with Ringer's solution and 10 IU/l heparin for 10 minutes, 
followed by perfusion with cryoprotectant solution containing 
Leibovitz L-15 medium (Life Technologies), 10% fetal bovine serum 
(v/v; Life Technologies) and 1.5 M dimethylsulfoxide for 10 minutes 
at a flow rate of 1.3 ml/min [163] at room temperature. 
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Ovarian fragments (10 x 5 x 1 mm) were sliced from the cortical 
region and immersed in the same cryoprotectant solution. 
Each ovary and all fragments (8-10) from a single ovary were 
inserted into a 16 mm diameter and 80 mm long glass test tube 
(Manara) containing 10 ml of the same solution. The tube wall is 1 
mm thick and made of quartz. Tubes were closed with specifically 
designed silicon plugs. All samples were equilibrated at +4°C before 
the freezing process. 
 
3.3 Cryopreservation procedures 
3.3.1 Conventional freezing 
Conventional slow freezing was performed in a Kryo 560M 
apparatus (Planer) with the following program [163]: 
a) from +4° to –40°C using a cooling rate of -0.5°C/min (seeding was 
induced at -7°C); 
b) from –40° to –100°C at -5°C/min; 
c) immersion in liquid nitrogen. 
 
3.3.2 Directional freezing 
Directional freezing was performed with a Multi-Thermal-Gradient 
(MTG, IMT Ltd., Ness Ziona). The 3 thermal blocks were set at +4°, -
10° and -70°C respectively, thereby imposing a temperature gradient 
around the tubes. Freezing tubes were pushed lengthwise along the 
thermal gradient and the speed was set at 0.01 mm/s resulting in a 
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cooling rate of -0.3°C/min down to  -70°C,  after which samples were 
plunged into liquid nitrogen [117, 172]. 
 
3.4 Thawing 
After minimum two weeks, the glass test tube were removes from 
the liquid nitrogen tank. Samples were thawed by plunging the test 
tubes into a 68°C water bath for 20 seconds and then into a 37°C 
water bath for 2 minutes.  The content of the tubes was quickly 
emptied into a petri dish (Sarstedt) containing Leibovitz L-15 
medium at 37°C. The cryoprotectant solution was rinsed out of the 
whole ovaries by perfusion via ovarian artery with 10 ml of 
Leibovitz L-15 medium at 37°C supplemented with decreasing 
sucrose concentrations (0.25 M, 0.125 M and 0 M) at 3 ml/min for a 
total of 30 minutes. Perfusion times were 10 minutes for each step 
[149, 170]. 
After thawing, ovarian fragments were washed three times for 10 
minutes each in Leibovitz L-15 supplemented with the same sucrose 
concentrations (0.25 M, 0.125 M and 0 M). The material was then 
randomly allocated for further analysis. Each experiment was 
performed on a minimum of three independent biological replicates 
and all samples were blinded for analysis. 
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3.5 Follicle culture 
The ability of primordial follicles to resume development after 
cryopreservation was studied culturing cortical fragments for 7 days 
[181]. After thawing, several ovarian fragments of approximately 2 x 
2 x 1 mm were derived from whole ovaries and isolated cortical 
pieces. Ovarian cortical fragments derived from fresh ovaries were 
used as control. Three randomly selected fragments from each ovary 
were immediately fixed in 10% formaldehyde solution for 
histological studies (time 0, control) as described in paragraph 3.6. 
Other randomly selected fragments were placed into 24-well culture 
dishes (Sarstedt) and individually cultured in 1ml of medium (see 
Table 6) for 7 days at 39°C under an atmosphere of 5% CO2 in air. 
The medium was replaced every 2 days. At the end of culture, 
samples were processed for further analysis. 
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FOLLICLE COLTURE MEDIUM 
αMEM  
Insulin 6.25 µg/ml 
Transferrin 6.25 µg/ml 
Selenium 6.25 ng/mL 
Glutamine 2 mM 
Pyruvate 0.23 mM 
Hypoxantine 2 mM 
Bovine Serum Albumin 1.25mg/ml 
Penicillin G 100 µg/ml 
Streptomycin 100 µg/ml 
Sheep FSH 200 mIU/ml 
Human recombinant bFGF 50 ng/ml 
 
Table 6. Composition of medium used for follicle culture 
3.6 Histology procedures 
3.6.1 Tissue fixation 
To improve the fixation, whole ovaries were cut in half through its 
major axis with scalpel and forceps and immediately fixed in 10% 
(v/v) formalin from 48 hours. Cortical fragments were directly 
immersed in 10% (v/v) formalin for 24 hours. 
 
 
3.6.2 Paraffin embedding 
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After fixation, samples were dehydrated by bathing them 
successively in a gradually increasing grade of mixtures of ethanol 
and water (50%, 70%, 90% and 100%). The samples were immersed 
in xylene and then passed through paraffin: xylene (50:50) solutions 
overnight.  On the following  day,  samples  were  washed  for 3 
times,  each  for 1 hour  with  melted paraffin (60°C). They were then 
isolated and embedded in the plastic blocks. Finally, the paraffin 
embedded blocks were preserved at room temperature. 
 
3.6.3 Preparation of histological sections 
Serial sections (thickness, 5 µm) were cut from each ovary at a 
regular interval of 100 µm using  the microtome  (Microm,  Bio-
Optica) at cooling.  They were then transferred  on slides and put on 
the hot rack for 24 hours 
 
3.6.4 Hematoxylin and eosin staining 
Slides were deparaffinazed in xylene, and rehydrated through a 
decreasing grade of alcohols (100%, 90%, 70% and 50%). 
Slides were then stained with hematoxylin (Emallueme  Carazzi,  
Bio-Optica)  combined  with an acid  dye eosin (Eosin  1% aqueous  
solution, Bio-Optica) according  to well-established   procedures.  
Excess   dyes  were removed by re-passing the slides through an 
increasing grade of alcohols (50%, 70%, 90% and 100%) until return 
to absolute Xylene. The samples still wet with xylene were mounted 
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with synthetic based mounting media, Biomount® (Bio-Optica, 
Milan, Italy) and covered with microscopic cover-slip. 
 
3.6.5 Immunohistochemistry 
The paraffin-embedded ovarian sections (thickness, 5µm) were 
mounted on poly-L-lysine coated slides (Microscope slides 
Polysine™, Bio-Optica), deparaffinazed (xilene, xilene:ethanol, 
absolute ethanol, 95% ethanol, 70% ethanol) and washed in 
phosphate-buffered saline (PBS). To unmask the antigen, section 
were immersed in a citrate-based antigen unmasking solutions 
(Vector Laboratories) and boiled for 5 minutes, using pressure 
cooker. Non-specific site were blocked with a solution of PBS 
containing 5% BSA and 10% non-immuneserum. Sections were 
incubated overnight with the primary antibodies listed in Table 7. 
Sections were washed three times with PBS and incubated with 
suitable secondary antibodies (Alexafluor; Life Technologies) for 45 
minutes. Nuclei were stained with 4’-6’-diamino-2-phenylindole 
(DAPI). Sections were washed three times in PBS, mounted with 
VECTASHIELD mounting medium to prevent photobleaching 
(Vector Laboratories) and covered with microscopic cover-slip. 
Blinded samples were observed under Eclipse E600 microscope 
(Nikon), pictures were acquired wit Nis Elements Software (Version 
4.0) and the images were analyzed using Image J software as 
described in paragraph 3.11. 
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ANTIBODY Description 
Host 
Species 
Company 
Catalog 
Number 
IHC 
Working 
Solution 
Ki67 
Proliferation 
marker rabbit Abcam ab15580 1:500 
γH2AX 
DNA damage 
marker mouse Abcam ab26350 1:200 
RAD51 DNA repair 
marker 
rabbit Santa Cruz sc-8349 1:200 
 
Table 7. List of antibodies used for immunohistochemistry. 
 
3.7 Morphologically analysis 
After hematoxylin and eosin staining, slides were observed under an 
Eclipse E600 microscope (Nikon) and pictured were acquired with 
Nis Elements Software (Version 4.0). For each measure, a minimum 
of four sections, 200 µm apart, form each sections were examined. 
Follicles were classified as primordial (one layer of flattened 
granulosa cells around the oocyte), intermediate (one layer of 
flattened to cuboidal granulosa cells around the oocyte), primary (a 
single layer of cuboidal granulosa cells around the oocyte) or  
secondary (oocyte surrounded by two or more layers of cuboidal 
granulosa cells). Follicles were further classified as normal, when a 
spherical oocyte with a non-pyknotic nucleus was surrounded by 
granulosa cells organized in discrete layers, or degenerated, when a 
misshapen oocyte with or without vacuolation with a pyknotic 
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nucleus was surrounded by disorganized granulosa cells detached 
from the basement membrane [182] (Figures 28). Stromal cell density 
was quantified by counting nuclei with ImageJ software as described 
in paragraph 3.11 (Figure 29). 
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Figure 28. Representative pictures of ovarian follicles in the 
cortical region. A= intact primordial follicles; B= degenerate 
primordial follicles; C= intact intermediate follicles; D= 
degenerated intermediate follicles; E= intact primary follicles; F= 
degenerated primordial follicles; G= intact secondary follicles; H= 
degenerated secondary follicles. 
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Figure 29. Representative figure of analysis of stroma cells 
densisty. (A) Original hematoxylin and eosin staining image; (B) 
The same image after conversion in 8-bit; (c) Output that show 
nuclear outlines. 
 
3.8 Blood vessel integrity 
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Vessels integrity was assessed using Indian Ink. Fresh ovaries were 
perfused with 10 ml Ringer’s solution supplemented with 10 IU/ml 
heparin, whereas thawed ovaries were perfused as describe in 
paragraph 3.4. Thereafter, six ovaries from each groups (CTR, DFct 
and CFct) were perfused via the ovarian artery with a solution of 
25% Indian Ink in 0.9% NaCl supplemented with 167 IU heparin/ml 
for 5 minutes [183], with a flow rate of 1.3ml/min. A perfusion was 
considered successful if Indian Ink was macroscopically seen to 
perfuse the whole ovary (Figure 30). After perfusion ovaries were 
fixed, embedded in paraffin for hematoxylin and eosin staining as 
described in paragraph 3.6. 
Perfused vessels were classified as intact or damaged, according to 
the presence or absence of Indian Ink in the lumen, respectively. 
Vessels were divided into three categories according to their size: 
small (Ø ≤ 75 µm), medium (Ø 21 µm-74 µm), and large (Ø ≥ 75 µm). 
Vessels number was determined in six randomly selected fields per 
section of both medulla and cortical tissue of each ovary. For each 
experimental groups a minimum of 200 vessels were counted. 
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Figure 30. Perfusion of sheep ovary with a Indian Ink/heparin 
solution. (1)  Beginning  of perfusion; (2-3) during perfusion; (4) 
after perfusion: ovary after transversal dissection. 
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3.9 Western Blotting 
Ovarian fragments (~2 mm3) derived from five different 
experimental groups at Days 0 and 7 of follicles culture were 
homogenized individually, lysed and constitutive proteins were 
extracted using ReadyPrep™ Protein extraction Kit (Bio-Rad), 
following the manufacture instruction. Protein concentration was 
assessed with DC Protein Assay (Bio-Rad).  Aliquots of 50 µg were 
prepared and resuspended in (1:1) 2x Laemmli sample buffer 
consisting of 4% (w/v) sodium dodecyl sulfate (SDS), 10% 2-
mercaptoethanol, 20% (w/v) glycerol, g on the 0.004% bromophenol 
blue and 0.125 M Tris–HCl (pH 6.8). Samples were loaded and 
electrophoresed on 8 or 10 % SDS-polyacrilamide gels depending on 
the molecular weight of the target molecule. Proteins were then 
transferred onto 0.45-µm pore size nitrocellulose filters (Life 
Technologies) according to Towbin et al [184] using 0.5 A/cm2. Equal 
sample loading and transfer efficiency were confirmed by staining of 
the membrane with Ponceau Red. The membrane was probed with 
the primary antibodies listed in Table 8, as described by Pennarossa 
et al. [185] and previously validated in sheep. Monoclonal anti-β-
actin was used as a loading control. Protein bands were visualized 
by Western Breeze® chemiluminescent kit (Life Technologies). 
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ANTIBODY 
Host 
species 
Company 
Catalog 
number 
WB 
working 
dilution 
HSF1 Goat Santa Cruz sc-8061 1:1000 
HSP40 Rabbit Abcam ab69402 1:10000 
HSP70 Mouse Abcam ab5439 1:5000 
HSP90 Mouse Abcam ab13492 1:1000 
β-Actin Mouse Sigma a5441 1:1000 
 
Table 8. List of antibodies used for western blot analysis. 
 
3.10 TUNEL assay 
DNA fragmentation was detected by In situ Cell Death Detection Kit, 
TMR red (Roche). Sections were placed on silanized slides (Bio-
Optica), deparaffinazed (xilene 10 min, xilene:ethanol 5 min, 
absolute ethanol 10 min, 95% ethanol 5 min, 70% ethanol) and 
washed with PBS. Unmask of antigens was carried out using 
Proteinase K solution for 30 minutes at 37°C in humid chamber. 
Samples were than incubate with TDT TUNEL reaction mixture for 1 
hour at 37°C in an humidified atmosphere in the dark. Positive 
controls were treated with DNAse I recombinant (50 U/ml; Roche) in 
50 mM Tris-Hcl (pH 7.5), 1 mg/ml BSA for 10 minutes at 25°C before 
DNA end labeling. For negative control, TDT was omitted from the 
reaction mixture. Sections were washed three times in PBS, mounted 
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with VECTASHIELD mounting medium to prevent photobleaching 
(Vector Laboratories) and covered with microscopic cover-slip. 
TUNEL-positive cells were calculated as cells per area of ovarian 
tissue using ImageJ software as detailed in paragraph 3.11. 
 
3.11 Image analysis 
To quantify fluorescent signal, picture were taken with constant 
exposure parameters in order to be analyzed with the image analysis 
software Image J (http://rsb.info.nih.gov/ij/). Threshold adjustments 
were applied to generate a black and white image. In each case, 
marker expression was normalized by DAPI fluorescent. To study 
the stromal cells density, cell proliferation and TUNEL positive cells, 
a specific plugins for counting the number cells within an image was 
used (ITC Image-based Tool for Counting Nuclei). The macro 
initially removes the image background with a Gaussian blur. The 
image is then segmented with a thresholding algorithm to highlight 
areas occupied by the nuclei and remove regions in the background 
(black nuclei). After conversion in 8-bit, the nuclei diameters and the 
minimum distance between nuclei centers were set. The black and 
white mask image is then automatically processed to identify each 
individual nucleus and the output is a count. 
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3.12 Semiquantitative Polymerase Chain Reaction 
Total RNA was extracted from the ovarian cortical tissue region 
using the TRIzol Reagent (Life Technologies) and reverse transcribed 
into cDNA in a total volume of 20 µl reaction mixture containing 1µl 
oligo(dT)12-18 (500 ng/µl). RT was performed with 200U Superscript 
II reverse transcriptase (Life Technologies) for 1hour at 42°C. cDNA 
amplifications were carried out in an automated thermal cycler 
(iCycler, Bio-Rad), using the appropriate conditions for Ki67 specific 
primers (forward 5’-atggggagtgagaaggaggt-3’; reverse 5’-
tccaagttccccttgcatac-3’; Tm 59°C). Sheep DNA was used as positive 
control.  The optimal cycle number at which the transcript was 
ampliﬁed exponentially was established running a linear cycle 
series, and the number of PCR cycles was kept within this range. An 
aliquot of each cDNA sample was ampliﬁed by PCR with β-actin 
gene-speciﬁc primers (forward primer: 5’-ccaaggccaaccgtgagaag-3’; 
reverse primer 5’-ccatctcctgcttcgaagtcc-3’; Tm 57°C). RT-PCR 
products were subjected to electrophoresis on a 2% agarose gel and 
the intensity of each band was assessed by densitometric analysis 
performed with the Quantity One software (Bio-Rad). The relative 
amount of Ki67 transcript was calculated by dividing the intensity of 
the Ki67 band by the intensity of the β-actin band. 
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3.13 Ex vivo culture of whole ovary 
Fresh ovaries and ovaries frozen as entire organ with directional 
freezing, were cultured ex vivo for up to  4 days using a perfusion 
system (Figure 31). 
This was a closed system where 100 ml of recirculating medium 
(Table 9) was pumped into the ovarian artery. Culture medium was 
pumped into the ovarian artery using a peristaltic pump and the 
flow rate through the ovary was maintained between 1 and 1.5 
ml/min. Whole ovaries were cultured at 38.5°C for 2 or 4 days. 
Medium was refresh every day. After culture, ovaries were fixed 
with 10% formaldehyde. 
 
Figure 31. Schematic drawing of the in vitro perfusion apparatus. 
 
 
93 
 
 
Perfusion medium 
M199  
Bovine serum albumin 40 mg/ml 
L- Glutamine 2 mM 
Penicillin G 100 µg/ml 
Streptomycin 100 µg/ml 
Hepes 25 mM 
 
Table 9. Composition of medium used for ovary ex vivo culture. 
 
3.14 Statistical analysis 
All experiments were repeated a minimum of three independent 
biological replicates. All data are reported as mean ± SEM. Mann-
Whitney U (Statistical Package for the Social Sciences, SPSS 20; IBM) 
test was used to analyze vessel number and one-way analysis of 
variance followed by Turkey’s post hoc tests (SPSS 20; IBM) were 
used for all the remaining experiments. Differences were considered 
statistically significant if P<0.05. 
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4. RESULTS 
 
PART I: COMPARISON OF CONVENTIONAL AND 
DIRECTIONAL FREEZING ON SHEEP WHOLE OVARY 
 
Morphologic assessment immediately after thawing 
Immediately after thawing we analyzed ovarian follicles 
morphology and stomal cells density. The rate of intact follicles in 
the DF group (89%± 1.7%) was significantly higher than that in the 
CF group (61%±3.4%), and it was not different from that in fresh 
control tissue (96%± 1.5%) (Figure 32). 
 
 
 
Figure 32. Overall distribution of morphologically normal follicles 
in control (CTR) and in thawed whole ovaries frozen with 
directional (DF) or with conventional freezing (CF). Values with 
different indices (a-b) are significantly different (P<0.05) 
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Quantitative assessment of stromal cell density indicated that DF 
ovaries had values (17,041 nuclei per mm2) similar to those of fresh 
organs (17,833 nuclei per mm2) but significantly higher than in CF 
ones (10,875 nuclei per mm2) (Figures 33 and 34). 
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Figure 33. Representative pictures of the medullar region of the 
different experimental groups. Scale bars 100 µm. 
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Figure 34. Quantitative assessment of density of stromal cells by 
image analysis. Values with different indices (a-b) are 
significantly different (P<0.05). 
 
Vessels integrity was studied using Indian Ink. Indian Ink only was 
observed only in blood vessels and not in the surrounding tissue, 
indicating an optimal perfusion (Figure 35A). Whole ovaries frozen 
with directional freezing and fresh ovaries displayed the same rate 
of intact vessels in ovaries, both in medulla (stromal vessels) and in 
the cortex (perifollicular vessels) (Figure 35B). Conversely, ovaries 
frozen with conventional freezing displayed a significantly lower 
number of intact vessels (P=0.009). No significant differences 
between ovarian medulla and cortex vessels were observed, either in 
fresh or in cryopreserved samples (Figure 35B). 
98 
 
 
Figure 35. Representative pictures of blood vessels in the different 
experimental groups classified in three different categories (A) 
and their distribution in the medulla and cortex regions (B). 
Values with different indices (a-b) are significantly different 
(P<0.05). Scale bars =100 µm. 
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Functional assessment 
After 7 days of in vitro culture the rate of primordial follicles that 
developed into the primary stage was higher in whole ovaries frozen 
with directional freezing than in ovaries cryopreserved with 
conventional freezing. The developmental competence of DF ovarian 
fragments was the same as in fresh control tissue, whereas CF 
fragments showed a significant decrease of the overall follicle 
number (P=0.038) (Figure 36). 
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Figure 36. Distribution of primordial, intermediate and primary 
follicles at the beginning (DAY 0) and the end (DAY 7) of the 
culture period. Values with different indices (a-c) are significantly 
different (p<0.05). 
101 
 
Consistent with their developmental capacity, the rate of 
morphologically normal primordial, intermediate and primary 
follicles in the directional freezing group was not different from that 
in the fresh group upon thawing. By contrast,  the conventional 
freezing group displayed a higher rate (P<0.05) of degenerated 
follicles and oocyte with pyknotic nuclei. Seven days later a 
significant reduction in the percentage of histologic normal follicles 
was found in the conventional freezing group (24% ± 5.7%) 
compared with directional freezing (77% ± 2.8%) and fresh groups 
(85% ± 2.43%) (Figure 37). 
 
Figure 37. Overall distribution of morphologically intact follicles 
during culture in the three experimental groups. Values with 
different indices (a-c) are significantly different (P<0.05). 
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Cell proliferation 
Differences in follicles viability were consistent with differences in 
cell proliferation rate, obtained through the analysis of the 
expression of Ki67. After 7 days of culture abundance of Ki67 
transcripts significantly increased in directional freezing group and 
in fresh tissue (P<0.05). By contrast, a reduction in Ki67 messenger 
RNA level was detected in conventional freezing tissue (P<0.05) 
(Figure 38A). Ki67 immunofluorescence results were in agreement 
with the observed transcript levels (Figure 38B). The percentage of 
proliferation was comparable among the different groups at the 
beginning of the culture (DAY 0). At the end of the culture (DAY 7) 
an average of only 9% ± 0.85% of cells expressed the Ki67 antigen in 
conventional freezing tissue, compared with 26% ± 0.64% and 30%  ± 
0.73% for directional freezing and fresh groups respectively (Figure 
38B). 
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Figure 38. Quantitative evaluation of cell proliferation assessed 
both as Ki67 messenger RNA level (A) and as percentage of 
immunopositive cells for encoded protein (B). Values with 
differences (a-c) are significantly different (P<0.05). 
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DNA double-strand breaks 
We investigated the occurrence of DNA double-strand breaks by 
analysis of the expression of γ-H2AX, a marker of DNA damage, 
and RAD51, a marker of DNA repair. As expected, virtually no γ-
H2AX and RAD51 positive signals were detected in fresh tissue 
(Figures 39 and 42). 
Clear signals of DNA damage were observed in directional freezing 
ovaries at the beginning of culture, together with a weak staining for 
DNA repair. However, the DNA damage significantly decreased 
after 7 days of culture concomitantly with a sharp increase of DNA 
repair, as indicated by a clear immune signal of RAD51 (Figures 40 
and 42). 
In contrast, a very strong immune staining for γ-H2AX was 
observed in conventional freezing ovaries immediately after 
thawing, indicating widespread by RAD51 labeling either at the 
beginning or at the end of culture, suggesting a lack of DNA 
repairing ability (Figures 41 and 42). 
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Figure 39. Representative pictures of positive cells for γ-H2AX 
(marker of DNA breaks; GREEN) and RAD51 (marker of repair 
ability; RED) in fresh tissue. Scale bars = 100µm. 
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Figure 40. Representative pictures of positive cells for γ-H2AX 
(marker of DNA breaks; GREEN) and RAD51 (marker of repair 
ability; RED) in directional freezing tissue. Scale bars = 100µm. 
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Figure 41. Representative pictures of positive cells for γ-H2AX 
(marker of DNA breaks; GREEN) and RAD51 (marker of repair 
ability; RED) in conventional freezing tissue. Scale bars = 100µm. 
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Figure 42. Quantitative assessment of γH2AX and RAD51 by 
image analysis. Values with different indices (a-c) are significantly 
different (p<0.05). 
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PART II: A 2X2 FACTORIAL DESIGN: COMPARISON 
BETWEEN OVARIAN CORTICAL FRAGMENTS AND WHOLE 
OVARIES FROZEN WITH CONVENTIONAL OR 
DIRECTIONAL FREEZING 
 
All experimental groups (which included: 1. Directional freezing of 
whole ovary; 2. Directional freezing of ovarian fragments; 3. 
Conventional freezing of whole ovary; 4. Conventional freezing of 
ovarian fragments)  were compared with each other and with a fresh 
control, shortly after thawing and after 7 days of in vitro culture. 
 
Morphological assessment of cryopreserved samples 
Follicle morphology was investigated immediately after thawing 
and cryoprotectant removal. The percentage of morphologically 
normal follicles was inversely related to the stage of development, in 
all groups including fresh control. Where compared with 
conventional freezing, there were more intact follicles of all 
developmental stages following directional freezing. Ovarian 
fragments showed a higher rate of normal morphology compared 
with whole ovaries when frozen with conventional freezing. 
Interestingly, the opposite situation was observed when whole 
ovaries and ovarian fragments were preserved with directional 
freezing (Table 10). 
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Table 10. Percentage (mean±s.e.m) of morphologically normal 
primordial, intermediate, primary and secondary follicles in fresh 
tissue (CTR) and in experimental groups immediately after 
thawing. *number of evaluated follicles. a,b,c Different superscripts 
in the same column indicate a significant difference amongst 
experimental groups for the same follicle type (P<0.05). 
 
 
In vitro follicles development 
At the end of the culture, the proportion of primordial follicles 
which developed to the primary stage both in whole ovaries (53% ± 
1.7%) and in ovarian fragments (44% ± 1.8%) cryopreserved with 
directional freezing was significantly higher than with conventional 
frozen whole ovaries (6% ± 0.5%, P=0.001) or fragments (32% ± 1.5%, 
P=0.004). 
Morphologically normal follicles (%)  
Follicle Type  
 Primordial Intermediate Primary Secondary All follicles 
CTR 97.5± 4.5 a 
(n=600)* 
91.2± 4.34a 
(n=350)* 
88.40±4.12a 
(n=300)* 
71.5±4.44 a 
(n= 60)* 
92.54± 4.36 a 
(n= 1310)* 
DFwo 94.8±4.15a 
(n=600)* 
89.28± 4.29a 
(n=350)* 
85.23±3.95a 
(n=300)* 
68.62±3.34 a 
(n=60)* 
89.93± 4.10 a 
(n= 1310)* 
DFof 88.7±4.12b 
(n=300)* 
80.17±4.30b 
(n=150)* 
72.91±3.68b 
(n=100)* 
53.25±3.21b 
(n= 20)* 
82.24± 4.82 b 
(n= 570)* 
CFwo 78.4±3.97c 
(n=600)* 
58.10±3.32c 
(n=350)* 
43.5±3.21c 
(n=300)* 
23.4±1.92c 
(n=60)* 
62.46± 3.52c 
(n=1310)* 
CFof 84.40±4.03d 
(n=300)* 
69.72±3.27d 
(n=150)* 
64.20±3.34d 
(n=100)* 
42.70±2.76d 
(n=20)* 
75.53± 3.52d 
(n= 570)* 
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The percentage of developing follicles in whole ovaries was higher 
than in ovarian fragments when frozen with directional freezing but 
lower when frozen with conventional freezing. Finally, whole 
ovaries frozen with directional freezing had a rate of growing 
follicles not significantly different from fresh ovaries (55% ± 1.9%, 
P=0.106) (Figure 43). 
 
 
 
 
Figure 43. Percentage (mean ± s.e.m) of primordial follicles 
developed in the primary stage after 7 days of culture. Values with 
different indices (a-d) are significantly different (P<0.005). CTR= 
fresh control (n=280); DFwo= directional freezing whole ovary 
(n=280); DFof= directional freezing ovarian fragments (n=260); 
CFwo= conventional freezing whole ovary (n= 230); CFof= 
conventional freezing ovarian fragments (n=250). 
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Cell proliferation and apoptosis 
Differences in developmental competence of primordial follicles 
were consistent with differences in cell proliferation rate as 
examined by the expression of Ki67. The percentage of proliferating 
cells was comparable among the different groups at the beginning of 
culture (DAY 0) (Figure 44). After 7 days of culture, Ki67-positive 
cells in fresh tissue (30% ± 0.78%) and in whole ovaries frozen with 
directional freezing (28% ± 0.73%) were the highest of all groups. 
The rate of cells expressing Ki67 in ovarian fragments frozen with 
directional freezing (23% ± 0.81%) was significantly higher than 
those in ovarian fragments frozen with conventional freezing (20% ± 
0.79%, P=0.03). An average of only 9% ± 0.85% of Ki67-positive cells 
was found in whole ovaries frozen with conventional freezing 
(Figure 44). 
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Figure 44. Percentage of immunofluorescence positive cells for 
Ki67 at the beginning (DAY 0) and the end (DAY 7) of in vitro 
culture. Values with different indices (a-e) are significantly 
different (P<0.05). n=2360 ± 340 nuclei counted for each section. 
 
TUNEL-positive cells were detected both ad Days 0 and 7 of culture 
in all experimental groups. Interestingly, apoptotic level were not 
related to cell proliferation. Immediately after thawing and the 
removal of cryoprotectant, the number of apoptotic cells per mm2 
was low and comparable among all groups (Figure 45). The TUNEL 
assay showed that the number of positive cells after 7 days of culture 
was comparable for all experimental groups except in whole ovaries 
frozen with conventional freezing, where a significantly higher 
percentage of TUNEL- positive cells was visible after 7 days (29.34 ± 
1.13, P=0.002) (Figure 45). 
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Figure 45. Number of TUNEL-positive cells per mm2 at the 
beginning (DAY 0) and the end (DAY 7) of in vitro culture. Values 
with different indices (a-e) are significantly different (P<0.05). 
n=2360 ± 340 nuclei counted for each section. 
 
Expression level of Heat Shock Protein 
The effect of heat stress response after cryopreservation was 
examined by quantititative analysis of heat shock protein 40 
(HSP40), heat shock protein 70 (HSP70), heat shock protein 90 
(HSP90) and heat shock transcription factor 1 (HSF1) proteins at the 
end of the warming and cryoprotectant removal steps and after 7 
days of in vitro culture. 
Changes were only observed in whole ovaries frozen with 
conventional freezing after 7 days of culture, where the protein 
levels were significantly higher than on Day 0 (Figure 46), indicating 
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that conventional freezing applied to the whole ovary induced the 
activation of protein involved in stress-response pathways. There 
were no differences within and between the other groups (Figure 
46). 
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Figure 46. Western blots and densytometric analysis of heat shock 
proteins in sheep ovarian proteins extract from all experimental 
groups at the beginning (DAY 0) and the end (DAY 7) of culture. 
Values are expressed as mean ± s.e.m of three replicated measured 
in arbitrary units. * P<0.05. n= 10 fragments (2x2x1mm) for each 
replicate. 
 
 
DNA damage and repair 
 
The expression of a marker of DNA damage, γ-H2AX and a marker 
of DNA repair, RAD51, were analyzed immediately after thawing 
and after 7 days of culture. No γ-H2AX and RAD51 signals were 
detected in fresh tissue (Figures 47 and 52). A the beginning of 
culture (Day 0), a clear signals of DNA damage, in the form of γ-
H2AX foci,  were observed in whole ovaries and cortical fragments 
frozen with directional freezing (Figures 48 and 49) and in cortical 
fragments frozen with conventional freezing (Figure 51), together 
with a weak staining of DNA repair. After 7 days of culture, DNA 
damage was significantly decreased while DNA repair activity 
increased, as indicated by a clear RAD51 signal. A very strong 
staining for γ-H2AX was observed in conventional freezing whole 
ovary group at Day 0 (Figure 50) indicating widespread DNA 
damage but RAD51 labeling was low at that time, suggesting a lack 
of DNA repair. 
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Figure 47. Representative pictures of positive cells for γ-H2AX 
(marker of DNA breaks; GREEN) and RAD51 (marker of repair 
ability; RED) in fresh ovaries. Scale bars = 100µm. 
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Figure 48. Representative pictures of positive cells for γ-H2AX 
(marker of DNA breaks; GREEN) and RAD51 (marker of repair 
ability; RED) in whole ovaries frozen with directional freezing. 
Scale bars = 100µm. 
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Figure 49. Representative pictures of positive cells for γ-H2AX 
(marker of DNA breaks; GREEN) and RAD51 (marker of repair 
ability; RED) in ovarian cortical fragments frozen with directional 
freezing. Scale bars = 100µm. 
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Figure 50. Representative pictures of positive cells for γ-H2AX 
(marker of DNA breaks; GREEN) and RAD51 (marker of repair 
ability; RED) in whole ovaries frozen with conventional freezing. 
Scale bars = 100µm. 
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Figure 51. Representative pictures of positive cells for γ-H2AX 
(marker of DNA breaks; GREEN) and RAD51 (marker of repair 
ability; RED) in ovarian cortical fragments frozen with 
conventional freezing. Scale bars = 100µm. 
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Figure 52. Quantitative assessment of γ-H2AX and RAD51 by 
image analysis. Values with different indices (a-g) are 
significantly different (p<0.05). 
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PART III: EX VIVO CULTURE OF WHOLE OVARY 
 
Ovarian morphology 
Follicle morphology was investigated after 2 and 4 days of ex vivo 
culture. The percentage of morphologically normal follicles in fresh 
and frozen ovaries cultured for 2 days (89% ± 2.9% and 87% ±2.4% 
respectively, p= 0.106) was not significantly different than that in un-
cultured ovaries (Day 0) (95% ± 2.9% and 93%±  2,6% respectively, 
p=0.093). However, after 4 days of culture, a reduction (p=0.048) of 
intact follicles was observed in both fresh and frozen ovaries (79% ± 
2.7% and 75% ± 2.1% respectively, p=0.095) (Figure 53). 
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Figure 53. Overall distribution of morphologically normal follicles 
in fresh ovaries (FRESH) and in frozen/thawed ovaries (FROZEN) 
at different days of ex vivo culture. Values with different indices 
(a-b) are significantly different (P<0.05). 
 
Cell proliferation and TUNEL assay 
Cell proliferation was evaluated by counting Ki67-positive cells. No 
differences on cell proliferation rate were found between fresh and 
frozen ovaries for all days analyzed. After 2 days of culture, the 
percentage of cells expressing Ki67 was comparable (p=0.087) to un-
cultured ovaries (Day 0) in both fresh and cryopreserved ovaries. 
Only after 4 days of culture, a reduction (p=0.048) of cell 
proliferation was observed in both fresh and frozen ovaries 
(21.3%±0.87% and 20.5%±0.83%, respectively, p=0.010) (Figure 54). 
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Figure  54. Percentage of immunofluorescence positive cells for 
Ki67 in fresh ovaries (FRESH) and in frozen/thawed ovaries 
(FROZEN) at different days of ex vivo culture. Values with 
different indices (a-b) are significantly different (P<0.05). n=1980 ± 
231 nuclei counted for each section. 
 
Similar results were observed for the apoptotic index. No 
significantly different (p=0.079) for apoptotic level were observed 
between day 0 and day 2 both in fresh and frozen ovaries. However, 
after 4 days of culture, the number of apoptotic cells per mm2  
increased (p=0.043) in both groups (Figure 55). 
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Figure 55. Number of TUNEL-positive cells per mm2 in fresh 
ovaries (FRESH) and in frozen/thawed ovaries (FROZEN) at 
different days of ex vivo culture. Values with different indices (a-
b) are significantly different (P<0.05). n=1980 ± 231 nuclei counted 
for each section. 
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5. DISCUSSION 
 
Cryopreservation of ovarian tissue is the only available option for 
preserving female fertility in pre-pubertal girls or in a series of 
circumstances when gonadotoxic treatments cannot be delayed [186, 
187]. This can be achieved through the excision and banking of 
whole organs or of ovarian cortical fragments. 
In theory cryopreservation of whole ovaries with an intact vascular 
pedicle should prevent post-transplantation ischemic damage by 
enabling the anastomosis of the severed vessels. However, 
cryopreservation of whole organ is much more complicated than 
ovarian cortical fragments due to the  heat transfer problems and the 
non-homogenous rate of cooling between the core and the periphery 
of the organ. Therefore, it is important to identify the technique that 
can provide the best cryopreservation of large specimens. 
Particularly in order to provide real advantages it is necessary that 
the three dimensional structure of the organ and its vasculature 
network remains largely intact. 
This has proved problematic when an entire ovary is frozen with 
conventional slow freezing procedures that  reduce the sample 
temperature through multidirectional heat transfer by convection 
which does not allow a uniform cooling between the core and the 
periphery of the specimen [98]. As a consequence ice growth takes 
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place with uncontrolled velocity thereby causing structural damages 
especially in the area with higher water content like vessels [102]. 
On the contrary directional freezing is based on the generation of a 
thermal gradient by a large mass of conductive material. The sample 
moves through it at a predetermined velocity resulting in a precise 
and uniform liquid-ice interface and in an efficient removal of the 
latent heat [102]. Therefore temperature gradient between the inner 
portion of the organ and its surface is reduced to a minimum, 
together with the formation of large disrupting ice crystals. 
The results obtained in this thesis by directly comparing directional 
and conventional slow freezing for preserving whole ovaries 
support this notion. 
The first benefit observed in our samples was a better preservation 
of vessel integrity that spanned all size categories and both inner 
and outer ovarian regions. Our results indicated that the perfusion 
of Indian Ink flowed with no noticeable difference between whole 
ovaries frozen with directional freezing and fresh controls (Figure 
33). 
Preservation of intact blood vessels was not the only advantage of 
directional freezing. The preservation of a stromal cell density 
indistinguishable from the fresh control (Figure 34) is particularly 
relevant since damages to the ovarian stroma are known to be 
caused by the freezing-thawing process when whole ovaries were 
analyzed [166, 188] and are characterized by stromal edema and 
130 
 
lower cell density.  These alterations reflect a structural damage that 
compromises follicular survival and development [189]. Therefore 
the extended damage of the ovarian stroma that we observed after 
conventional freezing is consistent with similar alterations observed 
in previous experiments on sheep ovaries [166, 188, 189]. 
Alteration of the stromal structure was associated with the  lower 
developmental competence exhibited by the primordial follicles of 
the whole ovaries frozen with conventional freezing at the end of the 
7 days culture period (Figure 36). In fact, whole ovaries frozen with 
conventional freezing displayed a lower percentage of normal 
follicles as compared with directional freezing and fresh groups 
(Figure 37). These result are consistent with previous studies that 
reported a significant decrease in the percentages of morphologically 
normal follicles in sheep and cow whole ovaries frozen with 
conventional freezing [166, 190]. 
Furthermore, we observed a lower rate of cell proliferation in whole 
ovaries frozen with conventional freezing both at the beginning and 
at the end of the culture period (Figure 38). This is certainly related 
to the higher rate of DNA damage observed at the same time 
because the presence of double-strand breaks into DNA triggers a 
complex set of responses which include cell cycle arrest. We have 
examined the expression of the histone variant γH2AX, the 
phosphorylated form of H2AX which is formed within minutes of 
DNA damage [191]. The presence of γH2AX at the foci which form 
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at DNA break sites attracts BRCA2 which, in turn, binds to RAD51 
and activates DNA repair [192]. 
Our results showed that DNA damage in directional freezing of 
whole ovaries was higher than in fresh controls. However upon 
culture progression, DNA repair activity was evident in directional 
freezing of whole ovaries leading to a substantial reduction of DNA 
damage, whereas DNA repair activity was virtually absent in whole 
ovaries frozen with conventional freezing, leaving the rate of DNA 
damage substantially unchanged (Figure 42). Evaluation of DNA 
damage and repair mechanisms allows a more sensitive assessment 
of cellular damage as compared to measuring apoptosis which is an 
irreversible process [193]. In this case the high levels of Rad51, a 
marker of DNA repair, observed in directional freezing of whole 
ovaries after 7 days of culture allows us to see that the DNA damage 
observed on day 1 of culture was reversible. The ability of  
directional freezing of whole ovaries to repair DNA damage is 
particularly relevant for its long term function after thawing since 
DNA double strand break repair efficiency has been identified as an 
important determinant of oocyte aging in women [194]. 
However, whereas no live births or pregnancies have been achieved 
following the cryopreservation of whole human ovaries, 24 live 
babies have been obtained after transplantation of frozen-thawed 
ovarian fragments [186]. This suggests that the use of ovarian 
fragments is the method of choice even if, at present, the average 
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functional life span of these samples ranges from 2 to 5 years [186, 
195]. 
Therefore it was of interest to determine whether directional 
freezing could also improve the viability of ovarian fragments and 
how these would compare with whole ovaries frozen with the same 
method. For this reason, in this thesis ovarian cortical fragments 
were cryopreserved with both freezing methods and the data 
obtained were compared with whole ovaries frozen with the same 
method. 
Our results, showed that the use of directional freezing significantly 
improved the integrity of all follicular structure from primordial to 
secondary stages and although the effect was evident in both whole 
organs and ovarian fragments, it was more efficient in whole organs 
(Table 10). 
Functional analysis of in vitro growth of primordial follicles 
confirmed the same pattern. Directional freezing was beneficial for 
both entire ovaries and ovarian fragments but directional freezing of 
whole ovaries was the only group whose viability was the same as 
that of fresh tissue (Figure 43). This result is somehow unexpected 
since cryopreservation efficiency is inversely related to the size of 
the sample. 
In fact, large biological samples suffer from a long isothermal period 
caused by the massive release of latent heat during the process of ice 
formation [162, 196].  The phenomenon is caused by the energy 
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generated by water molecules when they rejoin to form an ice 
crystal. Such energy is released in the form of heat that causes a 
temperature rise of the surrounding structures [116]. The heat is 
normally transferred to the ice crystals that have just been formed 
because these are made of conductive material. The consequence is a 
transient thawing followed by refreezing in a sequence that is 
repeated several times through the thickness of the sample causing 
severe cell damage [197, 198]. Damage is usually reduced by keeping 
the ratio of surface to volume as high as possible so that the 
excessive heat is removed by adjusting the cooling rate to achieve 
uniform freezing. The thinner the sample the faster the heat, released 
from its inner parts, is removed minimizing the damage. However 
the need to have samples as thin as possible is in contrast with the 
requirement of having a large follicle population upon thawing and 
it is impossible when using low surface to volume ratio samples like 
whole ovaries. The large mass of conductive material in the MTG 
apparatus serves the purpose of quickly removing the latent heat 
from large samples thereby preventing the thawing and freezing 
sequence  [109]. 
These considerations largely explain the better results of directional 
freezing compared to conventional slow freezing described in our 
experiments, but cannot account for the better performance obtained 
with whole ovaries than with smaller ovarian fragments. We 
hypothesize that the different ways that the cryoprotectant was 
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administered may have a role. The presence of the ovarian pedicle in 
entire ovaries enabled an extensive uniform perfusion through the 
vasculature [199]. 
Consistent with the favorable effect of directional freezing on 
primordial follicle viability in vitro we observed a higher cell 
proliferation rate compared to samples that underwent conventional 
freezing (Figure 44). 
In an attempt to understand the mechanisms that may have caused 
this effect we studied known responses to temperature stress, which 
is inherent to any form of cryopreservation. One of the best 
characterized responses to thermal stress is the expression of HSPs 
[200]. HSPs bind to other proteins, termed clients, which are 
damaged by thermal or other stress conditions and mediate their 
transport to target organelles for repair or degradation [201]. 
Our results show that the HSP machinery was significantly 
stimulated over baseline levels only in the case of conventional 
freezing of whole ovaries (Figure 46). This is consistent with 
particularly extensive protein damage in this group since the client-
chaperone binding and release cycles are repeated several times 
until the client has reached its final active conformation, or has 
entered the proteolytic system [202]. 
The presence of extensive cellular damage in whole ovaries frozen 
with conventional freezing was confirmed by the significant increase 
in apoptotic cells after 7 days of culture (Figure 45), consistent with 
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the notion that the accumulation of damaged proteins, if unresolved, 
can lead to apoptosis [203]. However protein damage is not the only 
cause of apoptosis as it can also be activated by a failure of DNA 
repair mechanisms [204]. In fact the high levels of DNA damage 
associated with a lack of DNA repair activity observed in 
conventional freezing of whole ovaries is consistent with the high 
apoptotic rate observed in the same group. 
In contrast to HSPs, γ-H2AX and RAD51 are not visible in the nuclei 
of intact cells therefore it was possible to detect their increased 
expression in our experimental samples. Results were consistent 
with the pattern of follicular viability since DNA damage was 
significantly lower in directional freezing samples followed by more 
intense DNA repair activity suggesting that the DNA damage 
observed on day 1 of culture was reversible (Figure 52). 
Our results, indicated that directional freezing improves the viability 
of cryopreserved ovarian tissue both in whole organs and cortical 
fragments, but we observed a better preservation of follicles when 
the samples were frozen as whole ovaries. 
However it must be remembered that a high risk of retransmission 
of malignancy exists if autotransplantation of ovarian tissue were 
performed in women who have suffered from systemic 
hematological malignancies [187], [205]. In this respect whole ovary 
cryopreservation cannot offer any improvement in case of 
autotransplantation, but it could provide some appealing alternative 
136 
 
for the development of methods aimed at grafting isolated follicles 
in an artificial ovary [206] or other, yet to be described, methods. 
Vanacker et al., developed the first  biodegradable artificial ovary 
with the aim to offer an environment where isolated follicles and 
ovarian cells can survive and grow [206]. However, to achieve this, 
the artificial ovary needs to hold isolated follicles in their original 
three-dimensional form, since it is essential to maintain intercellular 
interactions between granulosa cells and oocytes, which regulate 
many aspects of oocyte growth and development. Furthermore, as 
human ovarian follicles are exceptional in that they can grow to 
around 600× their size during folliculogenesis , the artificial ovary, 
unlike other artificial organs, should also be biodegradable. 
Furthermore, for these reasons,  more studies are required to assess 
the value of incorporating isolated pre-antral follicles and evaluate 
their survival and interaction with ovarian cells. 
In the experiment described in this thesis, we developed a perfusion 
system for ex vivo culture of  whole ovaries. This represents an 
experimental situation which is close to an in vivo situation, with 
preserved ovarian tissue architecture and intravascular flow. 
Fresh and frozen whole ovaries were cultured for 2 or 4 days and 
our results showed that none of the parameters considered, were 
affected by cryopreservation. 
Morphological analysis showed unaltered histological appearance 
and absence edema after 2 or 4 days of culture (Figure 53). 
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The high rate of Ki67 positive cells (Figure 54), associated with a 
small percentage of TUNEL positive cells (Figure 55), detected until 
day 2, demonstrated that our culture system can support ovarian 
tissue survival and proliferation. More experiments are needed in 
order to extend the culture period since a gradual decrease in 
expression of Ki-67 in concomitance with apoptotic index increment 
were detected from day 2 to 4. 
Previous studies were carried out in human postmenopausal [207] 
and in rat [208] ovary for a short culture period (8-10 hours). The 
experiment described in this thesis,  constituted the first attempt to 
maintain alive a large animal ovary outside the body. 
Based on these successful preliminary results, we believe this culture 
system can also be used for future studies aiming to stimulation of 
primordial follicles growth through ex-vivo perfusion for future in 
vivo or in vitro use. 
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6. CONCLUSION 
 
Data obtained indicated that directional freezing improves the 
viability of cryopreserved ovarian tissue not only when used with 
whole organs but also with ovarian fragments. This provides a way 
to further improve the efficiency of this procedure. 
The direct comparison of cortical fragments and whole organs, 
unexpectedly revealed that the latter show better preservation of 
early follicles in many aspects almost identical to those recorded in 
fresh control samples. This encourages a reconsideration of the 
possible use of whole ovary cryopreservation as a viable alternative 
to cortical fragments. 
Data obtained from the ex vivo culture, demonstrated that it is 
possible to culture fresh and frozen-thawed whole ovaries for up to 
4 days, suggesting that in the future this technique could provide 
appealing alternative to the re-transplantation of cryopreserved 
ovarian tissue, with the purpose to eliminate the risk of transmission 
of cancer cells in women who have systemic hematologic 
malignancies. 
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Design: Experimental animal study.
Setting: Academic research environment.
Animal(s): Adult ewes.
Intervention(s): Eighty-one ovaries were randomly assigned to fresh control, conventional freezing (CF), and directional freezing (DF)
group. Ovaries of CF and DF groups were perfused via the ovarian artery with Leibovitz L-15 medium, 10% fetal bovine serum, and
1.5 M dimethyl sulfoxide for 5 minutes. Each ovary was inserted into a glass test tube containing 10 mL of the same solution and cooled
to 100C or 70C, respectively. Ovaries were stored in liquid nitrogen for a minimum of 2 weeks.
Main Outcome Measure(s): Structural integrity of cortical and medulla regions, vascular integrity, follicle in vitro development, cell
proliferation, and DNA damage and repair.
Result(s): All examined parameters indicate that the structure of DF ovaries remains largely intact and comparable to fresh controls,
whereas signiﬁcant damages were observed in CF ovaries.
Conclusion(s): Directional freezing allows good preservation of whole ovaries, with most of the parameters taken into considerationUse your smartphone
almost identical to those recorded in fresh control samples. This encourages a reconsideration of
the possible use of whole-ovary cryopreservation as a viable alternative to cortical fragments.
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fragments and cryopreservation of the
whole ovary. The ﬁrst technique is
currently the most widely used, owing
to the higher efﬁciency of the cryo-
preservation methods and to the
less-invasive nature of the retransplan-
tation procedures (3–8). On the other
hand, the relatively small size of
grafted cortical fragments and
their avascular nature may limit
their functional longevity upon
transplantation (9). However, recent
follow-up studies of ovarian fragment
transplantation suggest that this may
not be the case because, in some cases,VOL. 100 NO. 4 / OCTOBER 2013
Fertility and Sterility®both fresh and cryopreserved tissue may remain functional
for up to 7 years (10, 11).
Whole ovary cryopreservation with vascular reanasto-
mosis, in theory, represents an appealing method to reduce
ischemic time and prolong graft longevity (12). In fact,
successful cryopreservation and transplantation of whole
ovaries have been reported in different experimental animal
species (mice, rat, rabbit, dog, and sheep) (13–17). However,
the method suffers from a number of drawbacks. In
particular, orthotopic transplantation has proved technically
very challenging and cannot prevent ischemic damage
(18, 19). In addition, the possibility exists to reintroduce
malignant cells, even if this risk is also present when
ovarian fragments are transplanted (20).
Nevertheless, it is important to improve the efﬁciency of
cryopreserving whole organs, because in large mammals and
humans this has been more problematic than in small
animals, owing to heat transfer in such large organs (21)
caused by the large thermal gradient existing between the
surface and the interior of the system (22). At present
there are two main methods for cryopreserving whole ovary:
conventional freezing (CF) and directional freezing (DF).
Conventional freezing operates on the principle of heat
transfer by convection (23, 24). Directional freezing is an
alternative approach to preserve the large organs, based on
the physical concept of DF, which enables precise
adjustment of the temperature gradients to achieve an
accurate cooling rate through the entire tissue (17, 25, 26).
This method has solved the problems associated with heat
release by maintaining a uniform cooling rate through the
entire organ. Although whole ovary cryopreservation with
DF followed by successful retransplantation has been
performed once in sheep (17), data regarding this newmethod
are limited. In particular a direct comparison with CF has
never been performed. The aim of this study was to compare
the efﬁciency of CF with DF of whole ovaries. On the basis of
our results (27) and those in the literature (17, 28), the sheep
ovary was chosen as a model because of its similarity to the
human ovary.
MATERIALS AND METHODS
Unless otherwise indicated, chemicals were purchased from
Sigma-Aldrich.Ovaries Collection
Sheep female reproductive tracts were collected at the local
slaughterhouse and transported to the laboratory in cold
(0–4C) 0.9% saline solution. A total of 81 ovaries were
randomly assigned to a fresh control group (CTR, n ¼ 27),
CF group (n ¼ 27), or DF group (n ¼ 27). Upon arrival to
the laboratory, ovaries of the CF and DF groups were perfused
via the ovarian artery with Ringer’s solution and 10 UI/L
heparin for 10 minutes, followed by perfusion with cryopro-
tectant solution containing Leibovitz L-15 medium
(Life Technologies), 10% fetal bovine serum (vol/vol; Life
Technologies), and 1.5 M dimethyl sulfoxide for 5 minutes
(29). Each ovary was inserted into a 16-mm-diameter glass
test tube (Manara) containing 10 mL of the same solution.VOL. 100 NO. 4 / OCTOBER 2013Conventional Freezing
Conventional freezing was performed in a Kryo 560M
apparatus (Planer) with the following program: [1] from 4
to 40C using a cooling rate of 0.5C/min (seeding was
induced at 7C), [2] from 40 to 100C at 5C/min,
and [3] immersion in liquid nitrogen (29).Directional Freezing
Directional freezing was performed with a Multi-Thermal-
Gradient (IMT). Brieﬂy, the technology operates on the
physical concept of DF and is based on a series of four
heat-conductive blocks arranged in a line. Different
temperatures are set along the blocks, thereby imposing a
temperature gradient. Freezing tubes were pushed along the
thermal gradient (þ4 to 70C), and the speed was set at
0.01 mm/s, resulting in a cooling rate of 0.3C/min, after
which samples were plunged into liquid nitrogen (17, 25).Ovarian Thawing
Ovaries frozen with CF and DF were thawed by plunging the
test tubes into a 68C water bath for 20 seconds and then into
a 37C water bath for 2 minutes. The cryoprotectant solution
was rinsed out of the ovaries by perfusion via the ovarian
artery with 10 mL N-2-hydroxyethylpiperazine-N0-2-
ethanesulfonic acid–Tyrode's albumin lactate pyruvate me-
dium (HEPES-TALP medium), supplemented with 0.5 mol/L
sucrose and 10 IU/mL heparin at 38C, followed by another
10 mL rinse with no sucrose (17, 25).Morphologic Analysis
Nine ovaries from each group were allocated to morphologic
and immunochemical analysis. To improve ﬁxation, ovaries
were cut in half, embedded in parafﬁn, and stained with
hematoxylin and eosin. Samples were observed under an
Eclipse E600 microscope (Nikon), and pictures were acquired
with Nis Elements Software (version 4.0). Follicles were
classiﬁed as primordial (1 layer of ﬂattened granulosa cells
around the oocyte), intermediate (1 layer of ﬂattened to
cuboidal granulosa cells around the oocyte), primary (a single
layer of cuboidal granulosa cells around the oocyte), or
secondary (oocyte surrounded by two or more layers of
cuboidal granulosa cells). Follicles were further classiﬁed as
normal, when a spherical oocyte with a non-pyknotic nucleus
was surrounded by granulosa cells organized in discrete
layers; or degenerated, when a misshapen oocyte with or
without vacuolation with a pyknotic nucleus was surrounded
by disorganized granulosa cells detached from the basement
membrane (30). Stromal cell density was quantiﬁed by
counting nuclei with ImageJ software (National Institutes of
Health) as described below.Immunohistochemistry
Ovarian cortical fragmentswereﬁxedwith 10% formaldehyde,
embedded in parafﬁn, and sectioned before immunostaining.
Slides were then boiled for 5 minutes in antigen-unmasking
solutions (Vector Laboratories) and then blocked with a1123
ORIGINAL ARTICLE: REPRODUCTIVE SCIENCEsolution of 1%bovine serum albumin. Samples were incubated
over night at 4Cwith the following primary antibodies: rabbit
polyclonal antibody speciﬁc for Ki67 marker of cell prolifera-
tion (1:50 dilution; Abcam) cross-reacts with the sheep antigen
(31, 32); mouse monoclonal anti-gH2AX, a DNA damage
marker, which speciﬁcally reacts with sheep (1:200; Abcam);
and rabbit monoclonal anti-RAD51, a DNA repair marker
(1:200; Santa Cruz Biotechnology). We validated its speciﬁcity
for the ovine antigen with a Western blot analysis of ovarian
proteins, which revealed a 37-kDa signal, the expected
molecularweight (datanot shown). Sectionswerewashed three
times with phosphate-buffered saline and incubated with
suitable secondary antibodies (Alexa Fluor; Life Technologies)
for 45 minutes. Nuclei were stained with 40,6-diamidino-2-
phenylindole. Samples were observed under an Eclipse E600
microscope (Nikon), pictures were acquired with Nis Elements
Software (version 4.0), and the images were analyzed using
ImageJ software as described below.Blood Vessel Integrity
Vessel integrity was assessed using Indian ink. Fresh ovaries
were perfused with 10 mL Ringer’s solution supplemented
with 10 IU/mL heparin, and thawed ovaries were perfused
as described above. Thereafter, six ovaries from each group
were perfused via the ovarian artery with a solution of 25%
Indian ink in 0.9% NaCl supplemented with 167 IU heparin/
mL for 5 minutes (33), with a ﬂow rate of 1.3 mL/min. A
perfusion was considered successful if Indian ink was
macroscopically seen to perfuse the whole ovary. After
perfusion ovaries were ﬁxed in 10% formaldehyde and
embedded in parafﬁn for hematoxylin and eosin staining.
Perfused vessels were classiﬁed as intact or damaged,
according to the presence or absence of Indian ink in the
lumen, respectively. Vessels were divided into three categories
according to their size: small (Ø%20 mm), medium (Ø 21–74
mm), and large (ØR75 mm). Vessel number was determined in
six randomly selected ﬁelds per section of both medulla and
cortical tissue of each ovary. For each experimental group a
minimum of 200 vessels were counted.Image Analysis
Pictures were taken with constant exposure parameters, to
ensure reproducible analysis with the image analysis
software ImageJ (http://rsbweb.nih.gov/ij/index.html) after
conversion in 8-bit grayscale. A minimum cut-off for
intensity and particle size was established. Nuclei on border
edges were excluded.Follicle Culture
Culture procedure was as previously described (34). Brieﬂy,
six fresh and frozen/thawed ovaries for each group were
cut in half, and large antral follicles, corpora lutea, and me-
dulla were removed. The isolated cortex of each ovary was
divided into several fragments of approximately 2  2  1
mm. Cryoprotectant was removed from CF and DF fragments
through stepwise washings of 10 minutes each in Alpha
Minimum Essential Medium (a-MEM) supplemented with1124sucrose (0.5 M, 0.25 M, 0.125 M, and 0 M). Three fragments,
for each ovary, were immediately ﬁxed in 10% formaldehyde
solution for histologic studies (time 0, control). Other frag-
ments were placed into 24-well culture dishes (Sarstedt)
and individually cultured in 1 mL of medium for 7 days at
39C under an atmosphere of 5% CO2 in air. The culture
medium was composed of a-MEM (Life Technologies) sup-
plemented with ITS (6.25 mg/mL insulin, 6.25 mg/mL trans-
ferrin, and 6.25 ng/mL selenium) (Life Technologies), 2 mM
glutamine (Life Technologies), 0.23 mM pyruvate, 2 mM hy-
poxantine, 1.25 mg/mL bovine serum albumin, 100 mg/mL
penicillin G, 100 mg/mL streptomycin, 200 mIU/mL sheep
FSH, and 50 ng/mL human recombinant basic ﬁbroblast
growth factor (R&D Systems) (34). Medium was replaced
every 2 days.Semiquantitative Polymerase Chain Reaction
Total RNA was extracted from the cortical region of six
ovaries for each group using TRIzol Reagent (Life Technolo-
gies) and reverse transcribed into complementary DNA in a
total volume of 20 mL reaction mixture containing 1 mL oli-
go(dT)12-18 (500 ng/mL). Reverse transcription was performed
with 200 U/mL Superscript II reverse transcriptase (Life Tech-
nologies) for 1 hour at 42C. Complementary DNA ampliﬁca-
tions were carried out in an automated thermal cycler
(iCycler; Bio-Rad), using the appropriate conditions for
Ki67-speciﬁc primers (forward 50-atggggagtgagaaggaggt-30;
reverse 50-tccaagttccccttgcatac-30; Tm 59C). Sheep DNA
was used as positive control. The optimal cycle number at
which the transcript was ampliﬁed exponentially was estab-
lished running a linear cycle series, and the number of PCR
cycles was kept within this range. An aliquot of each comple-
mentary DNA sample was ampliﬁed by PCR with b-actin
gene-speciﬁc primers (forward primer: 50-ccaaggccaaccgtga-
gaag-30; reverse primer 50-ccatctcctgcttcgaagtcc-30; Tm
57C). The reverse transcription–polymerase chain reaction
products were subjected to electrophoresis on a 2% agarose
gel, and the intensity of each band was assessed by densito-
metric analysis performed with Quantity One software (Bio-
Rad). The relative amount of Ki67transcript was calculated
by dividing the intensity of the Ki67 band by the intensity
of the b-actin band.Statistical Analysis
All experiments were performed in at least six biologically
independent replicates. Data are reported as mean  SEM.
Mann–Whitney U test (SPSS 19.1; IBM) was used to analyze
vessel numbers, and one-way analysis of variance followed
by Turkey’s post hoc tests (SPSS 19.1; IBM) were used for
all the remaining experiments. Differences were considered
statistically signiﬁcant at P< .05.
RESULTS
Morphologic Assessment Immediately after
Thawing
The percentage of morphologically normal follicles in
each group is shown in Figure 1A. The rate of intactVOL. 100 NO. 4 / OCTOBER 2013
FIGURE 1
Morphologic analysis of ovarian cortical andmedullar regions in fresh control and frozen–thawed ovaries. (A) Overall distribution ofmorphologically
normal follicles in CTR and in DF or CF groups after thawing. (B, C) Representative pictures of the medullar region of the different experimental
groups (B) and the quantitative results of image analysis (C). Values with different indices (a–b) are signiﬁcantly different (P<.05).
Maffei. Directional freezing of whole ovaries. Fertil Steril 2013.
Fertility and Sterility®follicles in the DF group (89%  1.7%) was signiﬁcantly
higher (P< .05) than that in the CF group (61%  3.4%),
and it was not different (P¼ .75) from that in fresh
control tissue (96%  1.5%) (Fig. 1A). Quantitative
assessment of stromal cell density indicated that DF
ovaries had values (17,041 nuclei per mm2) similar to
those of fresh organs (17,833 nuclei per mm2) but signif-
icantly higher than in CF ones (10,875 nuclei per mm2)
(Fig. 1B and C).VOL. 100 NO. 4 / OCTOBER 2013Indian ink was observed only in blood vessels and not in
the surrounding tissue, indicating an optimal perfusion
(Fig. 2A). The DF and CTR ovaries displayed the same rate
of intact vessels in ovaries, both in the medulla (stromal
vessels) and in the cortex (perifollicular vessels) (Fig. 2B).
Conversely, CF ovaries displayed a signiﬁcantly lower
number of intact vessels (P¼ .009). No signiﬁcant differences
between ovarian medulla and cortex vessels were observed,
either in control or in cryopreserved samples (Fig. 2B).1125
FIGURE 2
(A, B) Representative pictures of blood vessels in the different experimental groups classiﬁed in three diameter categories (A) and their distribution in
the medulla and cortex regions (B). Values with different indices (a–b) are signiﬁcantly different (P<.05). Scale bars ¼ 100 mm.
Maffei. Directional freezing of whole ovaries. Fertil Steril 2013.
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After 7 days of culture the rate of primordial follicles that
resumed their development reaching the primary stage was
higher in DF than in CF ovaries. The developmental
competence of DF ovarian fragments was the same as in fresh
control tissue, whereas CF fragments showed a signiﬁcant
decrease of the overall follicle number (P¼ .038; Fig. 3A).1126The percentage of intact follicles in ovarian tissue before
and after in vitro culture is show in Figure 3B. Consistent with
their developmental capacity, the rate of morphologically
normal primordial, intermediate, and primary follicles in the
DF group was not different from that in the CTR group
upon thawing. In contrast, the CF group displayed a higher
rate (P< .05) of degenerated follicles and oocytes withVOL. 100 NO. 4 / OCTOBER 2013
FIGURE 3
Functional assessment of cortical fragments cultured in vitro for 7 days. (A) Distribution of primordial, intermediate, and primary follicles at the
beginning (day 0) and at the end (day 7) of the culture period. (B) Overall distribution of morphologically normal follicles during culture in the
three experimental groups. (C) Quantitative evaluation of cell proliferation assessed both as Ki67 messenger RNA levels (left) and as percentage
of immunopositive cells for the encoded protein (right). Values with different indices (a–c) are signiﬁcantly different (P<.05).
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Fertility and Sterility®pyknotic nuclei. Seven days later a signiﬁcant reduction in
the percentage of histologic normal follicles was found
in the CF group (24%  5.7%) compared with the DF
(77%  2.8%) and CTR groups (85%  2.43%).
After 7 days of culture abundance of Ki67 transcripts
signiﬁcantly increased in DF and CTR tissue (P< .05); by
contrast, a reduction in Ki67 messenger RNA level was
detected in CF tissue (P< .05) (Fig. 3C, left). Ki67 immunoﬂu-
orescence results were in agreement with the observed
transcript levels (Fig. 3C, right). The percentage of prolifera-
tion was comparable among the different groups at day 0.
After 7 days of culture an average of only 9% 0.85% of cells
expressed the Ki67 antigen in CF tissue, compared with 30%
 0.73% and 26%  0.64% for fresh and DF tissue sections,
respectively (Fig. 3C, right).
Coherent with this pattern are the data observed
investigating the occurrence of DNA double-strand breaks.
These were obtained through the analysis of the expression
of g-H2AX, a marker of DNA damage, and of RAD51, a
marker of DNA repair, and are shown in Figure 4. As expected,VOL. 100 NO. 4 / OCTOBER 2013virtually no g-H2AX and RAD51 signals were detected in
fresh tissue. Clear signals of DNA damage, in the form of
g-H2AX foci, were observed in DF tissue at the beginning
of culture, together with a weak staining for DNA repair.
The DNA damage, however, signiﬁcantly decreased after
7 days concomitantly with a sharp increase of DNA repair,
as indicated by a clear RAD51 immune signal (Fig. 4A and
B). By contrast, a very strong immune staining for g-H2AX
was observed in CF ovaries immediately after thawing,
indicating widespread DNA damage, but this was not
accompanied by RAD51 labeling either at the beginning or
at the end of culture, suggesting a lack of DNA repairing
ability (Fig. 4A and B).
DISCUSSION
This article describes the ﬁrst direct comparison between
directional and conventional slow freezing for preserving
whole ovaries. We have used sheep ovaries because their
size and texture is comparable to human ovaries, although
their volume, on average, is smaller (25, 35–42).1127
FIGURE 4
Representative pictures of cells positive for gH2AX (marker of double-strand DNA breaks; green) and RAD51 (marker of repair ability; red). (A)
Immunostaining was carried out at day 0 and day 7 of in vitro culture. (B) Quantitative assessment by image analysis. Values with different
indices (a–c) are signiﬁcantly different (P<.05). Scale bars ¼ 100 mm.
Maffei. Directional freezing of whole ovaries. Fertil Steril 2013.
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Fertility and Sterility®In theory, cryopreservation of whole ovaries with an
intact vascular pedicle should prevent post-transplantation
ischemic damage by enabling the anastomosis of the severed
vessels. However, previous attempts showed that a large loss
of follicles, up to 98%, takes place even after vascular anasto-
mosis (15). The fact that extensive damage also occurs with
fresh ovaries suggests that ischemia induced by thromboem-
bolism in the ovarian vascular system plays a major role and
is due to the technically challenging nature of this complex
surgery. This not only causes extensive tissue necrosis but
may cause increased morbidity and mortality. In addition,
the prolonged surgical procedures due to the technical
complexity of the vascular surgery may cause the so-called
warm ischemia, which determines more or less extensive
follicular losses. Although advances in transplantation
techniques will decrease current limitations of the surgical
procedures, it is important to identify the technique that can
provide the best cryopreservation of large specimens.
In particular, to provide real advantages it is necessary that
the 3-dimensional structure of the organ and its vasculature
network remain largely intact. This has proved problematic
whenan entire ovary is frozenwith conventional slow freezing
procedures that are efﬁciently used for smaller entities like
oocytes or embryos. Conventional freezing devices reduce
the sample temperature throughmultidirectional heat transfer
by convection, which does not allow a uniform cooling
between the core and the periphery of the specimen (22). As
a consequence ice growth takes place with uncontrolled
velocity, thereby causing structural damage, especially in the
area with higher water content, like vessels (26).
Our data support this notion as speciﬁcally indicated by
the high rate of damaged blood vessels observed after CF,
both in the medullary and in the cortical region.
Conversely, DF is based on the generation of a thermal
gradient by a large mass of conductive material. The sample
moves through it at a predetermined velocity, resulting in a
precise and uniform liquid–ice interface and in an efﬁcient
removal of the latent heat (43). Therefore temperature
gradient between the inner portion of the organ and its
surface is reduced to a minimum, together with the formation
of large disrupting ice crystals. The ﬁrst beneﬁt observed in
our samples was a better preservation of vessel integrity
that spanned all size categories and both inner and outer
ovarian regions. Our results indicated that the perfusion of
Indian ink ﬂowed with no noticeable difference between DF
and fresh controls. This aspect is particularly important in
view of a possible in vivo retransplantation because it would
ensure a smooth resumption of the circulation. Indeed a fully
functional vascular supply was demonstrated by magnetic
resonance imaging in one sheep ovary 24 months after its
transplantation after cryopreservation with DF (25). However,
the success rate remains low (from 30% to 50%) (15, 17, 44),
leaving open the options for a fair risk evaluation between a
long-term functional whole ovary and a failed transplanta-
tion, which leaves no alternative options.
However, preservation of intact blood vessels was not the
only advantage of DF. The preservation of a stromal cell
density indistinguishable from that in the fresh control is
particularly relevant because damages to the ovarian stromaVOL. 100 NO. 4 / OCTOBER 2013are known to be caused by the freezing–thawing process
when whole ovaries or cortical fragments were analyzed
(45, 46) and are characterized by stromal edema and lower
cell density. These alterations reﬂect a structural damage
that compromises follicular survival and development (47).
Therefore the extended damage of the ovarian stroma
observed after conventional slow cooling is consistent with
similar alterations observed in previous experiments on
sheep ovaries (45–47). Alteration of the stromal structure
was associated with the lower developmental competence
exhibited by the primordial follicles of the CF group at the
end of the 7 day culture period. Because follicles were
cultured within small fragments of ovarian cortex a
structural damage of the stroma cannot be considered a
likely cause of this observation. Nor is the higher rate of
damaged blood vessels in the cortical region a probable
direct cause because in this experiment the cryoprotectant
was removed by rinsing the isolated fragments with culture
medium rather than through vascular perfusion. Two
observations indicate direct cellular damage as a more
plausible reason. In fact, ovaries frozen with CF displayed a
lower percentage of normal follicles as compared with DF
and CTR groups. These result are consistent with previous
studies that reported a signiﬁcant decrease in the
percentages of morphologically normal follicles in sheep
and cow whole ovaries frozen with CF (24, 46). We
observed a lower rate of cell proliferation in CF ovarian
fragments both at the beginning and at the end of the
culture period. This is certainly related to the higher rate of
DNA damage observed at the same time because
the presence of double-strand breaks into DNA triggers a
complex set of responses that includes cell cycle arrest.
Indeed, DNA damage in DF samples was higher than in
fresh controls, even if nodifferenceswere observed in the struc-
tural integrity between the two groups. However, upon culture
progression, DNA repair activity was evident in the DF sample,
leading to a substantial reduction of DNA damage, whereas
DNA repair activity was virtually absent in the CF samples,
leaving the rate of DNA damage substantially unchanged.
Evaluation of DNA damage and repair mechanisms allows a
more sensitive assessment of cellular damage as compared
with measuring apoptosis, which is an irreversible process
(48). In this case the high levels of Rad51 observed in DF sam-
ples after 7 days of culture allow us to see that the DNAdamage
observed on day 1 of culture was reversible. In fact, the forma-
tion of a Rad51–single-stranded DNA nucleoﬁlament is an
essential step that leads to DNA repair (49). The ability of DF
ovarian tissue to repair DNA damage is particularly relevant
for its long-term function after thawing because DNA
double-strand break repair efﬁciency has been identiﬁed as
an important determinant of oocyte aging in women (50).
In conclusion, this study indicates that DF allows good
preservation of whole ovaries, with most of the parameters
taken into consideration almost identical to those recorded
in fresh control samples. This encourages a reconsideration
of the possible use of whole ovary cryopreservation as a viable
alternative to cortical fragments.
However, it must be remembered that a high risk of
retransmission of malignancy exists if autotransplantation1129
ORIGINAL ARTICLE: REPRODUCTIVE SCIENCEof ovarian tissue were performed in women who have had
systemic hematologic malignancies (18, 20). In this respect
whole ovary cryopreservation cannot offer any
improvement in case of autotransplantation, but it could
provide some appealing alternative for the development of
methods aimed at grafting isolated follicles in an artiﬁcial
ovary or for the stimulation of primordial follicle growth
through ex vivo perfusion for future in vivo or in vitro use.REFERENCES
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study question: Does directional freezing improve the structural and functional integrity of ovarian fragments compared with conven-
tional slow freezing and to whole ovary cryopreservation?
summaryanswer: Compared with slow freezing, the use of directional freezing signiﬁcantly improves all structural and functional para-
meters of ovarian fragments assessed in vitro and, overall, whole ovaries were better preserved than ovarian fragments.
what is known already: Directional freezing has been developed to provide an alternative way to cryopreserve large biological
samples and it is known to improve the structural and functional integrity of whole ovaries. Conventional slow freezing of ovarian fragments is
the procedure more widely used in clinical settings but it causes substantial structural damage that limits the functional period after transfer
back into the patient.
study design, size, duration:Weperformeda2× 2 factorial designexperimentona total of 40 sheepovaries, divided into four groups
(n¼ 10ovariespergroup): (i)directional freezingofwholeovary (DFwo); (ii) directional freezingofovarian fragments (DFof); (iii) conventional freezingof
whole ovary (CFwo); (iv) conventional freezing of ovarian fragments (CFof). An additional eight ovaries were used as fresh controls.
participants/materials, setting, methods: Eweovarieswere randomlyassigned tooneof theexperimental groupsand frozen
accordingly. Upon thawing, ovarian tissuewas examinedmorphologically and cultured in vitro for 7 days. Sampleswere analyzed for cell proliferation and
apoptosis, for DNA damage and repair activity, and for the presence of a panel of heat shock proteins (HSPs) by immunohistochemistry.
main results and the role of chance: Most studied parameterswere signiﬁcantly improved (P, 0.05) in all samples cryopre-
servedwith directional comparedwith slow freezing.Theproportionof primordial follicles,whichdeveloped to theprimary stage inwholeovaries
(53+1.7%) and in ovarian fragments (44+ 1.8%) cryopreservedwith directional freezing,was greater thanwith slow frozenwhole ovaries (6+
0.5%, P ¼ 0.001) or fragments (32+ 1.5%, P ¼ 0.004). After 7 days of culture, cell proliferation in DFwo (28+0.73%) was the highest of all
groups (P, 0.05) followedbyDFof (23+0.81%),CFof (20+ 0.79%) andCFwo (9+0.85%).Directional freezing also resulted in a better pres-
ervationof the cell capacity to repairDNAdamage comparedwith slow freezing both inwhole ovaries and ovarian fragments. Apoptosis andHSP
protein levels were signiﬁcantly increased only in the CFwo group. Direct comparison demonstrated that, overall, DFwo had better parameters
than DFof and was no different from the fresh controls.
limitations, reasons for caution: The study is limited to an in vitro evaluation and uses sheep ovaries, which are smaller than
human ovaries and therefore may withstand the procedures better.
wider implications of thefindings: Improved integrity of ovarianmorphologymay translate to improvedoutcomes after trans-
plantation. Alternatively, the particularly good preservation of whole ovaries suggests they could provide a source of ovarian follicles for in vitro
culture in those cases when the presence of malignant cells poses a substantial risk for the patient.
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Introduction
A continuous improvement of cancer treatments is steadily increasing
the chances of survival in patients of all ages but this positive outcome,
at the same time, increases the challenges related to the patients’
quality of life. In young women this is often related to the maintenance
of fertility (Reinmuth et al., 2008) since theprobability of normal full-term
pregnancy is reduced to 30–50% in cancer survivors compared with the
corresponding healthy general population (Chung et al., 2013).
In particular, bone marrow transplantation (BMT), a common thera-
peutic procedure for several hematologic procedures, requires aggres-
sive chemotherapy and or radiotherapy, both of which are primary
causes of gonadal dysfunction and failure (Jadoul and Donnez, 2012).
The use of alkylating agents associated with abdominal ionizing radiation
in the range of 5–20 Gy will render infertile almost 100% of the patients
prepared for BMT (Anderson and Wallace, 2013; Donnez et al., 2013;
Wallace et al., 2005). The damaging effect will increase exponentially
from the age of 25 years and a model can predict with reasonable accur-
acy the ageofmenopausebasedon the radiationdoses and the age at the
time of treatment (Wallace et al., 2005). The model clearly shows that,
irrespective of the parameters applied, the risk of premature ovarian
failure is high.
All this brings an increasing demand for suitable treatments for fertility
preservation in female cancer patients which are strongly inﬂuenced by
the typeof cancer, the typeof treatment and ageat the timeof treatment.
Ovarian stimulation followed by oocyte or embryo banking is a possible
choice if it can be performed before initiation of cancer therapies, if the
tumor is not hormone sensitive, if the patient is sexually mature and if
there is a high risk that metastatic cells may have colonized the ovary
(Chung et al., 2013).
Ovarian tissue cryopreservation represents another alternative even if
it is still considered to be experimental by the American Society for Re-
productive Medicine. Indeed this approach may represent the only
option when dealing with pre-pubertal girls or with patients who
cannot delay the cancer treatment (Donnez and Dolmans, 2010,
2011; Grynberg et al., 2012; Silber, 2012; Donnez et al., 2013). It is pos-
sible to cryopreserve cortical strips or theentireorgan; however, todate,
ovarian cryopreservation and subsequent retransplantation in humans
has been limited to avascular cortical pieces (Demeestere et al., 2009;
Anderson and Wallace, 2011; Grynberg et al., 2012; Donnez et al.,
2013).
Current preference for the clinical use of avascular pieces of ovarian
cortex is based on several factors. The smaller size of tissue pieces in
comparison with the whole organ facilitates the adequate penetration
of the cryoprotectant crossing the stroma to reach granulosa cells and
oocytes (Hovatta, 2005). It also facilitates heat transfer during cooling
and warming which typically takes place by convection using slow-
programmable freezers (Grynberg et al., 2012; Donnez et al., 2013),
even if vitriﬁcation is beginning to be considered as a viable alternative
(Bordes et al., 2005; Keros et al., 2009). However, direct comparisons
between slow freezing and vitriﬁcation in human have produced conﬂict-
ing results (Gandolﬁ et al., 2006; Isachenko et al., 2009, 2010). Trans-
plantation of ovarian fragments either on the exposed medulla of the
contralateral ovary (Donnez et al., 2006) or in a peritoneal pocket
(Donnez et al., 2012) is technically easier than the vascular anastomosis
required for the transplantation of an entire ovary (Kim, 2010). Finally,
the cryopreservation of several fragments of the same ovary allows the
possibility to repeat the autotrasplantation procedure should the trans-
plantedpieces cease to function.At the same time theuseofovarian frag-
ments suffers from some limitations, the main one being the loss of over
50%of theprimordial follicles due to tissue ischemia that takesplace after
transplantation (Van Eyck et al., 2009; Van Eyck et al., 2010). This, to-
getherwith thedamages causedby cryopreservation, leads to a function-
al lifespan that, depending on the follicle density at the time of the
procedure, can vary, on average, from 2 to 5 years (Bromer and Patrizio,
2009; Donnez et al., 2013). In addition, since this procedure is largely
devoted to cancer patients, there is the real danger that the ovarian
tissue contains malignant cells posing a severe risk to the patient
(Meirow et al., 2008; Dolmans et al., 2010; Greve et al., 2012).
Transplantationof freshwholeovaryhas beenattemptedwith success
in human (Leporrier et al., 1987; Hilders et al., 2004; Silber et al., 2008)
and in several animal species (Bromer and Patrizio, 2009) demonstrating
that anastomosis of the ovarian pedicle is difﬁcult but feasible. However,
cryopreservation of the entire organ has proved more difﬁcult, largely
due to the physical constraints that limit an appropriate heat transfer
between the core and the periphery of the organ (Arav and Natan,
2009). In addition, the large volume of thewhole organ poses some limi-
tation to the perfusion and diffusion of cryoprotectants (Falcone and
Bedaiwy, 2005; Torre et al., 2013). Both are essential for preventing
intravascular ice formation which would irreversibly compromise a
rapid and efﬁcient resumption of the blood supply (Pegg, 2010). An efﬁ-
cient protocol for the cryopreservation and re-anastomosis of the entire
ovary could potentially reduce ischemic damage. However, data
obtained fromexperimentsmostly performed in sheep show someposi-
tive results (Grazul-Bilska et al., 2008) and pregnancies (Salle et al., 2002)
but also highlight stromal and vascular damage following either slow
freezing (Onions et al., 2009; Wallin et al., 2009) or vitriﬁcation (Salle
et al., 2003; Courbiere et al., 2006).
This has prompted the development of an alternativeway to cryopre-
serve large samples, such as whole ovaries, based on directional cooling
(Arav and Natan, 2009).
The technology for directional cooling is based on a series of heat con-
ductive blocks at set temperatures that are arranged in a line alongwhich
the sample proceeds at a pre-set velocity. The blocks have different tem-
peratures so that a gradient temperature can be imposed along the track.
The samples to be frozen are placed inside glass test tubes and moved
along the temperature gradient formed by the blocks. The freezing
rate is determined by the combination of temperature gradient and
speed of the sample along the track (Arav and Natan, 2012). If the vel-
ocity of the sample is slower than the speed at which the heat is
removed fromthe centerof the sample towards its periphery, heat trans-
fer is quickly removed in the direction opposite to that of the sample
movement, thanks to the large mass of the conductive material which
forms the blocks. All this results in a uniform cooling rate throughout
the sample (Gavish et al., 2008). This method has been used before
for the cryopreservation of sheep whole ovaries with good success
and maintenance of ovarian function for 6 years (Arav et al., 2005,
2010). However, the number of ovaries cryopreserved with this
method is limited and it has never been applied to ovarian fragments.
Tomove forward the cryopreservation of both avascular ovarian frag-
ments and of whole ovaries must improve (Donnez et al., 2013). There-
fore, the aim of the present study was to perform a direct comparison
between a convection-based programmable slow-freezer and the
multi-thermal-gradient apparatus for the cryopreservation of ovarian
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cortical strips and of whole ovaries. Based on our own results (Gandolﬁ
et al., 2006) and those in the literature (Shaw and Trounson, 2002; Arav
and Natan, 2009) all experiments were performed on sheep ovaries
owing to its similarity with the human ovary.
Materials andMethods
Unless otherwise indicated, chemicals were purchased from Sigma-Aldrich
(Italy).
Sheep female reproductive tracts were collected at the local slaughter-
house and transported to the laboratory in cold (0–48C) 0.9% saline
solution.
Eight ovaries were randomly assigned to fresh control group (CTR) and
10 to each experimental group. The experimental groups included the fol-
lowing: (1) directional freezing of whole ovary (DFwo); (2) directional freez-
ing of cortical tissue (DFof); (3) conventional freezing of whole ovary (CFwo)
and (4) conventional freezing of cortical tissue (CFof).
Sample preparation
Upon arrival to the laboratory, ovaries were randomly divided in three
groups, i.e. fresh controls, ovaries to be frozen as whole organs or as
ovarian fragments. Samples to be frozen as whole organs were perfused
via the ovarian artery with Ringer’s solution and 10 IU/l heparin for
10 min, followedbyperfusionwith cryoprotectant solution containing Leibo-
vitz L-15medium (Life Technologies, Italy), 10% fetal bovine serum (v/v; Life
Technologies, Italy) and 1.5 M dimethylsulfoxide for 10 min at a ﬂow rate of
1.3 ml/min (Grazul-Bilska et al., 2008) at room temperature.
Ovarian fragments (10 × 5 × 1 mm) were sliced from the cortical region
and immersed in the same cryoprotectant solution. Each ovary and all frag-
ments (8–10) from a single ovary were inserted into a 16 mm diameter
and 80 mm long glass test tube (Manara, Israel) containing 10 ml of the
same solution. The tube wall is 1 mm thick and made of quartz. Tubes
were closed with speciﬁcally designed silicon plugs. All samples were equili-
brated at +48C before the freezing process.
Conventional slow freezing
Conventional slow freezing was performed in a Kryo 560M apparatus
(Planer, UK) with the following program: (i) from 48 to 2408C using a
cooling rate of 0.58C/min (seeding was induced at 278C), (ii) from 2408
to 21008C at 58C/min and (iii) immersion in liquid nitrogen (Grazul-Bilska
et al., 2008).
Directional freezing
Directional freezing was performed with a Multi-Thermal-Gradient (MTG,
IMT Ltd., Ness Ziona, Israel). The three thermal blocks were set at 48,
2108 and 2708C, respectively, thereby imposing a temperature gradient
around the tubes. Freezing tubes were pushed lengthwise along the
thermal gradient and the speed was set at 0.01 mm/s resulting in a cooling
rate of 0.38C/min down to 2708C, after which samples were plunged
into liquid nitrogen (Arav et al., 2005, 2010).
Thawing
Samples were thawed by plunging the test tubes into a 688C water bath for
20 s and then into a378Cwaterbath for 2 min.The contentsof the tubewere
quickly emptied into a petri dish containing Leibovitz L-15 medium at 378C.
Whole ovaries were immediately perfused through the ovarian artery with
Leibovitz L-15 medium at 378C supplemented with decreasing sucrose con-
centrations (0.25, 0.125 and 0 M) at 3 ml/min for a total of 30 min (10 min
for each step; Jeremias et al., 2002; Bedaiwy et al., 2003).
Ovarian fragments were washed three times for 10 min each in Leibovitz
L-15 supplemented with the same sucrose concentrations (0.25, 0.125 and
0 M). Thematerial was then randomly allocated for further analysis. Each ex-
perimentwasperformedonaminimumof three independentbiological repli-
cates and all samples were blinded for analysis.
Follicle culture
The in vitro cultureof the thawed and fresh control sampleswasperformed as
previously described (Matos et al., 2007). Several ovarian fragments of2 ×
2 × 1 mm were derived from whole ovaries and isolated cortical pieces.
Three randomly selected fragments from each ovary were immediately
ﬁxed in 10% formaldehyde solution for histological studies (time 0,
control). Other randomly selected fragments were placed into 24-well
culture dishes (Sarstedt, Italy) and individually cultured in 1 ml of medium
for 7 days at 398C under an atmosphere of 5% CO2 in air. The culture
mediumwas composed ofa-MinimumEssential Medium (Life Technologies,
Italy) supplementedwith ITS (6.25 mg/ml insulin, 6.25 mg/ml transferrin and
6.25 ng/ml selenium; Life Technologies), 2 mM glutamine (Life Technolo-
gies, Italy), 0.23 mM pyruvate, 2 mM hypoxantine, 1.25 mg/ml bovine
serum albumin (BSA), 100 mg/ml penicillin G, 100 mg/ml streptomycin,
200 mIU/ml sheep FSH and 50 ng/ml human recombinant basic ﬁbroblast
growth factor (R&D Systems, Italy) (Matos et al., 2007). The medium was
replaced every 2 days.
Morphological analysis
Samples collected beforeor after cryopreservation and atDays 0 and 7of fol-
licle culturewere ﬁxedwith 10% formaldehyde, embedded in parafﬁn and the
sections either stained with hematoxylin and eosin or used for the terminal
deoxynucleotidyltransferase-mediated dUTP nick-end labeling (TUNEL)
assay or immunohistochemistry, as described below. Slides were observed
under anEclipse E600microscope (Nikon, Japan) andpictureswere acquired
with Nis Elements Software (Version 4.0). For each measure, a minimum of
four sections, 200 mm2 apart, from each sample were examined. Follicles
were classiﬁed as primordial (one layer of ﬂattened granulosa cells around
the oocyte), intermediate (one layer of ﬂattened to cuboidal granulosa
cells around the oocyte), primary (a single layer of cuboidal granulosa cells
around the oocyte) or secondary (oocyte surrounded by two or more
layers of cuboidal granulosa cells). Follicles were further classiﬁed as
normalwhena spherical oocytewith anon-pyknotic nucleuswas surrounded
by granulosa cells organized in discrete layers, or degenerated when a
mis-shapen oocyte, with or without vacuolation, with a pyknotic nucleus
was surroundedby disorganized granulosa cells detached from thebasement
membrane (Silva et al., 2004).
Immunohistochemistry
Sections were boiled for 5 min in antigen unmasking solutions (Vector La-
boratories, Italy) and then blocked with a solution of 1% BSA. Non-speciﬁc
sites were blocked with a solution of phosphate-buffered saline (PBS) con-
taining 5% BSA and 10% non-immune serum (Life Technologies). Samples
were incubated overnight at 48C with the following primary antibodies:
rabbit polyclonal antibody speciﬁc for the Ki67 marker of cell proliferation
(1:50 dilution; Abcam, UK); mouse monoclonal anti-gH2AX, a DNA-damage
marker (1:200; Abcam) and rabbit monoclonal anti-RAD51, a DNA-repair
marker (1:200; Santa Cruz) (Maffei et al., 2013). Sections were washed
three times with PBS and incubated with suitable secondary antibodies
(Alexaﬂuor; Life Technologies) for 45 min. Nuclei were stained with
4′,6-diamidino-2-phenylindole (DAPI). Blinded samples were observed
under an Eclipse E600 microscope (Nikon, Japan), pictures were acquired
with Nis Elements Software (Version 4.0) and the images were analyzed
using ImageJ software as described below.
116 Maffei et al.
 at B
IB
LIO
TECA
 FA
CO
LTA
' M
ED
ICIN
A
 V
ETERIN
A
RIA
 on January 8, 2014
http://hum
rep.oxfordjournals.org/
D
ow
nloaded from
 
TUNEL assay
To detect DNA fragmentation, sections were placed on silanized slides
(Bio-Optica, Italy) and apoptotic cellsweredetected by In situCellDeathDe-
tection Kit, TMR red (Roche, Italy) according to the manufacturer’s instruc-
tions. Positive controls were treated with DNAse I recombinant (50 U/mL;
Roche) in 50 mM Tris–Hcl, pH 7.5, 1 mg/ml BSA for 10 min at +258C
before DNA end labeling. For negative controls, TDT was omitted from
the reaction mixture. TUNEL-positive cells were calculated as cells per area
of ovarian tissue using the image analysis software ImageJ, as detailed below.
Cell proliferationandTUNELwereevaluatedpermm2 thereforeeverycell
type present in the examined area was considered.
Image analysis
Pictures were taken with constant exposure parameters in order to be ana-
lyzed with the image analysis software ImageJ (http://rsbweb.nih.gov/ij/
index.html). Threshold adjustments were applied to generate a black and
white image which was analyzed to quantify ﬂuorescent signal. In each
case, marker expression was normalized by DAPI ﬂuorescence.
Western blots
Ovarian fragments (2 mm3) derived from ﬁve experimental groups at
Days 0 and 7of culturewere homogenized individually, lysed and constitutive
proteins were extracted using ReadyPrep
TM
Protein Extraction Kit (Bio-Rad,
Italy). Protein concentration was assessedwith DC Protein Assay (Bio-Rad).
Aliquots of 50 mg proteins were prepared and resuspended in (1:1) 2×
Laemmli sample buffer (4% (w/v) sodium dodecyl sulfate (SDS), 10%
2-mercaptoethanol, 20% (w/v) glycerol, 0.004% bromophenol blue and
0.125 M Tris–HCl (pH 6.8). Samples were loaded and electrophoresed
on 8 or 10% SDS-polyacrylamide gels depending on the molecular weight
of the target molecule. Proteins were then transferred onto 0.45-mm pore
size nitrocellulose ﬁlters (Life Technologies) according to Towbin et al.
(1979) using 0.5 A/cm2. Equal sample loading and transfer efﬁciency were
conﬁrmed by staining of the membrane with Ponceau Red. The membrane
was probed with the primary antibodies listed in Table I, as described by
Pennarossa et al. (2012) and previously validated in sheep. Monoclonal
anti-b-actin was used as a loading control (data not shown). Protein bands
were visualized by Western Breezew chemiluminescent kit (Life Technolo-
gies, Italy).
Statistical analysis
All experiments were performed on a minimum of three independent bio-
logical replicates. Data are reported as mean+ SEM and analyzed using
one-way analysis of variance followed by Turkey’s post hoc tests (Statistical
Package for the Social Sciences 20, IBM). Differences were considered stat-
istically signiﬁcant if P, 0.05.
Results
All groups were compared with each other and with a fresh control,
shortly after thawing and after 7 days of in vitro culture.
In vitro follicle development
The percentage of follicle growth in each group, after 7 days of culture, is
shown in Fig. 1. Theproportionof primordial follicleswhichdeveloped to
the primary stage both in whole ovaries (53+ 1.7%) and in ovarian frag-
ments (44+ 1.8%) cryopreserved with directional freezing was signiﬁ-
cantly greater than with conventionally frozen whole ovaries (6+
0.5%, P ¼ 0.001) or fragments (32+ 1.5%, P ¼ 0.004).
Thepercentageof developing follicles inwholeovarieswashigher than
in ovarian fragments when frozen with directional freezing (P ¼ 0.005)
but lower when frozen with conventional freezing (P ¼ 0.001). Finally,
whole ovaries frozen with directional freezing had a rate of growing fol-
licles not signiﬁcantly different from fresh ovaries (55+1.9%, P ¼
0.106).
Morphological assessment of
cryopreservation damage
The percentage of morphologically normal follicles in each group imme-
diatelyafter thawing andcryoprotectant removal is shown inTable II. The
percentage of intact follicles was inversely related to the stage of devel-
opment, in all groups including fresh controls. There were more intact
follicles of all developmental stages following directional freezing when
compared with conventional freezing. Ovarian fragments showed a
higher rate of normal morphology compared with whole ovaries when
frozen with conventional freezing but the opposite was observed when
whole ovaries and ovarian fragments were preserved with directional
freezing. The percentage of morphologically normal follicles in the
DFwo group (89.93+ 4.10%) was not signiﬁcantly different from the
fresh control (92.54+4.36%).
Cell proliferation and apoptosis
Differences in developmental competence of primordial follicles were
consistent with differences in cell proliferation rate as examined by the
expression of Ki67. The percentage of proliferating cells was comparable
among the different groups at Day 0 (Fig. 2A). After 7 days of culture,
Ki67-positive cells in fresh tissue (30+ 0.78%) and in group DFwo
(28+0.73%) were the highest of all groups (P, 0.05). The rate of
cells expressing Ki67 in group DFof (23+ 0.81%) was signiﬁcantly
higher than those in group CFof (20+ 0.79%, P ¼ 0.03) and an
average of only 9+ 0.85% of Ki67-positive cells was found in group
CFwo (Fig. 2A).
TUNEL-positive cells were detected both atDays 0 and 7 of culture in
all experimental groups but apoptotic levels were not related to cell pro-
liferation. Immediately after thawing and the removal of the cryoprotect-
ant, the number of apoptotic cells per mm2 was low and comparable
among all groups. The TUNEL assay showed that the number of positive
cells after 7 days in culture was comparable for all experimental groups
........................................................................................
Table I List of antibodies used for western blot analysis
of proteins extracted from sheep ovaries.
Antibody Host
species
Company Catalog
number
WB
working
dilution
HSF1 Goat Santa Cruz
Biotech
sc-8061 1:1000
HSP40 Rabbit Abcam ab69402 1:10 000
HSP70 Mouse Abcam ab5439 1:5000
HSP90 Mouse Abcam ab13492 1:1000
b-Actin Mouse Sigma a5441 1:1000
HSF1, heat shock transcription factors 1; HSP40, heat shock protein 40; HSP70, heat
shock protein 70; HSP90, heat shock protein 90; WB, western blotting.
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exceptCFwo,wherea signiﬁcantly higher percentageofTUNEL-positive
cells was visible after 7 days (29.34+ 1.13, P ¼ 0.002) (Fig. 2B).
Expression level of heat shock-related
molecules
The effect on heat stress response after cryopreservation was examined
by quantitative analysis of HSP40, HSP70, HSP90 and HSF1 proteins at
the end of the warming and dilution/cryoprotectant removal steps and
after 7 days of culture. Changes were only detected in cortical tissue
from the conventionally cryopreserved whole ovaries after 7 days of
culture, where the protein levels were signiﬁcantly higher than on Day
0 (Fig. 3), indicating that conventional freezing applied to the whole
ovary induced the activation of proteins involved in stress-response
pathways. There were no differences within or between the other
groups (Fig. 3).
DNA damage and repair
The expression ofg-H2AX, amarker of DNAdamage, and of RAD51, a
marker of DNA repair are shown in Figs 4 and 5. Virtually no g-H2AXor
RAD51 signals were detected in fresh tissue. Clear signals of DNA
damage, in the form of g-H2AX foci, were observed in groups DFwo,
DFof and CFof at the beginning (Day 0) of culture, together with a
weak staining forDNA repair. After 7 daysDNAdamagewas signiﬁcant-
ly decreased while DNA repair activity increased, as indicated by a clear
RAD51 signal. Very strong staining for g-H2AX was observed in group
CFwo at Day 0 indicating widespread DNA damage but RAD51 labeling
was low at that time, suggesting a lack of DNA repair.
Figure 1 Functional assessment of sheep cortical fragments cultured in vitro for 7 days. Percentage (mean+ s.e.m.) of primordial follicles developed in
the primary stage after 7 days of culture. Values with different indices (a–d) are signiﬁcantly different (P, 0.05); one-way analysis of variance followed by
Turkey’s post hoc tests. CTR, control (n ¼ 280); DFwo, directional freezingwhole ovary (n ¼ 280); DFof, directional freezing ovarian fragments (n ¼ 260);
CFwo, conventional freezing whole ovary (n ¼ 230); CFof, conventional freezing ovarian fragments (n ¼ 250).
.............................................................................................................................................................................................
.............................................................................................................................................................................................
Table II Morphologically normal follicles.
Morphologically normal follicles (%)
Follicle type
Primordial Intermediate Primary Secondary All follicles
CTR 97.5+4.5a (n ¼ 600)* 91.2+4.34a (n ¼ 350)* 88.40+4.12a (n ¼ 300)* 71.5+4.44a (n ¼ 60)* 92.54+4.36a (n ¼ 1310)*
DFwo 94.8+4.15a (n ¼ 600)* 89.28+4.29a (n ¼ 350)* 85.23+3.95a (n ¼ 300)* 68.62+3.34a (n ¼ 60)* 89.93+4.10a (n ¼ 1310)*
DFof 88.7+4.12b (n ¼ 300)* 80.17+4.30b (n ¼ 150)* 72.91+3.68b (n ¼ 100)* 53.25+3.21b (n ¼ 20)* 82.24+4.82b (n ¼ 570)*
CFwo 78.4+3.97c (n ¼ 600)* 58.10+3.32c (n ¼ 350)* 43.5+3.21c (n ¼ 300)* 23.4+1.92c (n ¼ 60)* 62.46+3.52c (n ¼ 1310)*
CFof 84.40+4.03d (n ¼ 300)* 69.72+3.27d (n ¼ 150)* 64.20+3.34d (n ¼ 100)* 42.70+2.76d (n ¼ 20)* 75.53+3.52d (n ¼ 570)*
Percentage (mean+ s.e.m)ofmorphologically normal primordial, intermediate, primary and secondary follicles in fresh tissue (CTR) and inexperimental groups immediately after thawing.
DFwo, directional freezing of whole ovary; DFof, directional freezing of ovarian fragments; CFwo, conventional slow freezing of whole ovary; CFof, conventional slow freezing of ovarian
fragments.
*Number of evaluated follicles.
a,b,c,dDifferent superscripts in the same column indicate a signiﬁcant difference amongst experimental groups for the same follicle type as determined by one-way analysis of variance
followed by Turkey’s post hoc tests (P, 0.05).
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Discussion
Cryopreservation of ovarian tissue is now awell-established method for
preserving female fertility in a series of circumstances when gonadotoxic
treatments cannot be delayed or in patients before puberty (Grynberg
et al., 2012; Donnez et al., 2013). This can be achieved through the ex-
cision and banking of whole organs or of fragments of the cortical
region. However, whereas no live births or pregnancies have been
achieved following the cryopreservation of whole human ovaries, 24
live babies have been obtained after transplantation of frozen-thawed
ovarian fragments (Donnez et al., 2013). This clearly suggests that the
use of ovarian fragments is the method of choice even if, at present,
the average functional life span of these samples ranges from 2 to 5
years (Bromer and Patrizio, 2009; Donnez et al., 2013). In theory, the
cryopreservation of whole ovaries followed by the vascular anastomosis
of the ovarian pedicle of the thawedorgan should provide a larger follicu-
lar reserve and a longer life span of the transplant. However, currently
available data do not support this hypothesis. This is largely due to the
damage caused by the freezing procedures applied to a sample as large
as a human ovary. We have recently performed a direct comparison of
sheep ovarian tissue viability using whole ovaries cryopreserved with a
conventional programmable slow freezer or a directional freezing appar-
atus (Maffei et al., 2013).Our results indicated that ovarian structure and
function were signiﬁcantly better preserved by the directional freezer.
Therefore, it was of interest to determine whether directional freezing
could also improve the viability of ovarian fragments and how these
would compare with whole ovaries frozen with the same method.
In the present study, the morphological analysis of ovarian tissue im-
mediately after thawing showed that the useof directional freezing signiﬁ-
cantly improved the integrity of all follicular structure from primordial to
secondary stages. Since it is well known that the major cause of cellular
damage is intracellular ice formation (Mazur, 1977; Pegg, 2010), this ob-
servation suggests that the controlled direction of the ice front, fromone
end to the other of the samples, was effective in maintaining a precise
cooling rate thereby preventing the formation of intracellular ice. Al-
though the effect was evident in both whole organs and ovarian frag-
ments, it was more efﬁcient in whole organs since the rate of
morphologically intact follicles was not signiﬁcantly different from that
recorded in the fresh samples. Functional analysis of in vitro growth of
primordial follicles conﬁrmed the same pattern. Directional freezing
was beneﬁcial for both entire ovaries and ovarian fragments but DFwo
was the only group whose viability was the same as that of fresh tissue.
This result is somehow unexpected since cryopreservation efﬁciency is
inversely related to the size of the sample. Large biological samples, in
fact, suffer from a long isothermal period caused by the massive
release of latent heat during the process of ice formation (Balasubrama-
nian and Coger, 2005; Pegg, 2010). The phenomenon is caused by the
energy generated by water molecules when they rejoin to form an ice
crystal. Such energy is released in the formof heat that causes a tempera-
ture rise of the surrounding structures (Petersen et al., 2006). The heat is
normally transferred to the ice crystals that have just been formed
because these are made of conductive material. The consequence is a
transient thawing followed by refreezing in a sequence that is repeated
several times through the thickness of the sample causing severe cell
damage (Barratt et al., 1998; Koshimoto and Mazur, 2002). Damage is
usually reduced by keeping the ratio of surface to volume as high as
possible so that the excessive heat is removed by adjusting the cooling
rate to achieve uniform freezing. The thinner the sample the faster the
heat, released from its inner parts, is removed minimizing the damage.
However the need to have samples as thin as possible is in contrast with
the requirement of having a large follicle population upon thawing and it is
impossible when using low surface to volume ratio samples like whole
ovaries. The large mass of conductive material in the MTG apparatus
serves the purpose of quickly removing the latent heat from large samples
thereby preventing the thawing and freezing sequence (Gavish et al., 2008).
These considerations largely explain the better results of directional
freezing compared with conventional slow freezing described in our
experiments but cannot account for the better performance obtained
withwhole ovaries thanwith smaller ovarian fragments.Wehypothesize
that the different ways that the cryoprotectant was administered may
have a role. The presence of the ovarian pedicle in entire ovaries
enabled an extensive uniform perfusion through the vasculature
(Maffei et al., 2013). A study to compare outcomes of conventional to
directional freezing after vascular perfusion of cryoprotectants is
needed. In this study the ovarian fragments were directly immersed
into the cryoprotectant thus relying on diffusion. Our experiments
were performed in this way in order to mimic the different way
Figure2 Quantitative evaluationof Ki67 andTUNEL at the beginning
and the end of in vitro culture. Percentage (mean+ s.e.m) of immuno-
positive cells for Ki67 (A). Number of TUNEL-positive cells per mm2
(B). Values with different indices (a–e) are signiﬁcantly different
(P, 0.05); one-way analysis of variance followed by Turkey’s post hoc
tests; n ¼ 2630+ 340 nuclei counted for each section. CTR, fresh
tissue;DFwo, directional freezingwholeovary;Dfof, directional freezing
ovarian fragments; CFwo, conventional freezingwhole ovary;Cfof, con-
ventional freezing ovarian fragments.
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Figure3 Heat stress response after cryopreservation.Western blots and densitometric analysis of heat shock proteins in sheep ovarian proteins extract
from all experimental groups at Days 0 and 7 of culture. Values are expressed as mean+ s.e.m. of three replicates measured in arbitrary units. * P, 0.05
determinedwith one-way analysis of variance followed by Turkey’s post hoc tests; n ¼ 10 fragments (2 × 2 × 1 mm) for each replicate. HSP40, heat shock
protein 40; HSP70, heat shock protein 70; HSP90, heat shock protein 90; HSF1, heat shock transcription factor 1. CTR, fresh tissue; DFwo, directional
freezingwhole ovary;Dfof, directional freezing ovarian fragments; CFwo, conventional freezingwhole ovary; Cfof, conventional freezing ovarian fragments.
120 Maffei et al.
 at B
IB
LIO
TECA
 FA
CO
LTA
' M
ED
ICIN
A
 V
ETERIN
A
RIA
 on January 8, 2014
http://hum
rep.oxfordjournals.org/
D
ow
nloaded from
 
Figure 4 Representative pictures of cells positive for gamma H2A histone, member X (gH2AX, marker of double-strand DNA breaks, green) and
RAD51 recombinase (RAD51, marker of repair ability, red). Immunostaining was carried out at Days 0 and 7 of in vitro culture. CTR, fresh tissue;
DFwo, directional freezingwhole ovary; Dfof, directional freezing ovarian fragments; CFwo, conventional freezingwhole ovary; Cfof, conventional freezing
ovarian fragments. Scale bar ¼ 100 mm.
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samples would be treated in a clinical setting. Based upon our ﬁndings it
will be interesting to study the effect of cryoprotectant administration in
more detail.
Consistent with the favorable effect of directional freezing on primor-
dial follicle viability in vitro we observed a higher cell proliferation rate
compared with samples that underwent conventional freezing. In an
attempt to understand the mechanisms that may have caused this
effectwestudied known responses to temperature stress,which is inher-
ent to any form of cryopreservation.
One of the best characterized responses to thermal stress is the ex-
pression of HSPs (Rupik et al., 2011). HSPs bind to other proteins,
termed clients, which are damaged by thermal or other stress condi-
tions and mediate their transport to target organelles for repair or deg-
radation (Vabulas et al., 2010). They have also physiological roles and
are constitutively expressed in the absence of stress during many pro-
cesses including gametogenesis and embryogenesis (Hartl and Hayer-
Hartl, 2009).
We examined the expression of HSP70 because it is the most abun-
dant and the most highly conserved (Vabulas et al., 2010). This and
other members of the family act through repeated client-chaperone
binding and releasecycles sustainedbyATPhydrolysis andnucleotideex-
change reactions. Heat shock responses in vertebrates are regulated at
the transcriptional level by the heat shock transcription factor (HSF)
family composed of several members, with HSF1 regulating heat shock
gene expression inmammals (Fujimoto andNakai, 2010).When amam-
malian cell is exposed to thermal stress, HSF1 molecules present in the
cytoplasm as inactive monomers combine to form biologically active
trimers. These bind the heat shock response elements (HSEs), which
are present upstream of each heat shock gene and activate their tran-
scription (Fujimoto andNakai, 2010).Our results show that theHSPma-
chinerywas signiﬁcantly stimulatedover baseline levels only in the case of
conventional freezing ofwhole ovaries. This is consistentwith particular-
ly extensive protein damage in this group since the client-chaperone
binding and release cycles are repeated several times until the client
has reached its ﬁnal active conformation, or has entered the proteolytic
system (Kampinga and Craig, 2010). The presence of extensive cellular
damage in CFwo samples was conﬁrmed by the signiﬁcant increase in
apoptotic cells after 7 days of culture, consistent with the notion that
the accumulation of damaged or misfolded proteins, if unresolved, can
lead to caspase-8 oligomerization, activation and apoptosis (Pan et al.,
2011). However, protein damage is not the only cause of apoptosis as
it can also be activated by a failure of DNA repair mechanisms (Batista
et al., 2009). In fact the high levels of DNA damage associated with a
lack of DNA repair activity observed in CFwo samples is consistent
with the high apototic rate observed in the same group. This implies
that the amount of DNA damage taking place in cells of CFwo ovaries
is sufﬁcient to overwhelm their capability for DNA repair and lead to
their elimination through apoptosis.
Indeed the analysis of the dynamics of DNA repair mechanisms in
our different experimental groups enabled the identiﬁcation of different
levels of cellular damage and was more sensitive than measuring apop-
tosis, which is an irreversible process (Kale et al., 2012). We have
examined the expression of the histone variant gH2AX, the phos-
phorylated form of H2AX which is formed within minutes of DNA
damage (Yuan et al., 2010). The presence of g-H2AX at the foci
which form at DNA break sites attracts BRCA2 which, in turn, binds
to RAD51 and activates DNA repair (Huen and Chen, 2010). In con-
trast to HSPs, g-H2AX and RAD51 are not visible in the nuclei of intact
cells; therefore, it was possible to detect their increased expression in
our experimental samples. Results were consistent with the pattern of
follicular viability since DNA damage was signiﬁcantly lower in direc-
tional freezing samples followed by more intense DNA repair activity
suggesting that the DNA damage observed on Day 1 of culture was re-
versible. In fact, the formation of an Rad51-ssDNA nucleoﬁlament is an
essential step that leads to DNA repair (Seeber et al., 2013). The ability
of directional freezing to preserve the ability of ovarian tissue to repair
DNA damage is particularly relevant for its long-term function after
thawing since DNA double-strand break repair efﬁciency has been
identiﬁed as an important determinant of oocyte aging in women
(Titus et al., 2013).
In conclusion, this study indicated that directional freezing improves
the viability of cryopreserved ovarian tissue not only when used with
whole organs but alsowith ovarian fragments. This information provides
a way to further improve the efﬁciency of the cryopreservation proced-
ure. Thedirect comparisonof ovarian fragments andwhole organs unex-
pectedly revealed that the latter show better preservation of early
follicles, in many aspects almost identical to those recorded in fresh
control samples. However, the persistent technical difﬁculties linked to
the surgical procedures required for retransplantation is likely to still
Figure 5 Quantitative assessment of gH2AX and RAD51 by image
analysis.Values areexpressedasmean+ s.e.m.of three replicatesmea-
sured in arbitrary units. Different superscripts (a–g) indicate signiﬁcant
differences (P, 0.05) as determined with one-way analysis of variance
followed by Turkey’s post hoc tests. gH2AX, gamma H2A histone,
member X; CTR, fresh tissue; DFwo, directional freezing whole
ovary; Dfof, directional freezing ovarian fragments; CFwo, conventional
freezing whole ovary; Cfof, conventional freezing ovarian fragments.
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limit the use of whole ovaries in clinical settings. On the other hand, the
increasing concerns related to the danger of transferring malignant cells
with transplanted frozen–thawed ovarian tissue may lead to a re-
evaluation of the technique in terms of using whole ovaries as a source
of high-quality isolated follicles to be grown in artiﬁcial ovaries (Vanacker
et al., 2012) or other, yet to be described, methods.
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Parthenogenesis in non-rodent species: developmental competence
and differentiation plasticity
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Abstract
An oocyte can activate its developmental process without the intervention of the male counterpart. This form of reproduction, known as
parthenogenesis, occurs spontaneously in a variety of lower organisms, but not in mammals. However, it must be noted that mammalian oocytes
can be activated in vitro, mimicking the intracellular calcium wave induced by the spermatozoon at fertilization, which triggers cleavage
ivisions and embryonic development. The resultant parthenotes are not capable of developing to term and arrest their growth at different stages,
epending on the species. It is believed that this arrest is due to genomic imprinting, which causes the repression of genes normally expressed
y the paternal allele. Human parthenogenetic embryos have recently been proposed as an alternative, less controversial source of embryonic
tem cell lines, based on their inherent inability to form a new individual. However many aspects related to the biology of parthenogenetic
mbryos and parthenogenetically derived cell lines still need to be elucidated. Limited information is available in particular on the consequences
f the lack of centrioles and on the parthenote’s ability to assemble a new embryonic centrosome in the absence of the sperm centriole. Indeed,
n lower species, successful parthenogenesis largely depends upon the oocyte’s ability to regenerate complete and functional centrosomes in
he absence of the material supplied by a male gamete, while the control of this event appears to be less stringent in mammalian cells. In an
ttempt to better elucidate some of these aspects, parthenogenetic cell lines, recently derived in our laboratory, have been characterized for their
luripotency. In vitro and in vivo differentiation plasticity have been assessed, demonstrating the ability of these cells to differentiate into cell
ypes derived from the three germ layers. These results confirmed common features between uni- and bi-parental embryonic stem cells.
owever data obtained with parthenogenetic cells indicate the presence of an intrinsic deregulation of the mechanisms controlling proliferation
s. differentiation and suggest their uni-parental origin as a possible cause.
2012 Elsevier Inc. All rights reserved.
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Introduction
Cardiovascular disease (CVD) remains as the first cause of
death worldwide [1, 2]. It is known that a rising heart failure
incidence is associated with unhealthy life styles and in-
creasing life expectance. Current therapies are typically
symptomatic and, even though they provide some survival
benefit, they cannot reverse the loss of contractile cardiac
tissue due to ischemic injury. For this reason, high expect-
ances are associated to the recent developments in stem cell
biology and regenerative medicine that promise to replace
damaged or lost cardiac muscle with healthy tissue and thus
to improve the quality of life and survival in patients with
various cardiomyopathies [3].
The recent identification of different classes of cardiac
progenitor cells suggests that the heart, classically considered
a terminally differentiated, post-mitotic organ, may rather
contain a stem cell compartment, responsible for both tissue
turn-over and regeneration, which follows acute or chronic
damage to the cardiac tissue [4–6]. Several groups have
already reported the isolation of different types of cardiac
stem-like cells based on distinct cell surface markers, such
as c-kit, Isl-1 and Sca-1 [7–11] or the ability to generate
genuine cardiomyocytes and integrate into heart tissue as
induced pluripotent stem cells [12], or also in relation to their
capacity to influence the neovascularization of the ischemic
tissue, as satellite cells [13]. These cells are able to restore
cardiac function after ischemic injury, although with variable
efficiency [7, 14]. Another type of cells associated with
the heart was mesoangioblast, a class of vessel-associated
stem cells that can differentiate into various mesoderm cell
types. They were originally described in the mouse embryonic
dorsal aorta [15] and later similar cells have been identified
and characterized from postnatal small vessels of human
skeletal muscle [16] and mouse and human heart [4, 17].
However, the experiments carried out until now were
predominantly performed on mice and human. This restricts
significantly the possibility to apply the results obtained in
preclinical studies that cannot be performed using the hu-
man as a model and, at the same time, are limited by the
evident differences between mouse and humans, such as
their size, mice heart rate and their general anatomy [18,
19]. In particular, human and mouse hearts diverge in the
coronary architecture, the variations of which are much
bigger in humans compared to mice. As a consequence,
whereas the size and location of the ischemic area are fairly
constant in the mouse, a much larger variation exists in the
human [20]. Differences can also be appreciated at the
cellular level, as indicated by the higher capillary density
and the larger cross sectional area of the myocytes in hu-
man, in comparison to the mouse [21, 22]. Consequently,
extrapolation of murine systems, particularly after induction
of cardiovascular stress, must be meticulously monitored,
when applied clinically, because of the obvious differences
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Abstract Parthenotes have been proposed as a source of
embryonic stem cells but they lack the centriole which is
inherited through the sperm in all mammalian species, except
for rodents. We investigated the centrosome of parthenotes
and parthenogenetic embryonic stem cells using parthenoge-
netic and biparental pig pre-implantation embryos, human and
pig parthenogenetic and biparental embryonic stem cells,
sheep fibroblasts derived from post implantation parthenoge-
netic and biparental embryos developed in vivo. We also
determined the level of aneuploidy in parthenogenetic cells.
Oocytes of all species were activated using ionomycin and
6-dimethylaminopurine (6-DMAP). Over 60 % of partheno-
genetic blastomeres were affected by an excessive number of
centrioles. Centrosome amplification, was observed by micro-
scopical and ultrastructural analysis also in parthenogenetic
cell lines of all three species. Over expression of PLK2 and
down regulation of CCNF, respectively involved in the
stimulation and inhibition of centrosome duplication, were
present in all species. We also detected down regulation of
spindle assembly checkpoint components such as BUB1,
CENPE and MAD2. Centrosome amplification was accom-
panied by multipolar mitotic spindles and all cell lines were
affected by a high rate of aneuploidy. These observations
indicate a link between centrosome amplification and
the high incidence of aneuploidy and suggest that par-
thenogenetic stem cells may be a useful model to investigate
how aneuploidy can be compatible with cell proliferation and
differentiation.
Keywords Centrosome .Chromosome instability .Human .
Pig . Sheep . Parthenogenesis . Cell lines . Embryos . Foetus
Introduction
Mature oocytes can be activated in vitro leading to the gener-
ation of parthenotes that will form blastocysts morphological-
ly indistinguishable from those derived from fertilized eggs.
Parthenotes have been used as a source of embryonic stem
cells (ESC) in different species including mouse [1], rabbit [2,
3], pig [4] non-human primates [5] and human [6–11].
Parthenogenetic stem cells (ParthESC) show the tradi-
tional features associated with their biparental counterpart,
including expression of pluripotency markers, telomerase
activity, embryoid body formation, in vitro differentiation
and, in most cases, teratoma formation.
It has been suggested that the use of ParthESC for thera-
peutic applications may have some advantages. The main one
would be the reduced variability of the major histocompati-
bility alleles, due to their monoparental origin [12], which, in
turn, would greatly facilitate the matching between cell lines
and patients [13]. Moreover, parthenogenetic cell lines would
provide an exact match to the oocyte donor’s genome (both
nuclear and mitochondrial). The non embryonic nature of the
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Why is it so Diﬃcult to Derive Pluripotent Stem Cells in Domestic Ungulates?
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Content
Pluripotent stem cells are the focus of an extremely active ﬁeld
of investigation that is bringing new light on our understand-
ing of the mechanisms that control pluripotency and diﬀeren-
tiation. Rodent and primates are the only species where true,
or bona ﬁde, pluripotent stem cells have been derived. The
attempts to derive pluripotent stem cells from domestic
ungulates have been going on for more than 20 years with
little progress. Cell lines from these species present a series of
limitations that have precluded their use for both basic and
clinically oriented studies. However, in the last 3 years, some
substantial progress have been made making the currently
available ungulate pluripotent stem cells closest than ever
before to their human and mouse counterpart. This result has
been achieved through both conceptual and technical progress
that will be illustrated and discussed in this review.
Introduction
Organs counteract the physiological wear and tear
thanks to a small population of cells known as organ-
speciﬁc or adult stem cells. They are classiﬁed on the
basis of their potency that can span from unipotency
when only a single cell type can be generated to
multipotency when a stem cell can originate to all or
many cells of a single germ layer. When a stem cell can
originate, all cells from all three germ layers are deﬁned
as pluripotent. Pluripotency is limited to the epiblast, a
transient tissue that exists only for brief stage of
embryonic development; therefore, stable pluripotent
cells are not a physiological component of the body but
exist only in vitro (Smith 2001).
The translation of the knowledge on stem cell biology
into clinical applications is taking place at an increas-
ingly fast pace. The ease of such translation depends on
a delicate balance that includes the degree of plasticity
of the stem cell of interest, its physiological rate of
proliferation and its accessibility. As a result, clinical
applications of stem cells of say hematopoietic (Shepp-
ard et al. 2012) or epithelial (De Luca et al. 2006;
Pellegrini et al. 2009) origin are well advanced and in
many case have already entered the level of accepted
procedures, whereas the use of stem cells such as those
of muscle (Tedesco et al. 2010) or neuronal origin
(Lindvall and Kokaia 2010) are still far from a clinical
application both because their proliferation potential is
more limited and because they are not easy to access
especially those located in the central nervous system.
These limitations could be overcome by the use of
pluripotent stem cells that are attractive because easy to
propagate in vitro and therefore readily available.
An important step for the translation of basic
research into clinical applications is the use of animal
models that are intermediate between laboratory
rodents and humans. Domestic ungulates like ruminants
and pig have often been used for pre-clinical research
and their use in regenerative medicine could be beneﬁ-
cial as well.
However, whereas the derivation of organ-speciﬁc
stem cells has been successful (Spencer et al. 2011),
pluripotent stem cells have so far been diﬃcult to obtain
in these species.
True Embryonic Stem Cells
It is widely acknowledged that true, so-called bona ﬁde,
embryonic stem cells (ESC) can only be derived from
mouse (Evans and Kaufman 1981), human (Thomson
et al. 1998) and non-human primate embryos (Thomson
et al. 1995).
Cell lines derived from these species share some major
properties such as unlimited replication in vitro (self-
renewal), capacity to diﬀerentiate into any of the
diﬀerent tissues that make the body, expression of core
pluripotency factors such as OCT4, SOX2 and NANOG,
formation of teratomas if injected into immunodeﬁcient
mice.
However, in the years following the derivation of
primate ESC, it became progressively clear that they
present substantial diﬀerences when compared to mouse
ESC (mESC), even if they share the same deﬁnition of
ESC.
Diﬀerences begin in the culture dish where the
presence of LIF and BMP4 in the culture medium is
required to maintain the undiﬀerentiated state of pro-
liferating mouse ESC through the activation of the
JAK ⁄STAT3 pathway (Ying et al. 2003); however, the
stimulation of the same pathways in primate ESC leads
to a rapid diﬀerentiation (Xu et al. 2005). On the
contrary, primate ESC require the presence in the
culture medium of activin A and ⁄or basic ﬁbroblast
growth factor (bFGF or FGF2) and depend on the
activation of the activin ⁄Nodal pathway (Xu et al.
2008). Mouse ESC can be derived only from a small
number of ‘permissive’ strains, whereas primate ESC,
and human ESC in particular, show no limitations
related to a speciﬁc genetic background. Mouse and
primate ESC diﬀer also in their morphology. Small,
compact and domed colonies are typically formed by
mESC as opposed to primate ESC, which grow in
larger, ﬂat colonies. mESC colonies are propagated after
dissociation to single cells, but the same treatment
would rapidly kill primate ESC whose colonies need to
be detached from the feeder layer and fragmented
mechanically. In general, mESC grow more vigorously
and can easily adapt to clonal culture conditions
enabling the derivation of lines from single cells. This
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Huge amounts of work have been dedicated to the establish-
ment of embryonic stem cell lines from farm animal species
since the successful isolation of embryonic stem cells from the
mouse and from the human. However, no conclusive results
have been obtained so far, and validated lines have yet to be
established in domestic animals. Many limiting factors have
been suggested and need to be studied further to isolate truly
pluripotent cell lines from livestock. In this review, we will
discuss the diﬃculties in deriving and maintaining embryonic
stem cell lines from farm animal embryos and how can this
lack of success be explained. We will summarize results
obtained in our laboratory regarding derivation of pluripotent
cells in the pigs. Problems related to the identiﬁcation of
standard methods for derivation, maintenance and character-
ization of cell lines will also be examined. We will focus our
attention on the need for appropriate stemness-related marker
molecules that can be used to reliably investigate pluripotency
in domestic species. Finally, we will review data presently
available on functional key pluripotency-maintaining path-
ways in farm animals.
Introduction
The derivation of embryonic stem cells (ESCs) in farm
animal species could represent a great improvement in
developmental biology as well as applied biomedical
research. In particular, farm animal ESCs could pro-
vide a powerful tool for genetic engineering aimed at
improved production traits and products, for disease
resistance and for biopharming (Keefer et al. 2007).
These cells could also represent an excellent experimen-
tal model in pre-clinical trials, where the feasibility and
the clinical potential of stem cell therapies could be
studied. The close morphological and physiological
resemblance to humans could be greatly advantageous
for creation of biomedical models of human diseases and
cell transplantation therapies. Although huge amounts
of work have been dedicated to the establishment of
ESC lines from farm animals over the past 20 years, no
conclusive results have been obtained so far. Indeed,
although progress towards the derivation of ESCs from
porcine, bovine, caprine, ovine and equine species has
been made and despite the many peer-reviewed journal
articles describing ungulate ES or ES-like cell lines over
the past 20 years, validated lines have yet to be
established in farm animal species.
Why is it so diﬃcult to derive and maintain ESCs
from farm animal embryos? How can this lack of
success be explained? Several concomitant factors have
been suggested that hamper the process and still need to
be elucidated. In this review, we will discuss some of the
issues to be addressed and the hurdles to be overcome,
related to the identiﬁcation of standard methods for
the derivation, maintenance and characterization of cell
lines, the use of appropriate markers and elucidation of
functional key pluripotency-maintaining pathways
(Fig. 1). In particular, we will focus on the information
available for the pig, which is a desirable species to
create pluripotent cell lines, because of its striking
similarities in terms of anatomy, physiology, metabo-
lism and organ development with primates, and may
therefore represent an important pre-clinical model for
cell therapy approaches (Yang et al. 2000; Aleem Khan
et al. 2006; Brevini et al. 2007a; Keefer et al. 2007).
Timing of Derivation
The ﬁrst diﬀerentiation event in the mouse occurs at the
late morula stage, when cells forming the outer com-
partment adopt an epithelial fate and the ﬁrst two
lineages, trophectoderm and inner cell mass (ICM), can
be appreciated. Further diﬀerentiation of the ICM leads
to formation of the epiblast and the primitive endoderm.
In the interval between days 3.5 and 4.5, the hypoblast
begins its evolution towards the extra embryonic endo-
derm and the yolk sac, while the epiblast develops into
the embryo proper. The timing of this process is
diﬀerent in other species, and in particular, the interval
between fertilization and the formation of the three
early embryonic lineages is more protracted in porcine
and bovine embryos, where epiblast formation begins at
hatching and is complete towards day 12 (Vejlsted et al.
2005, 2006). This implies that no deﬁned epiblast is
present in these species before hatching. However, once
formed, it will persist until day 13, when the major part
of the epiblast diﬀerentiates into neural ectoderm and
forms the neural plate. This process is accompanied by a
gradual down-regulation of OCT4 and the onset of
beta-tubulin III expression, which is correlated with
neural diﬀerentiation, but, at the same time, indicates
that embryos at this stage are no longer suitable for ESC
derivation. Altogether, these observations indicate that
farm animal species have a longer interval during which
the epiblast is accessible and suggest that ICMs obtained
from farm animal pre-hatching blastocysts may not be
exactly equivalent to mouse epiblasts, usually isolated
for ESC derivation.
What is the optimal time for isolation and establish-
ment of porcine ESC lines? The available data are
controversial. Chen et al. (1999) showed that recently
hatched blastocysts had a higher success rate for
establishment of pig ES-like cell cultures when com-
pared with late-hatched blastocysts. Very poor out-
growth formation ability was detected in 5- to 6-day
embryos, whereas 10- to 11-day embryos led to estab-
lishment of ES-like cell lines (Hochereau-de Reviers and
Perreau 1993). Pluripotent epiblast cell cultures were
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ABSTRACT
Reduced oocyte competence causes the lower fertility
reported in domestic sows during the warm months of the year.
Somatic cells express heat shock proteins (HSPs) to protect
themselves from damage caused by thermal stress. HSPs are
classified as molecular chaperones and control the correct
folding of newly synthesized or damaged proteins. The present
work performed a comprehensive survey of the different
components of the heat shock chaperone machinery in the pig
ovary, which included the HSP40, HSP70, HSP90, and HSP110
families, as well as heat shock factors (HSF) 1 and 2. Pig ovarian
follicles constitutively expressed different members of these
families; therefore, we examined their ability to respond to heat
stress. In order to take into account the role of the complex
follicular architecture, whole pig ovaries were exposed to
41.58C for 1 h. This exposure significantly disrupted oocyte
maturation and determined the upregulation of the HSP70,
HSP40, HSPH1, HSPA4, HSPA4L, HSF1, and HFS2 genes,
whereas expression levels of HSP90A and HSP90B, as well as
those of genes unrelated to heat stress were not altered.
Unexpectedly HSP and HSF expression levels changed only in
oocytes but not in cumulus cells. Cumulus-oocyte complexes
isolated from ovaries collected in summer showed the same
pattern as those collected in winter. We conclude that the HSP
chaperone machinery is constitutively fully operational in the
pig ovary. However, following thermal stimuli or seasonal
variations, cumulus cell HS-related gene expression remains
unchanged, and only oocytes activate a response, suggesting
why this mechanism is insufficient to preserve their competence
both in vitro and in vivo.
cumulus cells, HSF1, HSF2, HSP110, HSP40, HSP70, HSP90,
oocyte, oocyte competence, ovary, seasonal infertility
INTRODUCTION
The domestic pig exhibits a period of depressed reproduc-
tive performance during late summer and early autumn months
[1–4]. This seasonal infertility is characterized by a reduction
in farrowing rate [4], an extended weaning-to-estrous interval
[5], and a delay in the onset of puberty [6]. All these
manifestations cause a considerable economic damage to the
swine industry.
It has been difficult to determine a specific cause for this
phenomenon because many different parameters are involved,
including heat stress, photoperiod, humidity, genetic back-
ground, and management [7]. A disruptive effect of heat stress
on the oocyte has been extensively described in the cow (e.g.,
see ref. [8]) and more recently in pig [2, 9]. However most cells
developed mechanisms based on the expression of heat shock
proteins (HSPs) to protect themselves from damage during
cellular stress [10].
HSPs are classified as molecular chaperones because they
bind to other proteins, named clients, which are damaged by
the stress conditions and mediate their transport to target
organelles for repair or degradation [11]. They are grouped in
six families of structurally unrelated molecules [12] whose
members also have physiological roles and are constitutively
expressed in the absence of stress in many processes including
gametogenesis and embryogenesis [13].
The HSP70 family (also known as HSPA) is found in all
eukaryotic cells and is the most abundant and most highly
conserved complex [11]. Members of this family act through
repeated client-chaperone binding and release cycles sustained
by ATP hydrolysis and nucleotide exchange reactions.
However HSP70s never work alone, rather they require at
least the presence of the two cofactors DnaJ protein (HSP40)
and nucleotide exchange factor (NEF) [14]. The DnaJ protein
facilitates client binding, stimulating ATPase activity, whereas
client dissociation is prompted by the ADP dissociation
stimulated by NEFs. Members of the HSP110 family, which
includes HSPA4, HSPA4L, and HASH1, are known NEFs that
remove ADP after ATP hydrolysis, enabling a new HSP70
interaction cycle with non-native protein substrate [15].
Another highly conserved and highly expressed HSP family
is HSP90, which in mammals, includes the two cytosolic
isoforms HSP90a and HSP90b [16]. Similar to HSP70, HSP90
proteins also exert their function in collaboration with a
number of cochaperones that regulate HSP90 activity in several
ways such as the recruitment of client proteins and the
regulation of the ATPase cycle [17].
Heat shock response in vertebrates is regulated at the
transcription level by the heat shock transcription factors
(HSFs) family, composed of several members, with HSF1
regulating heat shock gene expression in mammals [18]. When
a mammalian cell is exposed to heat stress, HSF1 molecules,
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Brief demethylation step allows the conversion of
adult human skin ﬁbroblasts into insulin-secreting cells
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The differentiated state of mature cells of adult organisms is
achieved andmaintained through the epigenetic regulation of gene
expression, which consists of several mechanisms including DNA
methylation. The advent of induced pluripotent stem cell technol-
ogy enabled the conversion of adult cells into any other cell type
passing through a stable pluripotency state. However, indeﬁnite
pluripotency is unphysiological, inherently labile, and makes cells
prone to culture-induced alterations. The direct conversion of one
cell type to another without an intermediate pluripotent stage is
also possible but, at present, requires the viral transfection of
appropriate transcription factors, limiting its therapeutic potential.
The aim of this study was to investigate whether it is possible to
achieve the direct conversion of an adult cell by exposing it to a
demethylating agent immediately followed by differentiating cul-
ture conditions. Adult human skin ﬁbroblasts were exposed for 18 h
to the DNA methyltransferase inhibitor 5-azacytidine, followed by
a three-step protocol for the induction of endocrine pancreatic dif-
ferentiation that lasted 36 d. At the end of this treatment, 35± 8.9%
ﬁbroblasts became pancreatic converted cells that acquired an epi-
thelialmorphology, produced insulin, and then released the hormone
in response to a physiological glucose challenge in vitro. Furthermore,
pancreatic converted cells were able to protect recipient mice against
streptozotocin-induced diabetes, restoring a physiological response
to glucose tolerance tests. This work shows that it is possible to con-
vert adult ﬁbroblasts into insulin-secreting cells, avoiding both a sta-
ble pluripotent stage and any transgenic modiﬁcation.
pancreatic beta cell | cell plasticity
Regenerative medicine requires new cells that can be delivered topatients for repairing and renovating degenerated or damaged
tissues (1). When such cells are not readily available, two main strat-
egies have been developed to obtain them: directed differentiation,
by which pluripotent cells, exposed to speciﬁc cell culture conditions
designed to mimic natural events, assume a speciﬁc cell fate, and
transdifferentiation, also referred to as reprogramming, which ena-
bles a fully differentiated cell type to be converted into another
without going through an undifferentiated pluripotent stage (2).
Induced pluripotent stem cell (iPSC) technology showed that
the stability of a mature phenotype can be overcome when trans-
forming a somatic cell of any patient in an unlimited source of
autologous pluripotent cells. The elimination of the immune re-
jection risk provided by iPSCs immediately boosted the clinical
potential of directed differentiation (3). However, the requirement
of permanent integration of viral vectors into the host genome to
generate iPSCs poses a severe limit to their current therapeutic use
(1). This has stimulated the development of several protocols for
a virus-free iPSC derivation, but at present, these approaches are
generally more technically demanding and less efﬁcient, and
therefore have not gained a widespread adoption (2). Similar lim-
itations apply to recent examples of successful transdifferentiation,
as the direct conversion of one mature cell type into another has
been obtained only with virus-based transfection protocols. As for
iPSC derivation, virus-free transdifferentiation protocols would be
highly desirable and are being actively pursued (4, 5).
The differentiated state of mature cells of adult organisms is
acquired through a gradual loss of differentiative potency (6),
leading to a progressive restriction in their options (7), and is
physiologically very stable. Differentiation is achieved and main-
tained through the epigenetic regulation of gene expression, which
consists of different mechanisms including DNA methylation,
histone modiﬁcation, nucleosome packaging and rearrangements,
higher-order chromatin structures, and the interplay between
chromatin and nuclear lamina (8). For this reason, the complete
reversal of this process requires extensive reprogramming that
makes it inefﬁcient and prone to errors (9).
We reasoned that part of the problem may derive from consid-
ering the achievement of a stable pluripotent state as an indispens-
able step, even if this does not occur during embryonic development,
where pluripotency is limited to a short window of time.
Among the different mechanisms involved in lineage speciﬁ-
cation and cellular reprogramming, DNA demethylation plays a
major role both during early embryonic development and during
somatic cell reprogramming (10). Therefore, we tested whether
a short exposure to a demethylating agent is sufﬁcient to allow the
direct conversion of an adult mature cell into another differen-
tiated cell type. To this purpose, we selected the cytidine analog
5-azacytidine (5-aza-CR), a well-characterized DNA methyl-
transferase inhibitor known to activate the expression of silent
genes (11) and to alter the differentiation state of embryonic (12)
and mesenchymal cell lines (13).
This approach would be useful for therapeutic applications only
if it can be applied to easily accessible primary cells; therefore, we
worked on adult dermal ﬁbroblasts that can be simply propagated
in vitro with a stable phenotype and that are little prone to genetic
instability. 5-aza-CR-treated skin ﬁbroblasts have been exposed to
an endoderm differentiation protocol, and we observed the efﬁ-
cient formation of pancreatic beta cell-like cells. We monitored
cell morphology and gene expression pattern (Table S1) during the
process and conﬁrmed that ﬁbroblasts were transiting along a brief
dedifferentiation state and were readdressed to the new cell line-
age. Pancreatic converted cells (PCCs) were shown to express early
and mature pancreatic lineage speciﬁc markers. A functional beta-
cell phenotype was validated by their intracellular production and
storage of insulin. Furthermore, exposure to glucose triggered
a dynamic response, inducing active insulin release in cell super-
natants. On transplantation into SCID, mice PCCs were able to
protect them against streptozotocin (STZ)-induced hyperglycemia.
Results
Fibroblasts obtained from skin biopsies formed a monolayer (Fig.
1A), displaying the vigorous growth in culture typical of this
cell population (doubling time, 18–24 h; Fig. S1A) and a stan-
dard elongated morphology. Uniform immunostaining with the
ﬁbroblast-speciﬁc marker vimentin (Fig. 1A) and total absence of
pluripotency or endoderm/pancreatic markers expression allowed
us to determine that we worked with homogeneous cell pop-
ulations (Fig. 2 and Figs. S2–S4).
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Reprogramming of Pig Dermal Fibroblast into Insulin
Secreting Cells by a Brief Exposure to 5-aza-cytidine
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Abstract Large animal models provide useful data for pre-
clinical research including regenerative medicine. However
whereas the derivation of tissue specific stem cells has been
successful. pluripotent stem cells so far have been difficult to
obtain in these species. A possible alternative could be direct
reprogramming but this has only been described in mouse and
human. We have recently described an alternative method for
reprogramming human somatic cells based on a brief demeth-
ylation step immediately followed by an induction protocol.
Aim of the present paper was to determine whether this
method is applicable to pig in the attempt to achieve cell
reprogramming in a large animal model for the first time.
Pig dermal fibroblasts were exposed to DNA methyltrans-
ferase inhibitor 5-aza-cytidine (5-aza-CR) for 18 h. After a
brief recovery period, fibroblast were subjected to a three-step
protocol for the induction of endocrine pancreatic differentia-
tion that was completed after 42 days. During the process pig
fibroblast rapidly lost their typical elongated form and gradu-
ally became organized in a reticular pattern that evolved into
distinct cell aggregates. After a brief expression of some
pluripotency genes, cells expression pattern mimicked the
transition from primitive endoderm to endocrine pancreas.
Not only converted cells expressed insulin but were able to
release it in response to a physiological glucose challenge
in vitro. Finally they were able to protect recipient mice
against streptozotocin-induced diabetes. This work shows,
that the conversion of a somatic cell into another, even if
belonging to a different germ layer, is possible also in pig.
Keywords Pre-clinical model . Epigenetic conversion .
Diabetes
Introduction
The use of animal models that are intermediate between labo-
ratory rodents and humans is an important step for translating
basic research into clinical applications [1]. Domestic ungulates
like ruminants and pig have often been used for several kind of
pre-clinical research and their use could be beneficial in regen-
erative medicine as well. However whereas the derivation of
organ specific stem cells has been successful [2, 3], pluripotent
stem cells have so far been difficult to obtain in these species.
Despite the first attempts to obtain embryonic stem cells
(ESC) in pig date back more than 20 years ago [4, 5] so far it
has been very difficult if not outright impossible to derive
bona fide embryonic stem cells [6–10]. In most cases what
have been defined as ES-like cell lines, showed several major
deficiencies ranging from short life in culture to lack of
controlled pluripotency or of true chimerism [10].
At present it is not clear whether the lack of ungulate ESC
is due to the lack of appropriate culture conditions or the
epiblast from these species is inherently different from that
of rodent and primates so that “suspending” it in vitro to
derive stable cell lines may not be possible [11].
A recent attempt showed promising results culturing day
10–12,5 elongated pig blastocysts in medium supplemented
with FGF2 instead of LIF [12]. The resulting cell lines showed
a robust self-renewal and the ability to differentiate into pre-
cursor cells derived from all three germ layer as well as into
trophectoderm and germ cell precursors. However, as for all
previous attempts neither chimera nor fully differentiated cell
types were obtained with these lines.
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